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Abstract
This thesis deals with the development of novel machine learning applications to
automatically detect brain disorders based on magnetic resonance imaging (MRI)
data, with a particular focus on Alzheimer’s disease and the autism spectrum dis-
order. Machine learning approaches are used extensively in neuroimaging studies
of brain disorders to investigate abnormalities in various brain regions. However,
there are many technical challenges in the analysis of neuroimaging data, for ex-
ample, high dimensionality, the limited amount of data, and high variance in that
data due to many confounding factors. These limitations make the development
of appropriate computational approaches more challenging. To deal with these
existing challenges, we target multiple machine learning approaches, including
supervised and semi-supervised learning, domain adaptation, and dimensionality
reduction methods.
In the current study, we aim to construct effective biomarkers with sufficient
sensitivity and specificity that can help physicians better understand the diseases
and make improved diagnoses or treatment choices. The main contributions
are 1) development of a novel biomarker for predicting Alzheimer’s disease in
mild cognitive impairment patients by integrating structural MRI data and
neuropsychological test results and 2) the development of a new computational
approach for predicting disease severity in autistic patients in agglomerative data
by automatically combining structural information obtained from different brain
regions.
In addition, we investigate various data-driven feature selection and classification
methods for whole brain, voxel-based classification analysis of structural MRI
and the use of semi-supervised learning approaches to predict Alzheimer’s disease.
We also analyze the relationship between disease-related structural changes and
cognitive states of patients with Alzheimer’s disease.
The positive results of this effort provide insights into how to construct better
biomarkers based on multisource data analysis of patient and healthy cohorts that
may enable early diagnosis of brain disorders, detection of brain abnormalities
and understanding effective processing in patient and healthy groups. Further,
the methodologies and basic principles presented in this thesis are not only suited
to the studied cases, but also are applicable to other similar problems.
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1 Introduction
1.1 Background and Motivation
The demand for brain research has increased over the past decades due to the
increasing prevalence of brain disorders and their growing economic impacts
(Gustavsson et al., 2011). Brain disorders, including developmental, psychiatric
and neurodegenerative diseases, are among the most serious health problems in our
society. The cause, diagnosis, and potential treatment of brain disorders require
careful study and a fundamental understanding of the human brain mechanisms.
Typically, neurological and psychiatric disorders are associated with anatomical
and functional abnormalities within the brain (Amaral et al., 2008; Honea et al.,
2005; Wang et al., 2015a); uncovering such abnormalities can lead to better
understanding of these diseases, their effects on the brain structure and function
as well as discovery of new methods for possible treatment or even prevention.
In the last few decades, neuroimaging techniques have become commonly used
tools for investigating structural and functional mechanisms of the brain, as well as
for discovering their associations with various brain disorders (Degenhardt et al.,
2016; Kelly et al., 2016; Slough et al., 2016). Such techniques are proving to be
extremely useful for both clinical and research purposes by providing the possibility
to visualize the brain structure and its functions in living subjects. Among the
different neuroimaging techniques, MRI is a widely used technique for visualizing
the inside of the brain due to its non-invasiveness and high spatial resolution
(Mosconi et al., 2007; Nielsen et al., 2013; Spencer et al., 2013). Structural MRI
technique is often used in clinical trials for medical diagnosis and disease detection
as well as determining the stage of a disease and treatment monitoring. In research
efforts, structural MRI is extensively used for studying and analyzing anatomical
abnormalities across the brain for different neurological and psychiatric disorders,
such as Alzheimer’s disease (Cuingnet et al., 2011; Misra et al., 2009), autism
spectrum disorder (Chen et al., 2011; Ecker et al., 2010a), and schizophrenia
(Shenton et al., 2001). However, discovering the complex disease effect on the
brain structure based on high dimensional MRI data is particularly a challenging
procedure, which makes the use of computer techniques essential in this field.
Currently, the use of computer techniques, particularly machine learning and
pattern recognition approaches, has become the focus of special interest in many
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neuroimaging studies (Khundrakpam et al., 2015; Misra et al., 2009; Sato et al.,
2013).
Statistical pattern recognition and machine learning (ML) approaches are a subfield
of computer science that is concerned with learning and discovering regularities or
patterns in data using statistical mathematics algorithms (Bishop, 2006). These
patterns can potentially be used to help understand more about a specific process
or used for predictive purposes. The use of such algorithms in neuroimaging data,
provides an opportunity to discover the particular functional or structural aspects
of the brain. This information may be extremely helpful for neuroscientists when
studying brain disorders and their effects on the brain structure and its functions.
Currently, the use of ML algorithms is of great interest in research trials when
developing biomarkers, which can provide early and more accurate diagnoses of
neurodegenerative disorders (Zhang et al., 2012). Biomarker can be defined as a
biological marker that responds to changes with the progression of the disease
(Strimbu and Tavel, 2010). In spite of significant efforts in this area, however,
there are still many technical challenges those often provide significant limitations
on the analysis of neuroimaging data. Thus, further research and advancements
in the field are needed to devise successful methodologies in order to identify
effective biomarkers that can be used, e.g., for diagnosis purposes or for predicting
disease progression in various brain disorders.
1.2 Objective of the Thesis
The objective of this thesis is to develop novel machine learning applications
that automatically predict brain disorders based on structural MRI data. For
this purpose, we consider two important brain disorders: Alzheimer’s disease
(AD) and autism spectrum disorder (ASD). The common aspect for these two
brain disorders is the changes in the brain structure due to the disease that are
hypothesized to be detectable using a structural MRI. Therefore, the current work
is divided into two parts to consider the ML-based applications for each disease
separately. More specifically, the objectives of this thesis are the following:
• Developing a more accurate biomarker for predicting Alzheimer’s disease in
mild cognitive impairment patients.
• Developing ML-based methods for investigating disease-related structural
abnormalities within the brain.
• Developing methods for an integrative analysis of structural MRI data
and neuropsychological test results/clinical information to improve the
predictability of these brain disorders, as well as for analyzing the relationship
between disease-related structural changes and the cognitive state of patients.
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• Devising methods to overcome the issues associated with multi-site, mul-
tiprotocol data and take advantage of the increased sample sizes provided
by such agglomerative data and better predict behavioral/disease outcomes
from reviewing brain imaging data.
This research work addresses the existing challenges associated with the use of
machine learning approaches in neuroimaging studies of brain diseases such as
high dimensionality, limited number of labeled data samples, and high variance
within data due to many confounding factors. For dealing with theses challenges,
we target multiple machine learning approaches including supervised and semi-
supervised learning, domain adaptation and dimensionality reduction methods.
This thesis consists of 5 publications. In Publication I, the issue related to the
limited number of labeled data samples was studied with semi-supervised learning
approaches. The integrative analysis of MRI data and neuropsychological test
results were investigated in Publications II & IV. The problem of high dimension-
ality of MRI data was studied in Publication III using different feature selection
approaches. Finally, in Publication V a new domain-adaptation-based predictive
model was developed to overcome the issues associated with multi-site data. In
particular, the main contributions of this thesis are the development of a novel
biomarker for predicting Alzheimer’s disease in mild cognitive impaired patients by
integrating structural MRI data and neuropsychological test results (Publication
II) and the development of a new computational approach for predicting disease
severity in autistic patients in agglomerative data by automatically combining
the structural information obtained from different brain regions (Publication V).
The results of the current work provide new insights for constructing better
biomarkers based on multisource data analysis of patients and healthy cohorts
that may enable early and more accurate diagnosis of brain disorders, detection
of brain abnormalities and discovery of new treatment opportunities.
1.3 Outline of the Thesis
This thesis is divided into 7 chapters that are organized as follows. Chapter 2
and 3 provide a description of AD and ASD, their effects on the brain structure
and brief overview of the previous work on the ML-based MRI studies of AD
and ASD, respectively. Chapter 4 introduces the methodology by describing an
overview of machine learning algorithms, including classification and regression
algorithms, supervised and semi-supervised methods, and different feature selection
and domain adaptation methods followed by model selection and performance
evaluation approaches. In Chapter 5, a brief description of magnetic resonance
image analysis approaches is provided. Chapter 6 summarizes the content of all
the Publications. Finally, Chapter 7 presents the conclusion.

2 MRI-based Machine
Learning for Alzheimer’s
Disease
This chapter begins by introducing the reader to Alzheimer’ disease (AD) and its
effects on the brain structure, followed by a brief description of machine learning-
based MRI study for Alzheimer’s disease. We also provide a brief review on the
use of supervised and semi-supervised approaches for predicting conversion to AD
in MCI patients. The purpose is to provide background information needed for
understanding the importance of the applications designed for this thesis as well
as introduce reader to certain previous studies relevant to this work.
2.1 Alzheimer’s Disease
Alzheimer’s disease (AD) is a common form of dementia that occurs most fre-
quently in the aged population. More than 30 million people worldwide suffer from
AD, and due to the increasing life expectancy, that number is expected to triple by
2050 (Barnes and Yaffe, 2011). Consequently, the economic burden of AD-related
health care will dramatically increase as well as more human suffering. AD is
caused by neurodegeneration that leads to memory deficits and problems in other
cognitive domains, producing a severe decline in the usual level of functioning.
Currently, there is no cure for AD, and even the cause of the disease is also poorly
understood (Weiner et al., 2013).
AD-related changes within the brain typically progress slowly over 10 to 20 years
(Morris, 2004). The initial AD pathology occurs in the brain while the patient is
still cognitively normal. When the first symptoms of AD appear, AD pathology
has likely already started several years ago and caused structural and functional
abnormalities within the brain. The first symptoms of AD, such as a mild memory
decline, are often confused with normal aging problems. However, as the disease
progresses, memory loss and problems with mental activities become serious
enough to be noticed. If these memory problems are not enough to interfere with
the patient’s daily life, the condition is considered to be mild cognitive impairment
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(MCI) (Markesbery, 2010).
Mild cognitive impairment is a transitional stage between age-related cognitive
decline and AD, and the earliest clinically detectable stage of progression toward
actual dementia or AD (Markesbery, 2010). According to the previous studies
(Petersen et al., 2009), a significant proportion of MCI patients, approximately
10% to 15% from referral sources like memory clinics and AD centers, will develop
into AD annually. Although the majority of these MCI patients will remain
stable or even improve, the AD typically starts with a MCI stage. However, the
mechanism that puts an MCI subject at greater risk for developing AD is not yet
clear.
Currently, the diagnosis of AD is via a clinical and neuropsychological examination
that provides only a diagnosis of probable AD (McKhann et al., 2011). Certain
diagnosis of AD is possible only through post-mortem microscopic examination of
the brain tissue derived from autopsy (Dubois et al., 2007). Due to uncertainty
in the diagnosis as well as the long-term progression of the disease, investigation
of AD is difficult, especially in the initial stages of the disease. Recent research
has focused on the early diagnosis of AD by developing biomarkers for identifying
those MCI patients who will develop AD (Misra et al., 2009; Ye et al., 2012;
Zhang et al., 2012). Developing more accurate biomarkers for predicting AD is of
great interest for providing an early diagnosis and disease monitoring, as well as
for drug discovery purposes. Effective biomarkers with sufficient sensitivity and
specificity can help physicians understand more about the disease and thus make
improved diagnosis and/or treatment choices.
2.2 Alzheimer’s Disease and the Brain
The human brain is the most complex organ in the body and it is the center of a
nervous system that consists of three major parts – the cerebrum, the cerebellum
and the brainstem. The cerebrum is the largest and the main part of the brain
and involves in complex brain functions, such as remembering, problem-solving,
thinking, and moving. The outer layer of the cerebrum, called the cerebral cortex,
consists of two hemispheres, each of which is divided into four lobes - the frontal
lobe, the parietal lobe, the occipital lobe, and the temporal lobe. The cerebral
cortex is composed of gray matter, consisting mainly of neuronal cell bodies.
Pathological changes associated with the development of AD cause synaptic loss
and neuronal death, which leads to significant volume reduction in the cerebral
hemispheres. Consequently, the brain shrinks, and the fluid-filled ventricles within
the brain enlarge. Fig. 2.1 shows that shrinkage in the brain and hippocampus and
the enlargement of the ventricles. The major underlying mechanism of Alzheimer’s
disease is associated with the accumulation of intracellular neurofibrillary tangles
composed of tau amyloid fibrils and extracellular β-amyloid plaques that lead to
neuronal death in the brain (Hardy, 2006). Commonly, neurofibrillary tangles
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Figure 2.1: A crosswise slice through the middle of the brain between the ears. (Left)
an overall shrinkage of the brain tissue. (Right) The shrinkage on the hippocampus and
the enlargement on the ventricles are marked with cycles. The cross section on the left
represents a healthy brain, and the one on the right represents a brain with Alzheimer’s
disease. From (Alzheimer’s Association, 2011).
and β-amyloid plaques do occur in the brain of non-demented individuals with
increasing age (Price and Morris, 1999). In AD patients, however, the formation
of tangles within the brain accelerates and causes a series of pathological changes
and loss of nerve cells (Mosconi et al., 2007). Deposition of these neurofibrillary
tangles start at the entorhinal cortex and hippocampus in the medial temporal
lobe and spread into the adjacent inferior temporal and posterior cingulate cortex
and then into the rest of neocortex and associated areas (Petrella et al., 2003).
The brain regions affected by AD at different stages are illustrated in Fig. 2.2.
Figure 2.2: Different stages of Alzheimer’s disease. From left to right show very early,
mild to moderate and severe. The blue-shaded areas show regions affected by AD. From
(Alzheimer’s Association, 2011)
The progress of AD pathology can differ considerably in different individuals
depending on many factors, such as age at diagnosis, the patient health conditions
and family support. In the early stage, brain regions corresponding to thinking,
planning, learning, and memory are damaged. As the disease progresses, the
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damage spreads further in the brain to the areas corresponding to language,
reasoning, sensory processing, and conscious thought. In Advanced AD, most
parts of the brain are damaged, and due to widespread cell death, the volume of
the brain significantly reduces. The severe AD patient is not able to communicate,
recognize family, and any care. Patients in this stage may also suffer from
immobility and have trouble swallowing that can finally lead to a coma and death
(Alzheimer’s Association, 2010).
According to previous studies, the progression of neuropathology in AD can be
observed many years before the clinical symptoms of the disease appear (Braak
and Braak, 1996; Delacourte et al., 1999; Morris et al., 1996; Mosconi et al., 2007;
Serrano-Pozo et al., 2011). Therefore, AD pathology has to be hypothesized to
be detectable using different neuroimaging techniques (Markesbery, 2010), such
as FDG-PET, and MRI. Among the different neuroimaging modalities, MRI
has attracted a significant interest in AD-related studies. Typically, Alzheimer’s
disease causes significant structural damages and neuronal death in the brain,
which can be detected as a volume reduction of brain tissue using a structural
MRI. For instance, the atrophy of the cerebral cortex that plays a significant role
in memory, thought, and language, can be detected by MRI as reduced tissue
volume in AD (Petrella et al., 2003). Over recent years, numerous MRI biomarkers
have been proposed for classifying AD patients at different disease stages (Chupin
et al., 2009; Coupé et al., 2015; Eskildsen et al., 2013; Gaser et al., 2013; Guerrero
et al., 2014; Wang et al., 2014), and these demonstrate the important role of
this neuroimaging technique in studying and diagnosing Alzheimer’s disease and
investigating AD-related structural brain abnormalities.
2.3 Literature Review of MRI-based Machine
Learning for AD
Machine learning approaches have gained increasing interest over recent years in
the neuroimaging investigation of Alzheimer’s disease, understanding AD-related
pathology and for providing early and more accurate AD diagnosis opportunities.
The use of machine learning methods offers investigators a powerful tool for ana-
lyzing complex data and makes it possible to utilize large amounts of neuroimaging
and clinical data recently made available by initiatives, such as the Alzheimer’s
Disease Neuroimaging Initiative (ADNI). Most of the recent ML-based AD related
studies have been performed on neuroimaging data, including FDG-PET (Gray
et al., 2012; Matsunari et al., 2014), MRI (Bron et al., 2015; Coupé et al., 2015;
Eskildsen et al., 2013; Gaser et al., 2013) as well as cerebrospinal fluid (CSF)
(Dyrba et al., 2015; Zhang et al., 2011) biomarkers for early detection of AD in
MCI patients by discriminating between progressive MCI patients (pMCI) and
stable MCI patients (sMCI).
A huge number of studies have focused on predicting conversion to AD in MCI
2.3. Literature Review of MRI-based Machine Learning for AD 9
Table 2.1: Semi-supervised classification of AD using the ADNI database.
Author Data Task Results Results
(supervised) (semi-supervised)
Ye et al. (2011) MRI sMCI vs. pMCI AUC= 71%, AUC = 73%
53 AD, 63 NC ACC= 53.3% ACC = 56.1%
237MCI SEN= 88.2% SEN = 94.1%
SPE= 42% SPE = 40.8%
Filipovych et al. (2011) MRI sMCI vs. pMCI AUC= 61%, AUC = 69%
54 AD, 63 NC SEN= 78.8% SEN = 79.4%
242MCI SPE= 51% SPE = 51.7%
Zhang and Shen (2011) MRI, PET, CSF AD vs. NC AUC= 94.6%, AUC = 98.5%
51 AD, 52 NC
99 MCI
Batmanghelich et al. (2011) MRI sMCI vs. pMCI AUC= 61.5%, AUC = 68%
54 AD, 53 NC
238 MCI
patients based on different neuroimaging data. Here we concentrate on previous
studies that are relevant to our research work. We use both supervised and semi-
supervised approaches (Publications I and II) for predicting AD, as well as studying
the integrative analysis of the MRI biomarker with cognitive measures (CM)
(Publications II and IV). Therefore, here we provide a few semi-supervised learnings
for a neuroimaging-based study of AD and some MRI-based and multimodal
neuroimaging studies for AD conversion prediction.
Typically, ML-based neuroimaging studies used for predicting the conversion to
AD in MCI patients are based on supervised learning approaches, where only
labeled data samples (sMCI and pMCI) are used to learn the model (Gaser et al.,
2013; Zhang et al., 2012). In contrast, semi-supervised learning (SSL) approaches
are able to use unlabeled data in conjunction with labeled data in a learning
procedure that improves classification performance. The use of these techniques
for predicting the conversion to AD in MCI patients is of great interest, since for
the labeled data (sMCI and pMCI) MCI subjects have to be followed for several
years after their first visit (data acquisition time) to obtain a sufficiently reliable
disease label (pMCI or sMCI). , while collecting MCI subjects’ data without a
final diagnosis is a much easier process. More recently, a few studies have utilized
semi-supervised learning algorithms for either the classification of AD patients
from healthy subjects (Zhang et al., 2011) or predicting conversion to AD in MCI
patients (Batmanghelich et al., 2011; Filipovych et al., 2011; Ye et al., 2011).
Table 2.1 provides a few studies that have investigated the use of different semi-
supervised approaches for the diagnosis of AD at different stages of the disease.
In Zhang and Shen (2011), MCI subject data were used as unlabeled data to
improve the classification performance when discriminating between AD and NC
subjects, and achieved a significant improvement, as the AUC score increased
from 0.95 to 0.985, which is high for discriminating AD vs. NC subjects. Ye et al.
(2011), Filipovych et al. (2011) and Batmanghelich et al. (2011) used AD and NC
subjects as the labeled data and MCI subjects as the unlabeled data and predicted
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disease-labels for the MCI subjects. In all of these studies, the improvement in the
predictive performance of the model was significant over the supervised learning.
In Table 2.2, some of supervised neuroimaging studies for the classification of pMCI
vs. sMCI are provided. These studies are based on either a single neuroimaging
modality, or they are multimodal-based studies that integrated imaging data from
multiple sources with demographic and cognitive information. These studies are
all based on the ADNI database; however, the criteria used for classification of the
subjects into stable or progressive MCI differed across the studies, which makes a
comparison between the studies difficult.
The use of MRI data for predicting a conversion to AD in MCI patients was
investigated, e.g., in Misra et al. (2009), Eskildsen et al. (2013) and Gaser
et al. (2013). They achieved high predictive performance (AUC > 0.75) for the
classification of sMCI vs. pMCI. However, in the study by Misra et al. (2009),
the dataset was small compared to the existing studies, which makes difficult
its comparison with other studies. Gaser et al. (2013) developed new framework
(BrainAGE) based on MRI data for estimating subjects’ ages; further, according
to differences between actual and estimated age, the subjects were classified into
pMCI or sMCI categories. They also showed that BrainAGE outperformed all
cognitive measures and CSF biomarkers in predicting conversion of MCI to AD
within 3 years of follow-up. Eskildsen et al. (2013) also investigated the predictive
performance of the MRI biomarker in MCI subjects by dividing pMCI subjects
into different groups, i.e., pMCI12, pMCI24 and pMCI36, and then they evaluated
the performance of the MRI biomarker in each group separately. In another
study by Davatzikos et al. (2011), the MRI were examined together with the CSF
biomarkers. In this study, the researchers developed a new framework, called
SPARE-AD for summarizing the brain atrophy patterns. The SPARE-AD score
was higher in pMCI subjects compared to the sMCI subjects. The atrophy in gray
matter and white matter of the temporal lobe, posterior cingulate/precuneous,
and insula with more AD-like CSF measure were also reported in the pMCI
patients. For the classification of pMCI vs. sMCI subjects, they achieved a
predictive accuracy of 0.56, using only MRI data and 0.62 when combining MRI
with the CSF measures.
In a different study by Zhang et al. (2012), a combination of MRI, PET, and
CM (i.e., MMSE and ADAS-Cog) was used for AD conversion prediction in MCI
subjects. They used both baseline and longitudinal data, i.e., data acquired at
different time points, for each modality. The longitudinal data were used mainly
for selecting the brain regions mostly affected by AD, by applying the sparse
linear regression for each modality. After selecting the best discriminative regions
based on longitudinal data, a multi-kernel SVM was applied on a combination of
all the features, from the different modalities. They used 88 ADNI MCI subjects
(38 pMCI and 50 sMCI) at 5 different time points and reported an AUC of 77%,
an ACC of 78%, a SEN of 79%, and a SPE of 78% to discriminate pMCI from
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Table 2.2: Supervised classification of AD conversion prediction using the ADNI
database.
Author Data Validation Results Conversion
scheme time
Misra et al. (2009) MRI LOOCV AUC= 77%, 0-36 months
27 pMCI, 76 sMCI ACC= 75%-80%
Ye et al. (2012) MRI, CM, Genetics LOOCV AUC= 86%, 0-48 months
142 pMCI, 177 sMCI
Davatzikos et al. (2011) MRI, CSF K-fold CV AUC= 73%, 0-36 months
69 pMCI, 170 sMCI Max ACC = 62%
Gaser et al. (2013) MRI, age Independent AUC= 78%, 0-36 months
133 pMCI, 62 sMCI test set
Eskildsen et al. (2013) MRI, age LOOCV AUC: 0-48 months
161 pMCI, 227 sMCI pMCI6 vs. sMCI= 81%,
pMCI12 vs. sMCI=76%,
pMCI24 vs. sMCI=71%,
pMCI36 vs. sMCI=64%
Zhang et al. (2012) MRI, PET, CM LOOCV AUC= 77%, 0-24 months
38 pMCI, 50 sMCI ACC= 78%
SEN = 79%,
SPE = 78%
Casanova et al. (2013) only CM LOOCV ACC= 65%, 0-36 months
188 NC, 171 AD SEN = 58%
153 pMCI, 182sMCI SPE = 70%
only MRI (GM) ACC = 62%,
SEN = 46%,
SPE = 76%
Yu et al. (2014) MRI, PET K-fold CV ACC= 67% 0-18 months
167 pMCI, 226 sMCI LOOCV SEN = 68%
SPE = 67%
Tong and Gao (2015) MRI K-fold CV AUC= 81% 0-36 months
229 NC, 191 AD ACC = 76%
164 pMCI, 100 sMCI SEN = 84%
134 uMCI SPE = 64%
Retico et al. (2015) MRI K-fold CV AUC = 71% 0-24 months
189 NC, 144 AD
166 sMCI, 136 pMCI
Liu et al. (2015) MRI K-fold CV ACC = 81% 0-18 months
128 NC, 97 AD SEN = 86%
117 pMCI, 117 sMCI SPE = 78%
Liu et al. (2016) MRI K-fold CV AUC = 83% 0-24 months
128 NC, 97 AD ACC = 79%
117 pMCI, 117 sMCI SEN = 88%
SPE = 76%
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sMCI patients.
Moreover, the combination of the MRI with cognitive measurements and clinical
information for AD conversion prediction in MCI patients was also considered
in several studies (Casanova et al., 2013; Ye et al., 2012). For instance, Ye et al.
(2012) applied sparse logistic regression with stability selection for integrating
and selecting potential predictors within different data types, including standard
cognitive measurements, APOE genotyping, and volumes of certain regions of
interest. They achieved a high predictive performance (AUC = 86%) for the
classification of sMCI and pMCI subjects in a relatively large group of MCI
subjects (177 sMCI and 142 pMCI).
Apart from these neuroimaging studies of AD that focused on the classification of
MCI subjects into pMCI and sMCI categories, more recently, new approaches have
been proposed for investigating the associations between disease-related structural
changes and the cognitive state of the patients using regression ML algorithms.
For example, the relationship between AD-related structural abnormalities and
various cognitive measures of dementia, including the Mattis Dementia Rating
Scale (DRS), Alzheimer’s Disease Assessment Scale-cognitive subtest (ADAS-Cog),
Minimental state examination (MMSE) and the RAVLT-Percent Retention, was
previously studied by Stonnington et al. (2010). They estimated these measures
based on gray matter density by using the relevance vector regression approach.
They showed that predicted and actual clinical scores were highly correlated
for the MMSE, DRS, and ADAScog tests. Moreover, they reported a higher
correlation of DRS, MMSE, and ADAS-Cog than RAVLT with whole brain gray
matter changes associated with AD. In Publication IV, we also investigated the
association between AD-related structural atrophy and RAVLT cognitive measure
by using the elastic-net linear regression approach.
In summary, the existing ML-based neuroimaging studies of AD show promising
results and demonstrate the potential role of these approaches for developing
effective biomarkers that can provide an early and more accurate diagnosis of
Alzheimer’s disease.
3 MRI-based Machine
Learning for Autism
In this chapter, the autism spectrum disorder and its effects on brain structure is
described. We also provide a brief review of the use of supervised approaches for
the classification of ASD from typically developing subjects in both single site and
multi-site studies. This chapter provides the background information required
for understanding the importance of the application designed and discussed in
Publication V, as well as introducing the reader to the previous studies relevant
to this work.
3.1 Autism Spectrum Disorder
Autism spectrum disorder (ASD) is a highly heterogeneous neurodevelopmental
disorder characterized by impairments in social interactions, developmental lan-
guage and communication skills combined with repetitive patterns of behavior
and restricted activities (Gillberg, 1993; Lord and Jones, 2012; Wing, 1997). The
severity and the range of symptoms in ASD can vary widely (Georgiades et al.,
2013; Kim et al., 2016), and due to this condition, it is thought of as a spectrum
disorder. ASD affects approximately 1% of children and nearly five times more
boys than girls (Kim et al., 2011). Over recent decades, a dramatic increase has
been reported in the prevalence of ASD due to various factors. Although the core
reasons are unclear, some factors such as increased awareness and media coverage,
broadening of the ASD diagnostic criteria and decreasing the age of diagnosis are
considered important factors (Gagnon, 2013; Levy et al., 2009; Neggers, 2014).
ASD is known as a highly genetic and multifactorial disorder with various neuro-
logical, environmental, and genetic factors acting together (Devlin and Scherer,
2012; Jeste and Geschwind, 2014; Levy et al., 2009). While the exact cause of
ASD remains unknown, the involvement of certain genes, inherited through the
parents, has been reported to make an individual more vulnerable to developing
ASD (Hughes, 2008; Jeste and Geschwind, 2014). ASD is usually diagnosed in
early childhood. The initial symptoms typically appear in the first two years
or so of life (Dawson et al., 2009; Ozonoff et al., 2008; Wiggins et al., 2015;
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Zwaigenbaum et al., 2013). The most common initial symptoms of ASD are
non-verbal communication and difficulty in social interaction that lead to its
diagnosis. Currently, there is no effective medical test for a certain diagnosis of
autism. Instead, the diagnosis is only based on specific behavioral evaluations
(Johnson et al., 2007). In particular, for diagnosis of ASD, the main current
assessment tools are the Autism Diagnostic Interview–Revised (ADI-R) (Lord
et al., 1994) and the Autism Diagnostic Observation Schedule (ADOS) (Ecker
et al., 2015; Lord et al., 1989). The ADI-R is a semi-standardized interview used
for measuring reciprocal social interaction, communication and language, and
restricted and stereotyped interests and behavior, and it is suited for individuals
with a mental age of at least 18 months. The ADOS is also a semi-structured
assessment of communication, social interaction, and stereotypical behaviors for
individuals with autism or other pervasive developmental disorders. The ADOS
applies to individuals who range from being nonverbal to verbally fluent, and range
in age from infants to adults. However, different ADOS modules are also utilized,
depending on the individual’s developmental and language level. Although the
use of these tools is very advantageous for the behavioral assessment of ASD,
they are not sufficient for providing an early and accurate diagnosis (Ecker et al.,
2015).
Over the last decades, a lot of research effort has focused on studying ASD
to understand the cause and the underlying mechanism of the disease as well
as offering effective treatment opportunities and delivering early and accurate
diagnosis. Despite these concerted efforts, however, the issues related to ASD
diagnosis, treatment and causation have remained unsolvable.
3.2 Autism Spectrum Disorder and the Brain
Brain studies have indicated distinct structural and functional differences between
a healthy and an autistic brain; however, inconsistent findings are also common
(Haar et al., 2014). The existence of wide-spread structural brain abnormalities
in ASDs, namely, the differences in total brain volume, the frontoparietotemporal
cortex, the corpus callosum, and cerebellar volume have been reported in many
structural imaging-based studies on ASD (Nicolson and Szatmari, 2003; Retico
et al., 2014).
Courchesne et al. (2001) reported no difference in whole brain volumes at birth
in children later diagnosed with autism compared to typically developing (TD)
children, and larger whole brain volumes in ASD children at age 2-4 years old.
They have also reported a significantly larger amount of white and gray matter
in the cerebrum in ASD children compared to TD children. However, larger
brain volume was not observed in older children and adults with autism. Larger
brain volume of autistic patients in early childhood was also reported by earlier
studies (Bailey et al., 1998; Fombonne et al., 1999; Kanner et al., 1943). Increased
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total brain volume with an accelerated grow in early childhood was also reported
in reviews by Nicolson and Szatmari (2003) and Williams and Minshew (2007).
Although there was a clear appearance of larger brain volumes in the early life
of autistic patients, the timing and persistence of that brain overgrowth remains
still unclear (Nicolson and Szatmari, 2003).
In addition to global brain volume changes in ASD, regional differences are also
reported. However, reports of increased total brain volume have been more
consistent than regional brain differences. Recent structural MRI-based studies
have reported inconsistent results on the volume of amygdala, hippocampus, and
basal gangalia with increased, decreased, and no difference in autistic patients
compared to the control subjects (Barnea-Goraly et al., 2014; Cody et al., 2002;
Nicolson and Szatmari, 2003; Schumann et al., 2004; Williams and Minshew,
2007). Furthermore, the decreased volume of Cerebellum and Corpus Callosum
was reported in several structural imaging studies with more consistency (Nicolson
and Szatmari, 2003; Wolff et al., 2015).
According to the available neuroimaging studies of ASD, there are significant
structural and functional brain differences between the neurotypical and ASD
subjects (Barnea-Goraly et al., 2014; Wolff et al., 2015). However, these differences
are not uniform across all ASD patients, suggesting a demand for further research
to investigate the phenotypic differences in ASD patients.
3.3 Literature Review of MRI-based Machine
Learning for ASD
Supervised machine learning approaches are extensively used for classification of
ASD patients from TD subjects using MRI data (Chen et al., 2011; Cody et al.,
2002; Ecker et al., 2010a, 2015; Gagnon, 2013; Wee et al., 2014). The use of
machine learning approaches provide a possibility to analyze neuroimaging data
quantitatively and identify ASD brain alterations, e.g., by statistically comparing
the neuroimaging data of ASD patients to that for TD subjects. Previous studies
have shown that ML approaches applied to MRI data can help to provide more
efficient diagnosis possibilities as well as new treatment choices and discover
ASD-related brain pathology (Ecker et al., 2015).
There are a large number of studies that have investigated the use of ML approaches
for the classification of ASD patients and TD subjects by using MRI data (Ecker
et al., 2010b,a; Jiao et al., 2010; Uddin et al., 2011; Wee et al., 2014; Zhou et al.,
2014). Here we refer only to a few previous studies to highlight some of the key
challenges in the use of these approaches in ASD studies. Table 3.1 provides a few
ML-based MRI studies on ASD subjects. The most common goal in these studies
is designing a model for the classification of ASD and TD subjects based on an
available training dataset with MRI data on ASD and TD subjects. However, the
type of feature set and MRI preprocessing differs in the different works.
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Table 3.1: Supervised machine learning of MRI based ASD studies.
Author Data Validation Results
(Jiao et al., 2010) Regional CT and K-fold CV AUC = 93%
volume for 66 brain structure ACC = 87%
22 ASD, 16 TD SEN = 95%
SPE = 75%
(Ecker et al., 2010a) Voxel-wise GM LOOCV ACC = 81%
and WM maps SEN = 77%
22 ASD, 22 TD SPE = 86%
(Ecker et al., 2010b) 5 morphological parameters Leave-two-out CV SEN = 90%
at each vertex of cortical surface SPE = 80%
Only CT of right hemisphere ACC = 90%
20 ASD, 20 TD, 19 ADHD SEN = 90%
SPE = 90%
(Wee et al., 2014) Regional and interregional K-fold CV AUC= 99.5%
morphological patterns of sMRI ACC = 96 %
58 ASD, 59 TD
(Sato et al., 2013) Inter-regional CT correlations LOOCV R = 36 %
82 ASD, 84 TD
The use of MRI data for the classification of ASD vs. healthy subjects was
investigated, e.g., by Jiao et al. (2010), Ecker et al. (2010a), Ecker et al. (2010b),
and Wee et al. (2014) (Table 3.1). All these studies achieved high classification
performance (ACC > 0.80), by using different supervised classification algorithms.
However, the type of MRI data and ML approach as well as the dataset differed
across the studies. For instance, Jiao et al. (2010) used regional brain volumes and
cortical thickness measurement and reported decreased cortical thickness in the left
and right pars triangularis, left medial orbitofrontal gyrus, left parahippocampal
gyrus, and left frontal pole, and increased cortical thickness in the left caudal
anterior cingulate and left precuneus in ASD subjects. Wee et al. (2014) utilized
regional and interregional morphological patterns extracted from structural MRI
via a multi-kernel learning technique and reported abnormal subcortical structures
as well as a significant rightward asymmetry pattern, particularly in the auditory
language areas in autistic brains. In these studies, a very high discriminative
power was reported by Wee et al. (2014) for identifying ASD from TD subjects.
Although, the great majority of ML-based ASD studies have focused on identifying
group differences between typically developing individuals and ASD patients, these
methods are not sufficient enough to detect the large source of the heterogeneity
associated with the severity of the disorder. More recently, new approaches have
been proposed for predicting the severity of behavioral impairments in the ASD
group by using regression ML approaches. These algorithms make the prediction
of quantitative outcomes possible. For example, a recent study by Sato et al. (2013)
investigated the prediction power of inter-regional cortical thickness correlations
for estimating the ADOS measure via the SVR (RBF kernel) approach for a
dataset of 82 autistic patients. They reported a correlation score of 0.36 between
the predicted and the observed ADOS scores based on whole-brain analysis.
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Moreover, they showed that the presence of autistic symptoms are associated
with the structural covariances for several brain regions, including right pars
triangularis, left post-central, left caudal middle frontal, left temporal pole, left
pars triangularis, left frontal pole, left entorhinal, and the right banks of the
superior temporal sulcus. Their experiments also pointed to a greater relevance
of the left hemisphere when estimating an ADOS score compared to the right
hemisphere. This is a relevant study with our study in Publication V, wherein we
estimated the severity score derived from the ADOS score in autistic patients.
While the existing ML-based ASD studies seem to provide promising results, it is
still important to note that these studies were performed on small sample-size
datasets (see Table 3.1), and they also reported inconsistent findings regarding
the ASD-related structural abnormalities in different brain regions. In addition
to small sample size, other factors, such as large behavioral heterogeneity in the
ASD group, and measurement-related differences between the various studies
are known to contribute to conflicting findings across different studies (Auzias
et al., 2014; Castrillon et al., 2014). Recently, Haar et al. (2014) investigated the
ASD-related anatomical differences in a large dataset of ASD and healthy subjects
from the multi-site ABIDE. They comprehensively studied the univariate analyses
of volumetric, thickness, and surface area measures for more than 180 anatomically
defined brain areas. Their experiments revealed significantly larger ventricular
volumes, smaller corpus callosum volume (central segment only), and increased
cortical thickness in several brain regions within the ASD group. However, they
did not find significant structural differences in most brain regions previously
reported on. In addition, they performed the multivariate classification analyses
of the ABIDE data, but the classification accuracies were weak (<60%). The
weak classification rate in the multi-site ABIDE data was also reported by Nielsen
et al. (2013) on functional connectivity MRI data.
The effect of scanner variations have been considered to be important in the poor
classification accuracy of these multi-site studies, although Haar et al. (2014)
suggested that their poor decoding accuracy for the classification of multi-site
ABIDE data was due to weak anatomical abnormalities in the ASD pathology
rather than between-site variations. The effect of scanner variation on the multi-
site analyses of cortical thickness abnormalities in ASD patients was also studied
by Auzias et al. (2014, 2016). They showed that scanner variation is a significant
confounding factor, which is distributed across the cortical surface and reaches its
peak in the frontal region.
In view of these considerations, there is an urgent need for larger sample sizes
and standardized multivariate pattern recognition approaches across various
acquisition sites if we are to discover clinically useful information. Large sample
sizes with improved computational algorithms may allow for the extraction of
core ASD-related neuroanatomical abnormalities from the noise introduced by
the heterogeneity of the disorder and the effect of scanner variations. Such
18 Chapter 3. MRI-based Machine Learning for Autism
abnormalities could serve as biomarkers and could provide new insights into the
causes of the disorder and potential interventions (Amaral et al., 2008; Auzias
et al., 2014).
4 Methods: Machine Learning
The chapter starts with a brief description of the machine learning concept followed
by a description of the supervised and semi-supervised approaches, classification,
and regression algorithms as well as the feature selection and domain adaptation
methods. Finally, the model selection and performance assessment approaches
are described. We focus only on the methodologies actually used in this thesis.
4.1 Machine Learning
Machine learning is a subfield of artificial intelligence related to the development
and evaluation of methods that enable computers to make intelligent decisions
through experience. The purpose of these methods is to automatically discover
patterns in data by utilizing different statistical methods and then using these
patterns, in adjusting certain program actions accordingly. Machine learning
approaches are widely used in solving prediction problems, where when given a
training set of input and output variables, the task is to find a mapping function
between the input and the output variables. The inferred model can then be
used for generating outputs corresponding to new inputs of data automatically.
The value of output, which is called a response variable, can be categorical
or continuous, thereby leading to the classification and a regression problem,
respectively.
Fig. 4.1 shows the general framework for designing a predictive model. The focus
of this work is in the leaning phase of utilizing machine learning approaches in
medical applications. The learning process can be divided into preprocessing and
modeling phases. The leaned model is evaluated then in a separate test set. Three
main steps in designing a predictive model are described bellow.
• Preprocessing: This step includes any action that leads to improvement in the
quality of data to make learning easier, such as feature selection/dimensionality
reduction for selecting relevant features in high dimensional data, domain
adaptation for improving the similarity of the data from different sources,
and pre-filtering for removing the effect of confounding factors from the
data.
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Figure 4.1: Designing a predictive model in a machine learning frame work. The learned
model can be used for predicting output for new test data.
• Modeling: After preparation of the data in a suitable feature set for learning,
computational approaches are used to map the chosen set of features into
decision values. There is a wide range of learning algorithms, each with its
strengths and weaknesses. There is no single learning algorithm that works
best in all situations. Selecting the best approach depends on many issues
and is quite task dependent.
• Evaluation: Evaluating the performance of a learned model for test data based
on different evaluation metrics.
Machine learning methods can be classified into supervised, unsupervised, and
semi-supervised learning categories. In supervised learning methods, the model is
learned based on training data with a known response variable, i.e., labeled data.
Unlike supervised learning, unsupervised learning methods rely on only predictor
variables from the training data and do not consider the response variables.
Semi-supervised learning methods fall between the supervised and unsupervised
methods; they are able to use training data with missing response variables, i.e.,
unlabeled data, in conjunction with labeled data in the learning process. The
great interest in semi-supervised approaches is related to the wide spread of
application domains where providing labeled data is both hard and expensive
compared to providing unlabeled data. Moreover, incorporating unlabeled data
in the learning procedure might improve the generalization ability of a learned
model, which motivates development of such algorithms. In transductive learning,
which has closed relations to semi-supervised learning, the unlabeled data are
used in training phase for increasing the generalization ability, even though the
data have label information 1.
1http://olivier.chapelle.cc/ssl-book/discussion.pdf
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4.2 Supervised Learning
Supervised learning algorithms (Bishop, 2006; Caruana and Niculescu-Mizil, 2006)
play a fundamental role in machine learning. The goal of supervised learning
is to analyze a set of available labeled training data D = {(x1, y1), ..., (xn, yn)},
to produce an inferred function that makes prediction for new unseen instances.
Particularly, the task is to find a function f , by mapping the d-dimensional input
vector x ∈ Rd into its corresponding response variable2 y, i.e.,
y = f(x), (4.1)
with the high probability of defining the correct response variable for a new
instance drawn from the same distribution as the training data. The function
f(x) is defined with a set of parameters that are optimized based on labeled
training data in the learning procedure. According to the type of response variable,
supervised learning algorithms can be divided into two main categories:
• Classification: In a supervised classification task, the aim is to assign the
feature vector x to one of the K discrete categories Ck, where k = 1, ...,K.
The classification applications in this thesis are binary classification problems,
where the response is a binary variable, i.e., c ∈ {−1,+1}.
• Regression: In a regression problem, the aim is to predict a real-valued re-
sponse variable y ∈ R from the feature vector x. The regression analysis is
commonly used for modeling the relationship between different variables.
In both supervised classification and regression tasks, the major issue is to discover
associated patterns in the training data and through the use of these patterns,
learn a model that can predict response variable for new unseen samples. The
most important issue in this learning process is considering the generalization
ability of the model as defined by the learning quality of the model for new unseen
instances. Since the learning is done based on training data, designing a model
with high performance in training data is easy. However, the idea is not to find a
new representation of the training data, but rather create a model that will be
able to generate the output variables for new unseen data as well. This makes
the role of training data in a supervised machine learning task important. For
creating a model with good generalization ability, the training data should be
large enough, diverse, and, at the same time, also compact in such a way that
it can cover the main and most important aspects of the problem. In medical
applications, the size of the existing datasets for studying various disorders is
commonly limited. Moreover, these problems are mostly diverse, complex, and
2The response variable can be generalized to multiple outputs, which it is then called as
multitask learning (https://en.wikipedia.org/wiki/Multi-task_learning).
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difficult to cover with the available data. However, there are different ways to deal
with these challenges to make the use of machine learning methods in medical
applications actually feasible.
4.2.1 Classification
In classification problems, the task is to organize data into different categories
according to their properties. There are different types of algorithms used for
classification purposes. For instance, logistic regression (Hosmer and Lemeshow,
2000; Peng et al., 2002) is a widely used linear classifier in both binary and
multiclass classification problems. The logistic regression method uses the logistic
function, also referred to as sigmoid function σ(α) = 11+exp(−α) , for modeling
the probability of the occurrence of an event. As Fig 4.2 illustrates, the logistic
function is a S-shaped monotonic and continuous function between 0 and 1, and
it maps the whole real axis into a finite interval [0,1].
Figure 4.2: Logistic sigmoid function.
In the case of binary classification problem with 0 and 1 response variables, the
probability of class 1 given the d-dimensional predictor variable x is modeled by
P (y = 1,x) = exp(w0 + wx)1 + exp(w0 + wx)
, (4.2)
where w and w0 are model parameters. The logistic regression model is also
applicable for a multi-class classification problem by modeling the probability
of occurrence for each class separately. For estimating the model parameters in
logistic regression, the commonly used method is the maximum likelihood approach
that maximizes the likelihood of the model in the training data (Bishop, 2006;
Haberman, 1974); given a set of N samples training dataD = {(xi, yi)|i = 1, ..., N},
the likelihood function is formulated as
N∏
i=1
P (yi|xi). (4.3)
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Alternatively, one can maximize the log-likelihood function for more computational
convenience:
log
N∏
i=1
P (yi|xi) =
N∑
i=1
logP (yi|xi). (4.4)
In order to find the maximum log-likelihood and solve the parameters, the deriva-
tives of the log-likelihood function should be set to zero. Thus, an iterative
technique, such as the Newton-Raphson algorithm, can be applied to find the
optimal model parameters (Fletcher, 1987). During testing, the posterior prob-
ability of the unseen data sample is calculated based on the model parameters,
calculated as in the training data. According to posterior probability, the test
sample is classified into a corresponding category. In this work, we use logistic
regression in Publications I, II, and III, in feature selection step for classifying
AD and NC subjects.
Logistic regression (Hosmer and Lemeshow, 2000) is an instance of a linear classifier
that divides the feature space by linear decision boundaries. The major advantage
of the linear models is their simplicity compared to nonlinear classifiers. They
are easy to interpret and are less prone to overfitting (Friedman et al., 2001).
However, in some applications, the underlying structure in data is nonlinear;
therefore, linear models are not able to find optimal decision boundaries. In such
cases, the kernel trick (Scholkopf, 2001; Schölkopf et al., 1998) may be used for
converting linearly inseparable data to linearly separable data. In this technique,
a kernel function φ is used for projecting the data from its original space into the
higher dimensional space X→ φ(X), where it becomes linearly separable.
A well-known kernel based on the supervised learning approach is the support
vector machine (Vapnik, 1995), suited for modeling both linear and nonlinear
relationships in data. Due to simplicity and good performance, SVM is used widely
in different classification and regression applications (Ye et al., 2012; Zhang et al.,
2015). This method was first introduced as a pattern recognition method (Boser
et al., 1992; Cortes and Vapnik, 1995; Vapnik and Vapnik, 1998), representing
a decision boundary between samples from two different classes in such a way
that the margin (the distance) between the decision boundary and the closest
training sample to it, is maximized. Fig. 4.3 attempts to explain the idea of
the SVM approach by visualizing a two-class SVM classifier. Given a dataset
of N training samples D = {(xi, yi)|i = 1, ..., N, yi ∈ {−1,+1}}, SVM solves the
following optimization problem:
min
w,b,ξ
{12 ||w||
2 + C
N∑
i=1
ξi} s.t. yi(wφ(xi)− b) ≥ 1− ξi, (4.5)
where ξi ≥ 0 is the slack variable, allowing for some degree of misclassification
in the training data to prevent overfitting, and C is the penalty parameter for
controlling the trade-off between a large margin and a small error. Thus, the idea
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is to find the weight vector w and the bias term b by minimizing the expected
risk in the training data. The SVM classification method is used in Publications
I, II, and III. In Publications I and II, it is used for comparison purposes between
supervised and semi-supervised learning when predicting the conversion to AD
in MCI patients. In Publication III, it is used as one of the main classification
algorithms.
Figure 4.3: A two-class SVM classifier where the placement of the decision boundary
is determined by a subset of samples called support vectors, which are shown by green
circles. Misclassified data points with the slack ξi ≥ 0 are shown by blue cycles.
Random forest (RF) is also a nonlinear machine learning method that finds the
nonlinear mapping function of the predictor variable to the response variable in
the original space. It is used widely for both classification and regression problems
(Breiman, 2001). RF is a ensemble learning based method consisting of multiple
decision trees all trained with different subsets of the original data. The results of
a RF model is based on the average results of the individual decision trees. In a
classification problem, RF outputs vote counts for different classes and give the
probability of being in each class for the corresponding data sample. Averaging of
the outputs of individual trees renders RFs tolerant to overlearning, which is the
reason for their popularity in classification and regression tasks, especially in the
area of bioinformatics (Díaz-Uriarte and De Andres, 2006; Zhang et al., 2003).
We use RF classification approach in Publication II, in constructing aggregate
biomarker.
4.2.2 Regression
In regression problems the aim is to predict a real-valued response variable y ∈ R,
given a d-dimensional predictor variables x. A simple and popular regression
method is linear regression (Bishop, 2006; Galton, 1894), which assumes a linear
relationship between the response variable and the predictor variables. Given
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a data set of N training samples D = {(xi, yi)|i = 1, ..., N}, where xi ∈ Rd and
yi ∈ R, the linear regression model can be formulated as follows:
y = w0 + w1x1 + ...+ wdxd + . (4.6)
The most common method for finding the regression coefficientsw = [w0, w1, ..., wd]T
is ordinary least squares (Hastie et al., 2003), which minimizes the sum of the
squared error (SSE) in the training data:
SSE = (y−Xw)T (y−Xw), (4.7)
where X is N × (d+ 1) input matrix, y is an N × 1 output vector. For minimizing
SSE, the first derivative of SSE with respect to w is set to zero to obtain a unique
solution for w. If the inverse of XTX exists, then the solution for w is
w = (XTX)−1XTy. (4.8)
The linear regression model works under the assumption that the relationship
between the response and the predictor variables is linear. In order to determine
the nonlinear relationship, a nonlinear regression model must be used. The
presented support vector machine can also be applied to linear and nonlinear
regression problems, resulting in support vector regression (SVR). To achieve the
maximal margin property in a regression problem, Vapnik (1995) proposed the
ε-SVR algorithm by devising the ε-insensitive loss function. In SVR, a specific
value is determined as an ε in the loss function, after which the task is to fit a
regression line surrounded by a tube with radius ε to the data. The data points
inside the tube are not considered when determining the regression line and only
the data points lying on the edges or outside the tube, i.e., the support vectors,
affect the course of the regression line. Given a dataset of N training samples
D = {(xi, yi)|i = 1, ..., N, yi ∈ R}, SVR aims to solve the following optimization
problem:
min 12‖wˆ‖
2 + C
N∑
i=1
(ξi + ξ∗i )
subject to

yi − (wˆTφ(xi)− bˆ) ≤ ε+ ξi,
(wˆTφ(xi) + bˆ)− yi ≤ ε+ ξ∗i ,
ξi, ξ
∗
i ≥ 0,  ≥ 0,
(4.9)
where ξi, ξ∗i ≥ 0 are the slack variables, and C is the penalty parameter. We
use the SVR approach in developing our proposed method for the estimation of
disease severity in ASD patients in Publication V.
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The linear regression is used in Publications II, IV, and V. In Publication II,
linear regression is used for estimating the aging effect from MRI data, and in
Publication IV it is used for estimating the relationship between RAVLT cognitive
measures and MRI data. Finally, in Publication V, we use linear regression as a
final step in the estimation of the disease severity score in ASD.
4.3 Semi-supervised Learning
Semi-supervised learning (SSL) approaches (Chapelle et al., 2009; Zhu and Gold-
berg, 2009) differ from the standard supervised learning methods in that they
make use of unlabeled data in the learning process. Commonly, learning is done
either in supervised learning manner with labeled training data samples (e.g.
classification) or unsupervised learning with unlabeled training data samples
(e.g. clustering). The aim of semi-supervised learning is to use both labeled and
unlabeled data and design algorithms that have improved performance; SSL is
halfway between supervised and unsupervised learning. These approaches are
motivated by the fact that in many application domains, acquiring sufficiently
labeled training data is often a hard, expensive, and time-consuming process,
whereas unlabeled data are more abundant and easier to collect.
For a SSL task, the training data consists of labeled data samples L = {xi, yi}li=1
and unlabeled data samples U = {xj}l+uj=1+l. The basic assumption is that the
size of an unlabeled dataset is much greater than a labeled dataset, i.e., L U
(Zhu and Goldberg, 2009). The goal of SSL is to learn a model F : X→ y such
that it is better than a model constructed based on labeled data alone. In such
applications, where we are interested, e.g., in predicting a phenomenon like brain
disorder at an early stage, for acquiring labeled data samples patients have to
be followed up for many years after the first visit to obtain a reliable clinical
diagnosis. Therefore, the disease label is often not available for a large number of
subjects. In this kind of application, SSL approaches are a good solution for the
use of data samples that have missing label information. Semi-supervised learning
methods are used for both classification and regression problems; however, in this
work, we only focus on semi-supervised classification problem whereas the idea
is to improve the performance for predicting AD in MCI patients by using both
labeled data samples (MCI subjects who have been followed up and it is known if
they will convert to AD or not) and unlabeled data samples (MCI subjects for
whom reliable future diagnosis cannot be firmly established).
In order to improve a model by incorporating a large amount of unlabeled data,
we must assume some structure applies to the underlying distribution of data to
make them informative. Cluster assumption is one of the most frequently used
assumptions in SSL, and it states that the points are probably in the same class
if they are connected by a path through high density regions, in other words, the
decision boundary is situated in a low density region instead of passing through
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Figure 4.4: Supervised vs. semi-supervised classification. The green line shows the
decision boundary using only two labeled data samples (green and red), while the red
line shows the decision boundary with two labeled data samples and a set of unlabeled
data samples.
high density regions (Chapelle et al., 2006). This concept is illustrated in Fig. 4.4
by showing the influence of unlabeled data in determining the decision boundary
using a toy example. It is seen as performing a clustering algorithm to cluster the
whole dataset and then labeling each cluster according to the labeled data.
In Publications I and II, we use a cluster-based, semi-supervised learning approach
called low density separation (Chapelle and Zien, 2005), for predicting AD in MCI
patients. This method uses a two-step algorithm for classifier learning. First it
derives a graph-distance kernel for enhancing the cluster separability, and then this
method applies a transductive support vector machine (TSVM) (Joachims, 1999).
In this way, the labeled samples determine the rough shape of the decision rule,
while the unlabeled samples fine-tune the decision rule to improve the performance.
This method is explained in detail in the Appendix of Publication II.
Note that the use of unlabeled data and the SSL method does not always improve
the model. Generally, unlabeled data improves the classification performance
when the assumed model is correct (Zhang and Oles, 2000). Further, the amount
of improvement depends strongly on the number of labeled and unlabeled data
and the problem complexity (Cohen et al., 2002). In Publication I, we provide
evidence that even a small number of unlabeled data can aid in the MRI-based
AD conversion prediction in MCI patients; however, the size of improvement
decreases when the number of labeled data increases.
4.4 Feature Selection
In machine learning applications of neuroimaging data, usually we are dealing
with training data that consists of a large number of input variables (features), of
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which many them may be redundant or not contain relevant information (Chu
et al., 2012). Further, the high dimensionality of data causes certain serious
challenges that influence the design and the performance of the ML applications.
In particular, correctly generalizing a ML model becomes exponentially harder by
increasing the dimensionality of the input space (Domingos, 2012). Especially,
the curse of a dimensionality problem arises when the number of data samples are
relatively small compared to the dimensionality of the data (Bellman, 1961). A
typical solution for this problem is adding a dimensionality reduction or feature
selection step prior to the designing of a ML model in high dimensional space. The
aim of the feature selection process is to reduce the dimensionality of the feature
space while still maintaining the main characteristics of the training samples.
The reasons for using feature selection in designing a ML algorithm is three-fold: 1)
Using only a subset of features containing relevant information from the viewpoint
of a ML task in order to improve the performance of the model by eliminating
the non-informative features (Chu et al., 2012); 2) reducing the computational
complexity for the designing of learning and predication models; and 3) providing
better understanding of the problem by identifying the significant features that
are contributing to the learning process.
Feature selection methods are often divided into filter, wrapper, and embedded
feature selection methods (Saeys et al., 2007). The framework of the different
feature selection categories are illustrated in Fig. 4.5. Filter methods estimate
feature importance according to the intrinsic properties of the data and completely
independent of the learning algorithm. Filter-based feature selection methods
are computationally fast and easily scalable to a very high dimensional dataset.
However, these methods ignore the effect of the selected feature subset on the
performance of the learning algorithm. An example of these methods is a simple
t-test based feature selection (Inza et al., 2004). For a binary classification problem
with c ∈ {+1,−1}, a t-score for each feature i is computed
ti =
|µ−1(i)− µ1(i)|√
0.5(σ2−1(i) + σ21(i))
, (4.10)
where µc(i) and σ2c (i) are the mean and variance of the feature i for the class c,
respectively. The feature importance is calculated based on the value of the t-scores
ti ; the ones with the highest t-scores are selected for classification purposes.
Unlike filter methods, wrapper feature selection methods (Kohavi and John,
1997) consider the selection of a best feature subset as a search problem by
examining various feature subsets with a predictive model. The goal of the
wrapper feature selection methods is finding an optimal feature subset while
still maximizing the performance of the selected predictive model. The wrapper
feature selection methods are very popular in ML applications; however, due to a
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Figure 4.5: Filter, wrapper and embedded feature selection methods.
high computational complexity, their implementation is limited when the number
of features is huge.
Embedded feature selection methods are an alternative to the wrapper approach
that incorporates the feature selection process as part of the model training. The
most popular form of embedded feature selection methods is a regularization
approach that performs feature weighting by regularizing the feature coefficients.
The regularization method constitutes one of the most powerful methods for
feature selection purposes in high dimensional data. Especially, these methods
have been increasingly applied and developed for neuroimaging applications
(Casanova et al., 2011b; Huttunen et al., 2013; Khundrakpam et al., 2015). In
the current work, we use voxel-based morphometry for preprocessing ADNI MRI
data, resulting in a very huge number of features for a single subject. Therefore,
we use a regularized logistic regression algorithm to select a good subset of
MRI voxels for AD conversion prediction with training data consisting of MRI
data of AD and healthy subjects. For regularizing the logistic regression, a
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regularization term J(w) is introduced to the general log-likelihood function in
Equation 4.4. Similarly to the maximum log-likelihood parameter estimation in
logistic regression, regularized logistic regression estimates the model parameters
by maximizing
N∑
i=1
logP (yi|xi,w) + λJ(w), (4.11)
where J(.) is a penalty function on the weight vector and λ ≥ 0 is the regularization
parameter that controls the degree of penalization. In this way, it performs
simultaneously parameter estimation and variable selection. The widely used
regularizers are LASSO penalty ∑Dj=1 |wj | (Tibshirani, 1996) and ridge regression
penalty ∑Dj=1w2j . The LASSO penalty acts as a variable selector by forcing many
parameters to have zero values, thus leading to a sparse solution. In applications
with highly correlated predictor variables, such as neuroimaging applications,
LASSO tends to select only one of them while ignoring other correlated variables,
albeit they would be relevant (Carroll et al., 2009). In contrast, a ridge regression
penalty shrinks the coefficients of the correlated variables toward each other
and assigns similar coefficients values to them. However, ridge regression does
not result in a sparse solution, but rather a combination of these two penalties,
i.e., elastic-net penalty, leads to a sparse model combined with the grouping
effect, thereby providing a good solution for applications with highly correlated
variables (Carroll et al., 2009; Zou and Hastie, 2005). Elastic-net logistic regression
optimizes the log-likelihood such that
N∑
i=1
logP (yi|xi,w) + λ[(1− α)||w||22/2 + α||w||1], (4.12)
where α ∈ [0, 1] defines the compromise between ridge (α = 0) and lasso (α = 1)
penalties. The elastic-net penalty is particularly efficient with high dimensional
and highly correlated predictor variables, and therefore, we use it as the main
feature selection method for this thesis in Publications I, II, IV, V. In Publication
III we comprehensively study different feature selection algorithms in the MRI
data.
4.5 Domain Adaptation
Domain adaptation is a new branch of ML techniques that seeks to improve
the similarity of the datasets coming from different sources with mismatched
distributions. A common assumption in any supervised learning task is that
the underlying distribution is same for all the data, i.e., training and test data.
However, in real world applications, this assumption does not often hold true
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due to the many factors that can affect the data distribution collected in distinct
situations. Domain adaptation techniques have been heavily studied in many
application domains, such as computer vision (Gopalan et al., 2011), and speech
and language processing (Blitzer et al., 2006). Recently, these methods have gained
new attention for machine learning-based neuroimaging applications, where the
goal is to analyze datasets collected at multiple sites without any standardization
protocol (Wachinger et al., 2016).
Domain adaptation methods are divided into unsupervised methods (Gong et al.,
2012, 2013; Shi and Sha, 2012) that rely only on labeled source data and unlabeled
target data, and semi-supervised methods(Donahue et al., 2013; Kumar et al.,
2010), indeed assuming that a small number of labeled target data samples are
available for learning. These algorithms are heavily studied for those situations
where the training and test data come from different domains, and the idea is
that the classifier trained in source domain (training data) can be also applied to
the data from target domain (test data). However, multiple domain adaptation
methods have been less studied.
In Publication V, we consider the situation where multiple datasets with mis-
matched distributions are available with an insufficient number of samples for
each single domain. Our goal is to find a common feature space within different
datasets for a reduction of between-domain variation. In this work, we use Partial
Least Squares-based (PLS) domain adaptation to identify a new low dimensional
feature space containing information that is maximally invariant between the
different domains. PLS is a linear feature transformation method for modeling
relationships between sets of observed variables. Similar to principal component
analysis (PCA), PLS constructs new predictor variables, i.e., latent variables, as
linear combinations of the original predictor variables. The difference between
PCA and PLS is that PLS considers response variables when constructing latent
variables, while PCA considers only the predictor variables. When using the PLS
approach for domain adaptation, the domain information of data samples can
be used during the learning process as a response variable. In this way, we are
considering unsupervised domain adaptation where the predictor variables and
domain information of data samples are only used. In Section 2.6 of Publication
V, the algorithmic description of PLS for multiple domain adaptation is offered.
4.6 Model Selection and Performance Evaluation
In the context of machine learning applications, model selection and performance
evaluation are two important concepts that are motivated by two fundamental
questions: 1) What is the generalization ability of a learned model, and 2) How
does one select the best choice within different models? Once a ML model is
created, the performance of that model should be evaluated based on performance
metrics in the new data samples that are not used in the training phase. This
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procedure is important in order to determine the generalization ability in a ML
model. In the following discussion, we describe the cross-validation approach used
often for splitting data into training and test sets in scarce data situations, and
also some major performance metrics in classification and regression tasks.
4.6.1 Cross-validation
The most important issue in a machine learning task is the generalization ability
as defined by the performance of a learned model in new samples not seen during
the training phase. Therefore, for reliably assessing the performance of a model
in new data samples, a separate test dataset is required. In a data-rich situation,
the dataset simply are divided into training and test sets for training the model
and performing evaluation (Hastie et al., 2003). However, in many applications,
the amount of available data is limited, thereby, dividing it into separate training
and test sets may result in a significant loss in modeling or testing capability. In
such situations, common methods for estimating the performance of a model are
re-substitution, bootstrapping, and cross-validation.
In re-substitution, the model is learned based on all the data and then tested
on that same data. This process uses all the available data for learning and
testing purposes, but it can suffer from over-fitting (Braga-Neto et al., 2004).
Bootstrapping (Efron and Tibshirani, 1994) and cross-validation (CV) (Kohavi,
1995) are re-sampling methods that divide data into two subsets for learning and
testing purposes. A bootstrap sample is created by randomly sampling n instances
from the data with replacement and using those for training the model. The test
set is created with rest samples that are not chosen. This procedure is repeated
several times, and overall performance is calculated by averaging the errors in the
test set across different computation times.
In this thesis, we use cross-validation to split data to training and test sets. The
most widely used form of cross-validation is K-fold cross-validation. In K-fold CV,
the dataset is randomly divided into K disjoint subsets (the folds) D1, D2, ...DK
of roughly an equal size. Fig. 4.6 illustrates the framework for the K-fold cross-
validation approach. In this way, all folds are used as test data one by one and
the remaining K − 1 folds are used for training the model. Therefore, training
and testing is iterated over the K folds, and overall performance is estimated by
computing the average performance across the different folds (Kohavi, 1995). In
the case of an imbalanced data set, where the proportion of data samples is not
equal within different categories, stratification is used to divide the data across
the folds with an approximately equal distribution of class labels.
The clear advantage of this method is utilizing all data samples for both training
and testing purposes, and using each sample for testing only once. A special case
of K-fold CV is when the K is taken equal to the number of samples, which in
this case is called a leave-one-out CV (LOOCV). This method is mostly suited for
small datasets; due to its computational expense, it is not suitable for datasets
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Figure 4.6: K-fold cross-validation.
with large number of instances. In K-fold CV, the proper number of folds is
usually selected based on the size of dataset. According to Kohavi (1995), having
large number of folds results in a lower bias of the true error in the cross-validation
approach, which in turn, results in a more accurate estimator. On the other hand,
having a large number of folds is computationally intensive and time consuming
due to need to repeat the training and testing phases. Typically a 5-fold or 10-fold
CV is used in most applications.
Cross-validation is one of the most common approaches for model selection and
estimation of the regularization parameters. Nested cross-validation is often
used for reliably assessing the performance of a learning algorithm in which
regularization parameters need to be also optimized during the learning phase.
This method involves two cross-validation loops. First an outer loop is created to
estimate the generalization performance of the learning model; then an inner loop
is created inside the outer loop to optimize the regularization parameters. In all
publications used in this thesis, we apply stratified two nested cross-validation loops
(10-folds for each loop) for the performance evaluation and also the estimation of
the regularization parameters in the learning models.
4.6.2 Performance evaluation
There are various metrics available for measuring the performance of a predictive
classification or regression model. The choice of error assessment measures for a
specific problem depends strongly on the nature of the problem and what really
should be measured. Next, we describe here some important performance metrics
used for classification and regression purposes in this thesis.
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Performance measures for classification
The main classifier performance measure is the classification rate or accuracy
(ACC) to show the probability of correctly classified samples. However, in many
problems, the accuracy alone as a classifier performance measure is not able
to determine the efficiency of the classifier. Commonly, a confusion matrix is
used to visualize the variety of performance measures in classification tasks. As
shown in Fig 4.7, in a binary classification problem with positive and negative
classes, the confusion matrix is constructed according to the true and predicted
class labels as a two-by-two table labeled with True Positive (TP: the number of
correctly classified positive samples); True Negative (TN: the number of correctly
classified negative samples); False Positive (FP: The number of misclassified
negative samples); and False Negative (FN: The number of misclassified positive
samples).
Figure 4.7: A confusion matrix template for the binary classification.
Different aspects of a model can be measured using a variety of performance
metrics drawn from the confusion matrix. The proper performance measure
depends strongly on the task and the type of data used for modeling. In some
applications, several measures are used simultaneously to estimate the performance
of a learning algorithm. In order to evaluate the performance of a classifier, we use
accuracy (ACC), sensitivity (SEN), specificity (SPE) and the area under the ROC
curve (AUC). Accuracy is the simplest metric, used for measuring the proportion
of correctly classified samples:
ACC = TP + TN
TP + TN + FP + FN (4.13)
However, classification accuracy does not provide any information about different
type of errors. In contrast, sensitivity and specificity provide a measure of true
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positive rate and true negative rate, respectively. The sensitivity, called also recall
or the true positive rate is calculated as:
SEN = TP
TP + FN , (4.14)
and the specificity or true negative rate is calculated as:
SPE = TN
TN + FP . (4.15)
Many classification algorithms create a continuous output, and a threshold is
required for denoting a value as a positive or negative class. Choosing the
appropriate threshold is important in order to obtain proper sensitivity and
specificity for a specific problem. Assessing the model performance with different
thresholds can be investigated graphically using a receiver operating characteristic
(ROC) curve. This ROC curve shows the relationship between sensitivity and
the specificity of a classifier, as the discrimination threshold changes. In a ROC
curve, the False Positive Rate (FPR) is plotted on the horizontal axis, while True
Positive Rate (TPR) is plotted on the vertical axis. The FPR of a classifier is
determined as:
FPR = 1− SPE = FP
TN + FP . (4.16)
The Area under the ROC curve (AUC) is interpreted as a performance measure
that is equivalent to the probability that a randomly chosen positive sample
obtains higher ranking by the classifier than a randomly chosen negative sample
does (Fawcett, 2006). The advantage of AUC as a performance measure is
its independency from the chosen discrimination threshold. Unlike ACC, the
AUC is not sensitive to the prior class probabilities and class specific error costs
(Airola et al., 2010). This aspect makes AUC a proper measure for performance
evaluations in unbalanced datasets, where the class distribution is not uniform
among the classes.
Performance measures for regression
For performance assessment in a regression problem, it is important to look
at how well the estimated model fits the test data samples. There are many
different error measures that are often used for comparing the predicted values
of the estimated regression model to the actual response variables. For instance,
mean square error MSE = 1N
∑N
i=1(yˆi − yi)2, which measures the average of
the square of the errors between the predicted yˆi and actual yi values. This
measure is used for minimizing the cost function of linear regression (see Equation
4.7). However, it is rather difficult to interpret as a performance measure. The
regression performance measures applied in this work (Publication IV and V)
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are the mean absolute error (MAE), Pearson correlation coefficient (R), and the
coefficient of determination(Q2). The mean absolute error quantifies how closely
the predicted yˆi and actual yi response variables are, as given by
MAE = 1
N
N∑
i=1
|yˆi − yi|. (4.17)
MAE provides the prediction errors in the equal scale with the original scale, i.e.,
it is a scale-dependent accuracy measure, suitable for comparing series on the
same scale. The Pearson correlation coefficient is widely used for measuring the
linear correlation between two variables, in this case between the predicted and
the actual response variables. The Pearson correlation coefficient is calculated by
R(yˆ, y) =
∑N
i=1(yˆi − ¯ˆy)(yi − y¯)√∑N
i=1(yˆi − ¯ˆy)2
√∑N
i=1(yi − y¯)2
, (4.18)
where ¯ˆy and y¯ are the mean of yˆ and y, respectively. The Pearson correlation
coefficient is simple to interpret, but it can hide the bias in the predictions, which
is made apparent by the coefficient of determination (Q2). The Q2 provides a
measure of how accurate predicted response variables are estimated by the model
according to the proportion of variance explained by the model. It is defined as
Q2 = 1−
∑N
i=1(yi − yˆi)2∑N
i=1(yi − y¯)2
, (4.19)
where y¯ is the mean of the actual outputs. The coefficient of determination is a
measure of how well the regression model estimates the actual response variables.
These three evaluation metrics (MAE,R,Q2)are used to evaluate the regression
model in the current work to provide complementary information.
5 Methods: Magnetic
Resonance Image Analysis
This chapter provides a description of the MRI analysis approaches used in this
thesis. First, a general description on structural MRI analysis is provided. Next,
we describe Voxel-based morphometry and cortical thickness analysis. Voxel-based
morphometry is used for preprocessing the ADNI MRI data used in Publications I,
II, III and IV, and cortical thickness analysis is used for preprocessing the ABIDE
MRI data used in Publication V.
5.1 Magnetic Resonance Imaging
The structural MRI technique provides a powerful tool for visualizing brain
structure in vivo and the ability to investigate brain abnormalities associated with
various neuropsychological disorders (Ashburner, 2009; Chen et al., 2011; Matsuda
et al., 2012; Takao et al., 2010). Brain disorders, such as Alzheimer’s disease and
autism, may cause pathological distortions within the brain that can be detected
as abnormal changes in the brain tissue using the MRI technique. Most typically,
MRI is used for assessing the morphological brain features for analyzing different
structural aspects of the brain like shape, size, and volume (Horton et al., 2014).
For analyzing a structural MRI, different approaches have been developed through
which researchers can quantify subtle alterations in the brain of diseased subjects.
Selecting the appropriate MRI analysis approach is critical to successfully identify
the disease-related structural abnormalities (Winkler et al., 2010).
A traditional approach for MRI analysis is a ROI-based technique, which is
performed either by visual assessment and manual tracing of different regions
across the brain (Chupin et al., 2009; Keller and Roberts, 2009; Takao et al.,
2010) or by automatic techniques (Lopez-Garcia et al., 2006; Ortiz et al., 2014).
The ROI-based technique for MRI analysis is a well-established method in clinical
trials and provides the possibility to investigate sub-regional neuroanatomical
changes across the brain (Holland et al., 2009). However, this method is limited
to individual anatomical regions with constant boundaries. Moreover, the man-
ual ROI-based MRI analysis is extremely time consuming and requires expert
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anatomical knowledge. ROI-based MRI analysis has been used in a number of
studies in ASD (Amaral et al., 2008; Hardan et al., 2000; Schumann et al., 2004)
and AD disorders (Chan et al., 2001; Wang et al., 2015b). Typically in these
studies, the morphometric measurements have been obtained from clearly defined
brain regions, such as the volume of hippocampus or amygdala. Then these
morphometric measurements are used for the quantitative analysis of sub-regional
brain structure (Ashburner and Friston, 2000).
Recently, a number of automated techniques have been developed for the analysis
of MRI data; unlike ROI-based analysis, these techniques are appropriate for
investigating the anatomical changes throughout the whole brain. Voxel-based
morphometry (VBM) and cortical thickness analysis are the two automated
techniques now widely used for examining the grey matter morphometric changes
in various diseases (Honea et al., 2005; Jiao et al., 2010; Lerch et al., 2005; Matsuda
et al., 2012). In the following sections, we provide a brief description of VBM and
the cortical thickness approaches for MRI analysis.
5.2 Voxel-based Morphometry
Voxel-based morphometry is an automated MRI analysis technique used for
quantifying the local concentration of grey matter across subjects. The use
of VBM-based analysis allows researchers to comprehensively investigate the
entire brain, in a voxel-wise manner. This method has been widely used for
the investigation of subtle brain alterations between groups with different brain
disorders (Boddaert et al., 2004; Bora et al., 2012; Honea et al., 2005; Zhang and
Davatzikos, 2013). VBM-based MRI analysis consists of several steps, including
spatial normalization for image alignment into standard space, segmentation
for tissue classification, modulation for adjusting the volume changes during
normalization, and spatial smoothing for calculating a weighted average of the
surrounding voxels for each point followed by the final step of statistical analysis
(Ashburner, 2009; Kurth et al., 2015).
Spatial normalization. The procedure starts with the spatial normalization of
high resolution MR images into the same stereotactic space by registering each
MR image into the same template image. This step is done to correct global
brain shape differences. Spatial normalization consists of affine transformation,
which includes translation, rotation, scaling, and shearing for each dimension
of the image, followed by a nonlinear step (Ashburner and Friston, 1999) to
compensate for the local differences in position, size, and shape of the images.
After registration of the MR images to the same template, the location of a voxel
in one image corresponds to the location of the same voxel in another image.
Segmentation. After normalization, brain images are segmented into tissue
classes of gray matter (GM), white matter (WM), and cerebrospinal fluid (CSF).
The segmentation is done based on image intensity and a priori probability maps,
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which encode the knowledge of the spatial distribution of different tissues (Mechelli
et al., 2005). Tissue classification can also includes correction for image intensity
non-uniformity (Ashburner and Friston, 2000). Finally, a modulation step is
undertaken on individual partitioned tissue maps to correct changes in the brain
volume caused by nonlinear spatial normalization. This step is done by multiplying
the spatially normalized tissue class by its relative volume before and after spatial
normalization. In particular, modulation converts the relative concentration of a
tissue class in a spatially normalized images into its absolute volume. (Mechelli
et al., 2005)
Spatial smoothing. This is a prior step to statistical analysis. In this stage,
the GM or WM images are smoothed by convolution with an isotropic Gaussian
kernel. In this way, each voxel contains the weighted average amount of GM
or WM from the surrounding voxels. The size of the kernel determines the
number of surrounding voxels for each point, selected based on the size of the
expected regional differences between the groups. The smoothing step is important
in statistical analysis because it makes the data more normally distributed as
required for using parametric statistical tests. (Takao et al., 2010)
After all these steps, the actual statistical analysis starts in which the differences
within the groups of subjects can be investigated in a voxel-wise manner. For
MRI processing of our ADNI data in Publications I, II, III, and IV, we used
voxel-based morphometry. This approach is considered suitable for studying AD,
and it has been used extensively for investigation of AD- related abnormalities in
recent years (Jednorog et al., 2015; Matsuda et al., 2012; Wang et al., 2015a).
5.3 Cortical Thickness Analysis
Cortical thickness analysis (Hutton et al., 2009) has been increasingly used for
investigating the cortical anatomy of the brain. Estimation of cortical thickness
measurements from a MRI is typically based on the inner and outer cortical
boundaries of gray matter, performed by using surface-based (Fischl and Dale,
2000; MacDonald et al., 2000) or voxel-based techniques (Hutton et al., 2008).
The procedure can start by doing brain tissue classification into GM, WM, and
CSF; this step is similar as the segmentation in VBM-based MRI analysis (Hutton
et al., 2009). In a surface-based technique for estimation of cortical thickness
measurements, the image information and surface geometry are used to construct
the gray and white matter surfaces. Then the cortical thickness measure is derived
by estimating the distance between the two surfaces in each point. In the voxel-
based technique, the cortical thickness measurements are defined based on voxel
information by using the length of the trajectory between the two boundaries. The
cortical thickness measurements are used in different brain studies, such as normal
aging studies (Hutton et al., 2009; Khundrakpam et al., 2015), studies related to
human intelligence (Choi et al., 2008), and studies various neurological disorders
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(Cannon et al., 2015; Lerch et al., 2005; Smith et al., 2016). For MRI processing
of our ABIDE data in Publication V, we used cortical thickness measurements.
Recently, this approach has been used extensively in different ASD- related studies
for the investigation of brain abnormalities (Jiao et al., 2010; Sato et al., 2013;
Smith et al., 2016).
6 Summary of Research Efforts
This chapter offers a summary of publications included in this thesis. Section 6.1
describes the research done on ADNI data with Alzheimer’s disease and Section
6.2, describes the research work related to ASD using multi-site ABIDE data that
is followed by an overall discussion. Finally, the author’s contributions to the
publications are explained in Section 6.4.
6.1 Contributions of Publications I, II, III, and IV
6.1.1 ADNI data
The data used for studying AD were obtained from the Alzheimer’s Disease
Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). The ADNI was
launched in 2003 as a public-private partnership, led by Principal Investigator
Michael W. Weiner, MD. The ADNI was launched in 2003 by the National Institute
on Aging (NIA), the National Institute of Biomedical Imaging and Bioengineering
(NIBIB), the Food and Drug Administration (FDA), private pharmaceutical
companies and non-profit organizations, as a $60 million US, 5-year public-private
partnership. The primary goal of ADNI has been to test whether serial MRI, PET,
other biological markers, and clinical and neuropsychological assessments can be
combined to measure the progression of MCI and early AD. Determination of
sensitive and specific markers of very early AD progression will aid researchers and
clinicians in their development of new treatments and monitor their effectiveness,
as well as lessen the time and cost of clinical trials.
The Principal Investigator for this initiative is Michael W. Weiner, MD, VA
Medical Center and University of California San Francisco. ADNI is the result of
the efforts of many co-investigators from a broad range of academic institutions
and private corporations and their subjects recruited from more than 50 sites
across the U.S. and Canada. The initial goal of ADNI was to recruit 800 subjects,
but ADNI was followed by ADNI-GO and ADNI-2. To date, these three protocols
have recruited over 1500 adults, ages 55 to 90, to participate in research, consisting
of cognitively normal older individuals, people with early or late MCI, and people
with early AD. The follow up duration of each group is specified in the protocols
for ADNI-1, ADNI-2, and ADNI-GO. Subjects originally recruited for ADNI-1 and
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ADNI-GO had the option to be followed in ADNI-2. For up-to-date information,
go to www.adni-info.org.
Data used in this effort include all subjects for whom baseline MRI data (T1-
weighted MP-RAGE sequence at 1.5 T, typically 256 × 256 × 170 voxels with
a voxel size of approximately 1 mm × 1 mm × 1.2 mm), at least moderately
confident diagnoses (i.e. confidence > 2), hippocampus volumes (i.e. volumes of
left and right hippocampi, calculated by FreeSurfer Version 4.3), and test scores on
certain cognitive scales (i.e. ADAS: Alzheimer’s Disease Assessment Scale, range
0–85; CDR-SB: Clinical Dementia Rating ‘sum of boxes’, range 0–18; MMSE:
Mini-Mental State Examination, range 0–30) were available. For a diagnostic
classification at the baseline, 825 subjects were grouped as:
1. AD (Alzheimer’s disease), if diagnosis was Alzheimer’s disease at baseline
(n = 200);
2. NC (normal cognitive), if diagnosis was normal at baseline (n = 231);
3. sMCI (stable MCI), if diagnosis was MCI at all available time points (0–96
months), but at least for 36 months (n = 100);
4. pMCI (progressive MCI), if diagnosis was MCI at baseline, but conversion
to AD was reported after the baseline within 1, 2, or 3 years, and without
reversion to MCI or NC at any available follow-up (0–96 months) (n =
164);
5. uMCI (unknown MCI), if diagnosis was MCI at baseline, but the subjects
were missing a diagnosis at 36 months from the baseline, or the diagnosis
was not stable at all available time points (n = 130).
We used various datasets of subjects in each work for different purposes. Details
are provided in Section 6.1.3.
6.1.2 Image processing
As described in Publications I, II,III, and IV, preprocessing of the T1-weighted
images was performed using the SPM8 package 1 and the VBM8 toolbox2, running
under MATLAB. All T1-weighted images were corrected for bias-field inhomo-
geneties and then spatially normalized and segmented into gray matter (GM),
white matter, and cerebrospinal fluid (CSF) within the same generative model
(Ashburner and Friston, 2005). The segmentation procedure was further extended
by accounting for partial volume effects (Tohka et al., 2004), by applying adaptive
maximum a posteriori estimations (Rajapakse et al., 1997), and using a hidden
1http://www.fil.ion.ucl.ac.uk/spm
2http://dbm.neuro.uni-jena.de
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Markov random field model (Cuadra et al., 2005) as described previously (Gaser,
2009).
Figure 6.1: MRI Axial section before preprocessing (left) and after preprocessing (right)
taken from an 84.9 years old cognitively normal man.
This procedure resulted in maps of tissue fractions of WM and GM. Only the
GM images were used in this research effort. Following the pipeline proposed
by (Franke et al., 2010), the GM images were processed with affine registration
and smoothed with 8-mm full-width-at-half-maximum smoothing kernels. After
smoothing, images were re-sampled to a 4 mm isotropic spatial resolution. This
procedure generated, for each subject, 29852 aligned and smoothed GM density
values that were used as MRI features. Fig. 6.1 shows an axial section of MRI
before applying the described image preprocessed steps (left) and after them
(right) taken from an 84.9 years old cognitively normal man.
6.1.3 Research Summary
The use of machine learning approaches for the development of a MRI-based
biomarker in AD conversion prediction is a challenging process for many technical
reasons. In this work, we investigated the key challenges for the use of MRI data
in a ML-based study of AD within different frameworks. In the following section,
a brief description of each work is presented.
Semi-supervised Learning for MRI based AD Conversion Prediction
(Publication I)
One of the main challenges in machine learning-based, neuroimaging studies of
brain disorders is the insufficient number of labeled data samples for such learning
due to difficulty in collecting labeled data samples. The use of a semi-supervised
approach provides the possibility of using unlabeled data in conjunction with
labeled data to design improved models with limited labeled data samples. In
Publication I, we investigated the use of semi-supervised learning (SSL) approaches
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for predicting AD in MCI patients based on only MRI data. Considering the
difficulty of collecting labeled data samples, i.e., pMCI and sMCI for predicting AD
in MCI patients, the aim of this work was to determine how to gain improvement
by using unlabeled data (uMCI subjects) and using semi-supervised learning over
supervised approaches. To this end, we studied the use of two well-known, cluster
based, semi-supervised methods, i.e., low density separation (LDS) and semi-
supervised discriminant analysis (SDA), in the classification of pMCI vs. sMCI
subjects. We compared the performance of these methods to the corresponding
supervised methods by using real and synthetic MRI data for MCI subjects.
In the context of semi-supervised learning, it is important to understand the
value of unlabeled data in the performance of the learned model as well as to
determine when the unlabeled data are truly useful. Therefore, we investigated
the relationship between a different proportion of labeled and unlabeled data in
order to establish bounds of utility for the use of unlabeled data. Further, with the
simulated data, the effect of data variance in the performance of semi-supervised
approaches was explored. Since the cluster assumption breaks down with higher
variance, we generated different datasets by varying the variance in the data and
comparing the performance of the semi-supervised approaches in these datasets.
With real MRI data, i.e., MRI data of MCI subjects from ADNI, the use of
unlabeled data and semi-supervised methods markedly improved the classification
performance of sMCI vs. pMCI subjects. These results are illustrated in Fig.1 of
Publication I, which shows the classification performance (based on AUC) of LDS
and SDA compared to SVM and LDA. Based on these results, AD conversion
prediction significantly improved in MCI patients by using both studied semi-
supervised methods (LDS and SDA) and uMCI data, independently on how
many labeled samples were available. More importantly, even a small number of
unlabeled samples improved the conversion predictions. With the simulated data,
the use of unlabeled data improved the classification performance in most cases.
However, as expected, the improvement was quite dependent on the noise level
in the data (see Table 1 and 2 of Publication I). These experiments showed that
data variance is a major factor in the performance of the studied semi-supervised
methods, especially in the case of the LDS method; in this case, adding unlabeled
data degraded the performance of the predictive model when data variance was
high.
Moreover, we used semi-supervised learning in designing our MRI biomarker for
predicting AD in MCI patients in Publication II. We applied LDS on the MRI data
of MCI subjects, i.e., pMCI, sMCI and uMCI, to produce the disease prediction
in MCI patients.
Aggregate Biomarker for AD Conversion Prediction (Publication II)
Beside the MRI data, we are considering the cognitive information of the subjects,
obtained with distinct cognitive tests for AD conversion prediction. Therefore, we
are aiming for the development of a more accurate biomarker, which integrates
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different data types in an efficient way. In Publication II, we developed an
aggregate biomarker for predicting AD in MCI patients by combining MRI data
with several cognitive measures via a random forest (Breiman, 2001) classifier.
More specifically, the aggregate biomarker is produced via a multi-step procedure
that combines several ideas into a coherent framework including:
• Removing normal aging effects from the MRI data before training the
classifier to prevent possible confounding between AD and age related
atrophies.
• Feature selection via elastic-net logistic regression in AD and NC subjects
for selecting the most relevant brain voxels corresponding to AD.
• Designing MRI biomarker via low density separation based on the MRI data
using all MCI subjects, i.e., sMCI, pMCI, and uMCI subjects.
• Developing the aggregate biomarker by integrating the MRI biomarker with
patient’s cognitive measurements via random forest.
Figure 6.2: Workflow of the aggregate biomarker.
The framework of the aggregate biomarker is illustrated in Fig. 6.2. Each of
these steps provides a significant contribution to the accuracy of the combined
prediction model. Removing aging effects and feature selection are pre-steps for
classifier training. The rationale for removing aging effects from MRI data is
related to the fact that the effects of normal aging on the brain are likely to be
similar (equally directed) to the effects of AD, leading to an overlap between
the brain atrophies caused by age and AD. This overlap, in turn, produces a
possible confounding effect on the estimation of disease-specific differences (Franke
et al., 2010; Dukart et al., 2011). We thus estimated the age-related effects on
the gray matter densities of healthy subjects via a linear regression model and
consequently removed the estimated aging effect from gray matter densities of all
subjects. Thereafter, a feature selection stage based on an elastic-net regularized
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Table 6.1: Summery of the main results in Publication II. The results are after feature
selection and removing aging effect.
Classifier Data AUC ACC SEN SPE
SVM MRI (age removed) 74.30% 69.15% 86.73% 40.34%
LDS (MRI biomarker) MRI (age removed) 76.61% 74.74% 88.85% 51.59%
LDS + RF (aggregate biomarker) MRI (age removed)+ CM 90.20% 81.72% 86.65% 73.64%
logistic regression was applied to the MRI data of NC and AD subjects to select
a task-related discriminative subset of MRI voxels.
Training the classifier was a two-step procedure consisting of first designing the
MRI biomarker based on semi-supervised learning and then combining the MRI
biomarker with the cognitive measures based on supervised learning to form the
aggregate biomarker. In the first step, low density separation was applied to the
MRI data of all MCI subjects, i.e., sMCI, pMCI, and uMCI subjects. The use of
a semi-supervised learning approach instead of supervised learning in this step
provides the opportunity of utilizing uMCI subjects in the learning phase. For
the second step, we constructed the aggregate biomarker via a simple classifier
ensemble i.e., a random forest classifier. Table 6.1 shows the main results and the
improvement gained by each step described above.
Combining different machine learning approaches when developing the aggregate
biomarker provides us the opportunity to use different available data types in a
very efficient way and obtain the most information. Considering the value of each
step in the predictive performance of the aggregate biomarker, the combination
of the MRI data with the cognitive measures was the most beneficial step for the
high performance of the aggregate biomarker. Particularly, the combination of
MRI data with cognitive measures is crucial to achieve good estimation accuracy
for the AD conversion prediction. The simplest method is to combine the MRI
data and the cognitive measurements as a long feature vector and using that
vector as a feature set for the classifier. However, this is not a proper way due
to the different natures of MRI data (close to continuous) and the cognitive
measurements (mainly discrete) (Zhang et al., 2011). Therefore, we integrated the
MRI biomarker, derived by a LDS classifier, as a feature representing AD-related
structural atrophy with age and cognitive measurements. This new feature set
was used as input for the random forest (RF) classifier. An RF consists of a
collection of decision trees all trained using different subsets of the original data,
outputting vote counts for different classes. Therefore, the aggregate biomarker
approximates the probability of converting to AD for each MCI patient. Fig. 6.3
show the AUC curve for different ways of combining the MRI data and cognitive
measurements when constructing the aggregate biomarker.
Moreover, the importance of each measure, i.e., MRI, age, and cognitive test, were
evaluated in the prediction of AD in MCI patients through random forest. Since,
random forest can produce an estimate of feature importance via an out-of-bag
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Figure 6.3: ROC curves of subject’s classification to sMCI or pMCI using only MRI ,
i.e., MRI biomarker, only age and CM, i.e., RF(age and MRI), and with MRI, age and
cognitive measurements with different combination ways. (Fig. 6 of Publication II)
error estimate (Breiman, 2001; Liaw and Wiener, 2002), it is often used for ranking
the importance of input variables. Fig. 9 of Publication II shows the importance
of different measures that are utilized for constructing the aggregate biomarker.
According to this figure, the MRI biomarker and RAVLT cognitive measure are
the most important features, followed by the ADAS-cog total, FAQ, ADAS-cog
total Mod, age, CDR-SB, and MMSE for predicting a conversion to AD.
The Feature Selection for Whole Brain MRI (Publication III)
A fundamental problem when using MRI-based supervised classification algorithms
is the high dimensionality of the data due to a high number of voxels in the images
of a single subject. A typical solution for this problem is dimensionality reduction
or feature selection approaches. In Publication III, we analyzed various data
driven feature selection and classification methods for the whole brain voxel-based
classification analysis of the structural MRI data for two different problems: 1)
Classification of AD vs. NC and 2) classification of MCI vs. NC with two different
sample sizes. The main difference between these two problems is the degree of
complexity, as the classification of MCI vs. NC subjects can be considered a much
harder problem than AD vs. NC classification. Moreover, as MCI is a transitional
stage between normal aging and dementia, the classification of MCI vs. NC is a
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more relevant problem for clinical purposes. We studied filter-based and stability
selection-based approaches as well as different embedded feature selection methods.
These methods were compared with respect to their classification accuracy and
variation due to independent subject samples, as well as the stability of the
selected features between different subject samples. For the filter-based feature
selection approach, we applied the t-test (Inza et al., 2004) followed by a linear
SVM classifier. For embedded feature selection approaches, we considered LASSO,
elastic-net and GraphNet specified for neuroimaging applications.
The results of this study showed the importance of larger sample size, since
the larger sample size resulted in significant improvement in both problems
(AD vs. NC and MCI vs. NC). However, for the more complex problem, i.e.,
MCI vs. NC, the performance of different methods differed significantly, as
especially the performance of embedded feature selection methods (elastic-net and
graphnet) was significantly higher than the filter-based methods. Moreover, the
experiments showed that an increasing complexity of the classification problem
reduced the stability of selected features with different feature selection methods.
The consistency of those results also increased with increasing the sample size.
In addition to Publication III, where we comprehensively studied various feature
selection techniques for the sMRI-based machine learning study of AD, feature
selection was used as an important step in the remaining Publications. In order
to select the most relevant features among all the candidates’ features, elastic-net
regularizer was applied with either a logistic regression classifier for classification
problems (Publications I and II) or a linear regression model for regression
problems (Publications IV and V).
Predicting RAVLT From Gray Matter Density (Publication IV)
Integrating neuropsychological test information and brain atrophy biomarkers
would be extremely valuable for early AD diagnosis. In Publication II, we showed
the value of cognitive measures in the AD conversion prediction. Among the
different cognitive measures used in constructing the aggregate biomarker, the
RAVLT was the most important measure in the predictive model as determined by
the out-of-bag variable importance score in the random forest classifier (Breiman,
2001; Liaw and Wiener, 2002). In publication IV, we explored the association
between the RAVLT cognitive measures (RAVLT immediate and RVLT percent
forgetting (see Section 2.2 of Publication IV)) and AD-related structural brain
atrophy. In particular, we predicted RAVLT scores from gray matter density
images by applying elastic-net linear regression to form a multivariate brain atrophy
pattern for predicting the RAVLT scores. We considered various datasets of
subjects with different AD severity levels in the learning and evaluation procedures
when evaluating the dependency between the RAVLT cognitive measures and the
AD-related structural atrophy.
The results of this study revealed a strong association between information detected
by the RAVLT cognitive scores and the AD-related structural atrophy. Table 6.2
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Table 6.2: Summery of the main results in Publication IV.
AD, MCI, NC AD, NC AD,MCI MCI, NC AD MCI
RAVLT R = 0.50 R = 0.61 R = 0.39 R = 0.43 R = 0.32 R = 0.15
immediate Q2 = 0.25 Q2= 0.37 Q2 = 0.15 Q2 = 0.18 Q2 = 0.10 Q2 = 0.02
MAE = 7.86 MAE = 8.30 MAE = 6.57 MAE = 7.88 MAE = 5.57 MAE = 6.92
RAVLT R = 0.43 R = 0.53 R = 0.29 R = 0.32 R = -0.14 R = 0.16
percent Q2 = 0.185 Q2= 0.28 Q2 = 0.08 Q2 = 0.09 Q2 = -0.03 Q2 = 0.02
forgetting MAE = 25.53 MAE = 25.33 MAE = 23.39 MAE = 26.58 MAE = 14.08 MAE = 26.07
shows the generalization performance for the prediction of RAVLT scores using
different datasets based on elastic-net linear regression. As expected, including
subjects from similar groups, such as “AD and MCI” or “NC and MCI” produced
lower predictive performance compared to using groups of subjects with significant
structural differences within the brain, such as “AD and NC”. According to
these results, both the studied RAVLT measures, i.e., RAVLT Immediate and
RAVLT Percent Forgetting, are reliable measures for AD diagnosis, and reflect
the underlying AD pathology well.
6.2 Contributions of Publication V
6.2.1 ABIDE data
The data used in this study were obtained from the ABIDE database (Di Martino
et al., 2009). ABIDE is a publicly available dataset that involved 16 international
sites, from 532 individuals with ASD and 573 typical controls, yielding 1112
datasets composed of MRI (functional and structural) and phenotypic information
for each subject. The sequence parameters as well as the type of scanner varied
across the sites, though all data were collected using 3 T scanners. The scan
procedures and parameters are described on the ABIDE website.
In this study, only ASD subjects were included. Image preprocessing and the
QC decreased the number of ASD subjects from 532 to 317 from 16 different
sites. Next, we excluded ASD subjects with missing ADOS total and module
information and then included only subjects from sites containing at least 20
subjects. The remaining 156 subjects came from 4 different sites (NYU, PITT,
TRINITY, USM) which were used for estimating the severity score in autistic
patients.
6.2.2 Image processing
The T1-weighted volumes were processed using CIVET, a fully automated struc-
tural image analysis pipeline developed at the Montreal Neurological Institute.
CIVET corrects intensity non-uniformities using N3 (Sled et al., 1998); aligns
the input volumes to the Talairach-like ICBM-152-nl template (Collins et al.,
1994); classifies the images into white matter, gray matter, cerebrospinal fluid, and
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background (Tohka et al., 2004; Zijdenbos et al., 2002); extracts the white-matter
and pial surfaces (Kim et al., 2005); and warps these to a common surface template
(Lyttelton et al., 2007). Cortical thickness (CT) is measured in native space using
the linked distance between the two surfaces at 81,924 vertices. The thickness map
was then blurred to impose a normal distribution on the corticometric data and
to increase the signal to noise ratio; a 30-millimeter full width at half maximum
surface-based diffusion smoothing kernel was used.
Quality control (QC) on the CIVET results was performed by two independent
reviewers. Data with artifacts due to motion, low signal to noise ratio, hyperin-
tensities from blood vessels, or poor placement of the gray or white matter (GM
and WM) surfaces for any reason were excluded.
6.2.3 Research Summary
Recently, large multi-center datasets are becoming available for studying different
brain disorders including the autism spectrum disorder. For estimating disease
severity from cortical thickness measurements in autistic patients, we are con-
sidering a dataset collected in four different centers without any standardization
protocol. Therefore, we are aiming for the development of a domain-based adapta-
tion approach to maximize the consistency of the imaging measures over multiple
scanners before assessing the ASD pathology. In Publication V, we developed a
novel approach for estimating ASD severity score in multi-site ABIDE data. The
proposed approach has two main steps:
• Domain adaptation stage: Dividing the cortical thickness measures into
separate regional subsets according to the Automated Anatomical Labeling
(AAL) atlas, and applying PLS in each subset separately to produce the
region-specific site-adapted subsets of cortical thickness components.
• Learning stage: Applying SVR to each site-adapted subset separately and
then, concatenating the resulted outputs as a new dataset for use as input
with elastic-net linear regression to estimate the ASD severity score.
The framework of this proposed approach is illustrated in Fig. 6.4. The main
novelty of our approach is it addresses the challenges associated with multi-site,
multi-protocol data for machine learning analysis. In addition to the PLS-based
domain adaptation, the other novel technical characteristic of the proposed method
is our treatment of the whole-brain problem of prediction as a set of regional
prediction problems. We divide the cortical thickness measures into regional
subsets, determine a predictive score for each region separately, and then combine
the regional scores into a whole brain measure of disease severity. This process
allows us to divide the problem into several sub-problems with lower complexity
while better retaining the original spatial resolution of the thickness measures.
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Figure 6.4: The workflow for estimating severity score in ASD subjects.
According to the experimental results in Publication V (see Fig 3 of Publication
V), both of these properties are important for successful predictions. Moreover,
the importance of each brain region for predicting symptom severity is evaluated
based on the absolute value of each regression coefficient in an elastic-net linear
regression model. Fig 5 in Publication V shows the importance of top brain
regions and Fig 6 provides a visualization of those regions.
The proposed approach resulted in a significantly higher predictive performance
than has previously been reported in the literature on multi-site data. The results
of this work demonstrate the utility of the proposed approach for detecting ASD-
related structural brain abnormalities from the multi-site, multi-protocol ABIDE
dataset and indicates the potential of designing machine learning methods to meet
the challenges of agglomerative data successfully.
6.3 Discussion
The previous sections have introduced a summary of the main contributions from
the publications presented in this thesis. These contributions can be broadly
divided into two categories; 1) investigating the main technical challenges for the
use of ML algorithms in MRI data, and 2) developing ML based methods for
predicting AD as well as detecting disease severity in ASD patients using mainly
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MRI data.
For investigating the main challenges associated with the use of ML approaches
in MRI data, we studied the use of various feature selection techniques, semi-
supervised learning approaches as well as domain adaptation methods. Different
feature selection techniques were utilized for selecting the most discriminative
voxels between AD and NC subjects or MCI and NC subjects in ADNI MRI
data (Publication III). We found that regularizer approaches, especially elastic-
net regularizer, is a very efficient way for reducing the dimensionality of MRI
data. More specially, these approaches provide the possibility to embed feature
selection step into model training, while at the same time being computationally
efficient (Saeys et al., 2007). These approaches have been increasingly applied and
developed for feature selection in various neuroimaging applications (Casanova
et al., 2011b; Huttunen et al., 2013; Khundrakpam et al., 2015).
One of the major goals of this research work was to investigate the use of unlabeled
MCI subjects with semi-supervised learning in predicting AD in MCI patients.
This idea was studied in Publications I & II. The results of Publication I, show
the advantage of the use of semi-supervised learning over traditional supervised
learning by using real MRI data from ADNI, and simulated MRI data. In this study,
we provided evidence that adding unlabeled data improves significantly the MRI-
based AD conversion prediction, but the size of improvement is strongly dependent
on the number of labeled data samples used in the training phase. In Publication
II, the semi-supervised method (LDS) was shown to outperform its counterpart
supervised method (SVM) in the design of MRI biomarker. However, adding
uMCI subjects as unlabeled data in the semi-supervised learning procedure (LDS
classifier) only provided slightly improvement in the classification performance
and the improvement was not enough to reach the statistical significance. This is
probably due to a relatively small number of uMCI subjects compared to existing
labeled MCI subjects. Basically, in semi-supervised learning approaches, the size
of an unlabeled dataset is assumed to be much greater than the size of a labeled
dataset (Zhu and Goldberg, 2009). Due to limited amount of existing unlabeled
MCI subjects, this problem was not further studied.
We also explored the issues associated with multi-site, multi-protocol data for
designing ML based predictive model in order to take advantage of the increased
sample sizes provided from different scanners. This technical problem was studied
in Publication V for predicting symptom severity in ASD patients from cortical
thickness measurements, by using data from four sites from the ABIDE dataset.
The effect of scanner variation in multisite analyses of cortical thickness abnormal-
ities in ASD patients was previously studied by Auzias et al. (2014, 2016). They
showed that scanner variation is a significant confounding factor that is distributed
across the cortical surface. In order to maximize the consistency of the imaging
measures over the multiple scanners/protocols, we developed a PLS based domain
adaptation approach that is applied on cortical thickness measurements prior to
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actual learning phase. Adding PLS based domain adaptation step significantly
improved the predictive performance of the model for estimating symptom severity
in ASD patients compared to the results of a model designed by any of the sites
alone. These results indicate the potential role of suggested approach for designing
machine learning methods to meet the challenges of agglomerative data.
In addition, we have introduced a new biomarker, i.e., the aggregate biomarker, for
predicting AD in MCI patients by integrating structural MRI data and neuropsy-
chological test results (Publication II) as well as a new computational approach
for predicting disease severity in autistic patients by automatically combining
structural information obtained from different brain regions (Publication V). We
also analyzed the relationship between disease-related structural changes and
cognitive states of patients with Alzheimer’s disease in order to find how accurately
the cognitive state of the patients reflect the structural atrophy caused by AD
(Publication IV).
For constructing the aggregate biomarker, we proposed a novel way of integrating
MRI data (MRI biomarker) and cognitive measures into a single biomarker for
determining the probability of converting to AD in MCI patients. According to the
experimental results, the aggregate biomarker has strong predictive performance in
the MCI-to-AD conversion prediction. Moreover, the framework of computational
approach for predicting symptom severity in ASD patients is also novel and very
efficient, especially for analyzing high dimensional neuroimaging data. In this
framework, the cortical thickness measures of each brain region is separately
analyzed and the structural information obtained from different brain regions are
combined into a single value for determining the ASD symptom severity. This
treatment of the whole-brain problem of prediction as a set of regional problems of
prediction enabled us to divide the problem into several sub-problems with lower
complexity while better retaining the original spatial resolution of the thickness
measures.
In this work we have focused on the use of structural MRI data and cognitive
measures of the patient in our analysis, as it was the primary goal of the thesis.
However, a very fascinating research area would be to analyze the integration of
neuroimaging data with other data types such as genetic information that are
known to contain useful information in studying brain disorders.
6.4 Author’s Contribution to the Publications
In Publications I, II, IV and V, the author of this thesis, as first author, imple-
mented the methods and performed the experiments and bore the main respon-
sibility for the preparation of the manuscripts. The preprocessing of data was
done in all by the co-authors. The ideas for designing the methods were formed
in collaboration with the thesis supervisor, Jussi Tohka.
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In Publication III, the author of this thesis was the second author and responsible
for the execution of the experiments that were computationally demanding. She
also contributed to the methods implementation and the writing of the manuscript.
7 Conclusion
Machine learning applications are becoming increasingly important in the neu-
roimaging studies of various brain disorders. These techniques give investigators
a powerful tool for analyzing complex data and thus make it possible to utilize
the large amounts of neuroimaging and clinical data that have recently been
made available by the many initiatives for studying different brain disorders. The
purpose of this effort was to develop new computational approaches for structural
MRI-based studies of Alzheimer’s disease and the autism spectrum disorder by
using publicly available data from the ADNI and ABIDE databases.
In this research work, the existing technical challenges associated with the use
of machine learning approaches in neuroimaging studies of brain diseases were
specifically addressed. The key challenges studied included the high dimensionality
of MRI data, the limited number of labeled training data samples and analysis
of multi-site datasets. Different feature selection approaches were explored for
the problem of high dimensionality of MRI data (Publication III), while semi-
supervised methods were proposed for the problem of limited number of labeled
training data samples (Publication I). These two problems were investigated with
the ADNI and Alzheimer’s disease dataset, due to suitability of this dataset for
studying the challenges. A domain adaptation method was utilized for addressing
the challenge associated with multi-site, multi-protocol data for machine learning
analysis (Publication V). This problem was studied in the multi-site ABIDE
dataset for estimating disease severity in ASD patients.
In addition to investigating these challenges, we developed a new computational
approach for predicting the conversion to AD in MCI patients, i.e., the aggregate
biomarker (Publication II), as well as a novel approach for the estimation of
disease severity in autistic patients (Publication V). These two approaches are
the main contributions of these thesis. Further, we built a predictive model to
use for investigating the relationship between disease-related structural changes
and the cognitive state of patients with Alzheimer’s disease (Publication IV).
Overall, this thesis provides a comprehensive analysis of the use of machine
learning applications in the neuroimaging field when studying brain disorders. Our
results indicate the important role of these approaches for further neuroimaging
investigation of brain disorders and understanding disease-related pathology as
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well as providing early and more accurate diagnosis opportunities. We believe that
machine learning approaches can effectively contribute to bringing new insights
to certain challenging questions in the neuroscience field that have to date hardly
been addressed. More research work is still required to make these methodologies
clinically useful.
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Abstract—This paper investigates the use of semi-supervised
learning (SSL) for predicting Alzheimers Disease (AD) conver-
sion in Mild Cognitive Impairment (MCI) patients based on
Magnetic Resonance Imaging (MRI). SSL methods differ from
standard supervised learning methods in that they make use of
unlabeled data - in this case data from MCI subjects whose
ﬁnal diagnosis is not yet known. We compare two widely used
semi-supervised methods (low density separation (LDS) and semi-
supervised discriminant analysis (SDA)) to the corresponding
supervised methods using real and synthetic MRI data of MCI
subjects. With simulated data, using SSL instead of supervised
learning led to higher classiﬁcation performance in certain cases,
however, the applicability of semi-supervised methods depended
strongly on the data distributions. With real MRI data, the SSL
methods achieved signiﬁcantly better classiﬁcation performances
over supervised methods. Moreover, even using a small number
of unlabeled samples improved the AD conversion predictions.
I. INTRODUCTION
Mild Cognitive Impairment (MCI) is a transitional stage
between age-related cognitive decline and Alzheimers disease
(AD). For the effective treatment of AD, it would be important
to identify MCI patients with the high risk for conversion to
AD. Neuroimaging data is considered to be important for the
task because the progression of the AD pathology within the
brain starts many years before clinical symptoms and various
machine learning algorithms have been applied to construct
neuroimaging biomarkers to predict MCI-to-AD conversion at
an individual level, e.g., [1], [2]. However, the success of these
methods has been limited so far, with a possible exception
of the short-term conversion prediction [1]. One reason for
this is probably the limited number of labeled data available:
collecting data labels is challenging, since at the time of
imaging it is not known whether an MCI subject will develop
AD or not and subjects have to be followed-up for several
years after the imaging to obtain a reliable clinical diagnosis.
Semi-supervised learning (SSL) is halfway between super-
vised and unsupervised learning [3]. In addition to labeled data
(data from MCI subjects who have been followed up and it
is known if they will convert to AD or not), SSL methods
0Data used in preparation of this article were obtained from the Alzheimers
Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such,
the investigators within the ADNI contributed to the design and implemen-
tation of ADNI and/or provided data but did not participate in analysis
or writing of this report. A complete listing of ADNI investigators can
be found at http://adni.loni.usc.edu/wp-content/uploads/how to apply/ADNI
Acknowledgement List.pdf
make use of unlabeled data (data from MCI subjects for whom
reliable future diagnosis cannot be established). While in typi-
cal SSL applications in machine learning (speech recognition,
text classiﬁcation, etc.) the number of available unlabeled
data is expected to be huge, in our case the number of both
unlabeled and labeled data is relatively small. Therefore, it
is important to study when the semi-supervised learning is
useful, i.e., when unlabeled data can improve the classiﬁcation
accuracy and what the potential bottlenecks of SSL methods
are. The few SSL applications [4], [5], [6] to MRI-based
MCI-to-AD conversion prediction have used a data from AD
subjects and normal controls as the labeled data and tried to
classify the MCI subjects into two groups (progressive and
stable MCI; pMCI and sMCI). The success of these methods
has been limited, the best performing method reached area
under the ROC curve (AUC) of 0.73 for a short-term (15-
month) conversion prediction [5], but, on the other hand, the
use of unlabeled data has improved the predictions. We here
set to investigate a slightly different problem, where MRIs
from pMCI and sMCI subjects for whom a reliable diagnosis
is available are used as labeled data. Unlabeled data are MRIs
of the MCI subjects who have not been followed up for long
enough (at least 3 year follow-up is expected here) or for
who a reliable diagnosis cannot be assigned. We study semi-
supervised learning methods for the early (up to 3 years before
clinical diagnosis) detection of the MCI-to-AD conversion and
compare them to relevant supervised methods with data from
ADNI cohort and simulated data reminiscent of the ADNI data.
We will vary the number of labeled and unlabeled data to
establish bounds for the usefulness of the use of unlabeled
data. With simulated data, we will also address the feature
selection combined with semi-supervised learning.
II. MATERIALS AND METHODS
A. ADNI data
Data used in this work is obtained from the Alzheimers
Disease Neuroimaging Initiative (ADNI) database http://adni.
loni.usc.edu/. The ADNI was launched in 2003 by the National
Institute on Aging (NIA), the National Institute of Biomedical
Imaging and Bioengineering (NIBIB), the Food and Drug
Administration (FDA), private pharmaceutical companies and
non-proﬁt organizations, as a 60 million, 5-year public-private
partnership. The primary goal of ADNI has been to test
whether serial MRI, PET, other biological markers, and clinical
and neuropsychological assessment can be combined to mea-
sure the progression of MCI and early AD. Determination of978-1-4799-4149-0/14/$31.00 c�2014 IEEE
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sensitive and speciﬁc markers of very early AD progression
is intended to aid researchers and clinicians to develop new
treatments and monitor their effectiveness, as well as lessen
the time and cost of clinical trials. ADNI is the result of efforts
of many co-investigators from a broad range of academic
institutions and private corporations, and subjects have been
recruited from over 50 sites across the U.S. and Canada. For
up-to-date information, see www.adni-info.org.
We use MRIs from 404 MCI subjects, 200 AD subjects,
and 231 normal controls for whom baseline MRI data (T1-
weighted MP-RAGE sequence at 1.5 Tesla, typically 256 x
256 x 170 voxels with the voxel size of 1 mm x 1 mm x 1.2
mm) were available. The data from AD subjects and normal
controls were only used for generating simulated data and to
aid the feature selection with the classiﬁcation of MCI subjects
into pMCI and sMCI classes. For the diagnostic classiﬁcation
at baseline, 404 MCI subjects were grouped as (i) sMCI (stable
MCI), if diagnosis was MCI at all available time points, but at
least for 36 months (n = 115); (ii) pMCI (progressive MCI),
if diagnosis was MCI at baseline but conversion to AD was
reported after baseline within 1, 2 or 3 years, and without
reversion to MCI or NC at any available follow-up (n = 151);
(iii) uMCI (unknown MCI), if diagnosis was MCI at baseline
but they are not diagnosed at the end of the project (n = 138).
The MRIs were preprocessed into gray matter tissue images in
the stereotactic space as described in [1], smoothed with 8-mm
FWHM Gaussian kernel, resampled to 4 mm spatial resolution
and masked into 29852 voxels.
B. Feature selection
Due to the high dimensionality of the data (29852 fea-
tures/voxels), the feature selection is performed before ma-
chine learning analysis of the data. Because MCI is a trans-
lational stage between age-related cognitive decline and AD,
we assume that the voxels that are discriminative between AD
subjects and normal controls are also discriminative between
pMCI and sMCI subjects. Thus, we performed the feature
selection using the data from AD subjects and normal controls
(without using any data from MCI subjects). The subset of
voxels best separating AD subjects from controls was identiﬁed
using elastic net regularized logistic regression (based on a
combination of L1 (LASSO) and L2 (Ridge) regularizer) [7].
This is an embedded feature selection method that is widely
applied in neuroimaging. We selected the parameter values for
the regularized logistic regression using a parametric Bayesian
estimate of the classiﬁcation error [8], [9].
C. Simulated data generation
We generate simulated MRI data separately for both groups
(pMCI and sMCI). First, a subset of voxels discriminating AD
and healthy subjects were identiﬁed within MRI data by using
sparse logistic regression (based on L1 (LASSO) regularizer)
[7]. The analysis identiﬁed 158 voxels spread across the whole
brain with the largest number of voxels in hippocampi and
temporal and frontal cortices, matching well to previously
observed atrophy patterns in AD. These voxels are simulated
to be discriminative between pMCI and sMCI classes. Data
generation process consists of the following steps:
1) We divide the ADNI data from MCI subjects randomly into
two subsets in order to simulate training and testing datasets
separately and to model the natural variation in the data. Data
from 76 pMCI (Dptrain) and 58 sMCI (D
s
train), 75 pMCI
(Dptest) and 57 sMCI (D
s
test) subjects were used for generating
simulated training and testing datasets.
2) For 158 discriminative voxels v ∈ VD, the mean µv(G) and
variance σ2v(G) of GM image values are computed separately
for each group G = Dstest, D
s
train, D
p
test, D
p
train. For the non-
discriminative voxels v ∈ VN , µv(G) and σ2v(G) are computed
by pooling the data from two classes into Dtest = Dstest ∪
Dptest and Dtrain = D
s
train ∪ Dptrain, i.e., for these voxels
µv(D
s
test) = µv(D
p
test) and µv(D
s
train) = µv(D
p
train). A
simulated image representing a group G is created by, for each
voxel, drawing a random number from Gaussian distribution
with mean µv(G) and the variance σ20σ
2
v(G), where σ
2
0 is
parameter to be varied.
3) Finally, the data is spatially smoothed by using the 3-D
Gaussian ﬁlter with 5 mm isotropic FWHM to introduce a
spatial dependence between the voxel values.
D. Learning algorithms
We selected to study two widely used, fairly recent SSL
algorithms: low density separation (LDS) [10] and semi-
supervised discriminant analysis (SDA)[11]. We combined
SDA with 10 nearest neighbors method to perform the classiﬁ-
cations as recommended in [11]. We next give a brief overview
of the LDS and SDA algorithms and refer to [10], [11] for
details. LDS is a two step algorithm, which ﬁrst derives a
graph-distance kernel for enhancing the cluster separability and
then it applies transductive support vector machine (TSVM)
[12] for classiﬁer learning. Note that SSL methods applied
to MCI-to-AD conversion prediction include TSVM [6] and
Laplacian SVM [5]. LDS can be seen as an improved version
of TSVM and related to Laplacian SVM. SDA is a SSL
dimensionality reduction method that seeks to build a linear
projection respecting the discriminant structure from labeled
samples, such as in linear discriminant analysis (LDA), as
well as the intrinsic geometric structure from both labeled
and unlabeled samples. The LDA is a traditional supervised
dimensionality reduction that achieves the projection vector
by simultaneously maximizing the between class separability
and minimizing the within-class separability of the labeled
samples. However, in the case of scarce labeled samples over-
ﬁtting may occur leading to inaccurate projection direction.
A common way to prevent overﬁtting is adding a regularizer.
When a set of unlabeled samples is available, SDA incorpo-
rates the information from unlabeled samples via a graph based
regularization into the LDA objective function.
The support vector machine (SVM) with a RBF kernel
as implemented in [13] and regularized LDA [14] were used
as supervised methods in comparisons. The RBF kernel was
selected instead of the linear one because its use led to
better results in the preliminary testing. Even with the feature
selection, data dimensionality here exceeds the number of
samples and we used the regularized version of LDA with
Tikhonov regularizer as described in [11], [14]. The parameters
for all learning algorithms are selected via cross-validation
within the training set in the case of experiments with real data.
In the case of experiments with simulated data, the parameters
are selected in a separate validation dataset (simulated with the
parameters of training set) of a relatively large size to ensure
good parameter values.
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III. EXPERIMENTS AND RESULTS
A. Simulated data
We generated different datasets based on ADNI MRI data
as described in Sect. II.C. Since the SSL methods studied here
are based on the cluster assumption, we investigated the effect
of the number of unlabeled data in different data sets with
different variance of the data. (The cluster assumption states
that if the feature vectors are in the same cluster, they probably
have the same label. This assumption clearly breaks down
with higher variances.) We generated datasets with different
σ0 for this purpose. We generated 200 labeled samples (100
per class) with different number of unlabeled samples Nu
ranging from 100 to 2000. We note that having Nu as large as
2000 may appear unrealistic, however, we wished to test the
methods also in the case of large unlabeled dataset. We used
the AUC as the performance criterion [15]. Each experiment
was repeated 10 times (with a different, randomly generated
simulated dataset) and we report the average AUCs across
these 10 repetitions. We performed two types of experiments
to address the importance of feature selection. 1) We used the
knowledge of the simulated discriminative voxels and fed only
the data from these 158 voxels to learning algorithms. 2) We
performed the feature selection in simulated training data using
elastic net regularized logistic regression as described in Sect.
II.B.
The AUCs in Tables 1 and 2 indicate that the data vari-
ance was a major factor in semi-supervised learning when
considering SVM-based schemes (SVM and LDS). When the
data variance was not too high, adding unlabeled data im-
proved the classiﬁcation performance with LDS. However, in
datasets with higher deviations adding unlabeled data degraded
the performance of the classiﬁer as the cluster assumption
broke down. When the variance was high (σ0 = 1.5), su-
pervised method (SVM) outperformed the semi-supervised
method (LDS) and adding more unlabeled data degraded
the classiﬁcation performance with LDS. The data variance
was not a factor between SDA and LDA in a sense that
semi-supervised method (SDA) was always superior to its
supervised counterpart (LDA). Also, the SDA achieved its
optimal performance with already relatively small number of
unlabeled data (Nu = 100) and it did not beneﬁt from larger
numbers of unlabeled data. LDS was better of the two SSL
methods with the 3 lowest variance levels, but with the highest
variance SDA was better than LDS.
Comparing the AUCs in Tables 1 and 2 shows the impor-
tance of feature selection in the performance of the classiﬁer.
Not surprisingly, knowing which voxels were discriminative
resulted in a better performance than using the feature se-
lection (as we would need to do in real life). However,
the AUCs sometimes improved as much as by 0.15 by
knowing the important features beforehand (see, e.g., LDS,
Nu = 2000, σ0 = 1.5). The amount of improvement did not
vary much between the learning algorithms, however it was
clearly more important to know the discriminative features
when the data variance was higher, probably indicating that
the feature selection becomes more difﬁcult when the noise
level increases. Finally, application of the learning algorithms
to the full data with 29852 features led to performances close
to the chance level (AUC ≈ 0.5) and thus feature selection
was a required step (results not shown).
TABLE I. AVERAGE AUCS, WITH KNOWN FEATURES. Nu IS THE
NUMBER OF UNLABELED DATA.
σ0 SVM LDS LDS LDS LDA SDA SDA SDA
Nu 0 100 1000 2000 0 100 1000 2000
0.8 0.946 0.952 0.961 0.964 0.767 0.924 0.918 0.917
1.0 0.897 0.890 0.909 0.909 0.706 0.869 0.859 0.857
1.25 0.835 0.811 0.833 0.832 0.636 0.798 0.792 0.789
1.5 0.703 0.676 0.693 0.688 0.577 0.738 0.740 0.736
TABLE II. AVERAGE AUCS, WITH FEATURE SELECTION
σ0 SVM LDS LDS LDS LDA SDA SDA SDA
Nu 0 100 1000 2000 0 100 1000 2000
0.8 0.850 0.856 0.890 0.895 0.636 0.829 0.820 0.814
1.0 0.734 0.739 0.747 0.755 0.535 0.721 0.705 0.699
1.25 0.678 0.705 0.662 0.668 0.510 0.632 0.619 0.617
1.5 0.596 0.572 0.548 0.538 0.506 0.580 0.575 0.573
B. ADNI data
In this section, we present the experimental results for the
ADNI MRI data described in Sect. II.A. while varying the
number of labeled and unlabeled data used for training the
classiﬁer. We ﬁrst randomly selected (without replacement)
only a limited number of labeled data for training (60,100,
or 140 samples, equally divided between the pMCI and sMCI
classes). Then, we randomly selected (without replacement)
a limited number of data from sMCI, pMCI, and uMCI
subjects to be used without label information as unlabeled
data (from 50 to 350 samples, with the increments of 50
samples). These random selections were repeated 100 times
to create 100 different datasets per a conﬁguration. For the
evaluation of the classiﬁer performance and estimation of the
nuisance parameters for the classiﬁers, we computed the AUCs
using two nested cross-validation loops (stratiﬁed 10-fold for
each loop, inner loop for the parameter selection, outer for
performance evaluation; note that the number of samples was
selected so that each fold can be balanced).
Fig. 1 shows the average AUCs across 100 different sam-
plings for the studied methods (SVM, LDS, SDA, LDA) for
ﬁxed numbers of labeled samples (indicated by different colors
in Fig. 1) and with increasing number of unlabeled samples.
When the number of unlabeled samples was zero, the used
methods were SVM and LDA and otherwise the used methods
were LDS and SDA. The feature selection within the training
set (by regularized logistic regression) resulted in worse AUCs
with all 4 methods than the feature selection with AD and NC
data of Sect. II.B, and thus only the AUCs with the feature
selection of Sect. II.B are reported. Using unlabeled data
and SSLs improved the classiﬁcation performance markedly,
even with 50 unlabeled samples, the average AUCs always
improved, on average by 0.05. The highest improvement (from
0.58 to 0.67) was with SDA compared to LDA with 60 labeled
samples. In order to make statistically precise statements, we
computed the p-value for unpaired AUC scores (across 100
different re-samplings of the data) with a permutation test.
The improvement was always signiﬁcant when comparing SSL
methods (LDS and SDA) to the corresponding supervised
methods (in each case p < 0.00001 except for the case
of LDS vs. SVM with 60 labeled samples p = 0.0045).
Thus, the use of SSL signiﬁcantly improved the classiﬁcation
performance. The AUCs of the two SSL methods with 60
and 100 labeled samples and all available unlabeled data
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Fig. 1. The mean AUC score of LDS and SDA methods within 100 computation times with respect to different number of unlabeled data using original MRI
data. When the number of unlabeled data is zero, the corresponding supervised methods (SVM and LDA) are used.
was statistically similar (p > 0.2) and with 140 labeled
samples LDS outperformed SDA in terms of the average AUC
(p = 0.0025). The differences between the AUCs within a
ﬁxed SSL method when the number of unlabeled data was
varied were statistically not signiﬁcant.
IV. CONCLUSION
We studied the value of unlabeled data from MCI subjects
without ﬁnal diagnosis in the MRI-based MCI-to-AD conver-
sion prediction. We compared two semi-supervised learning
methods, LDS and SDA, and their supervised counterparts,
SVM and regularized LDA, by using ADNI MRI data and
simulated data while varying the number of labeled and unla-
beled samples. The use of SSL and unlabeled data signiﬁcantly
improved the classiﬁcation performance with the ADNI data,
independently on how many labeled samples were available.
Importantly even a small number of unlabeled samples im-
proved the conversion predictions. With the simulated data, the
use of unlabeled data improved the classiﬁcation performance
in most cases, however, the improvement was smaller than with
the real data and, as expected, diminished with increasing noise
level. Of the two SSL methods studied, LDS had the superior
performance.
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Early diagnosis
Mild cognitive impairment (MCI) is a transitional stage between age-related cognitive decline and Alzheimer's
disease (AD). For the effective treatment of AD, itwould be important to identifyMCI patients at high risk for con-
version to AD. In this study, we present a novel magnetic resonance imaging (MRI)-basedmethod for predicting
the MCI-to-AD conversion from one to three years before the clinical diagnosis. First, we developed a novel MRI
biomarker ofMCI-to-AD conversion using semi-supervised learning and then integrated itwith age and cognitive
measures about the subjects using a supervised learning algorithm resulting in what we call the aggregate
biomarker. The novel characteristics of the methods for learning the biomarkers are as follows: 1) We used a
semi-supervised learning method (low density separation) for the construction of MRI biomarker as opposed
to more typical supervised methods; 2) We performed a feature selection on MRI data from AD subjects and
normal controls without using data from MCI subjects via regularized logistic regression; 3) We removed the
aging effects from the MRI data before the classiﬁer training to prevent possible confounding between AD and
age related atrophies; and 4)We constructed the aggregate biomarker byﬁrst learning a separateMRI biomarker
and then combining it with age and cognitivemeasures about theMCI subjects at the baseline by applying a ran-
dom forest classiﬁer. We experimentally demonstrated the added value of these novel characteristics in
predicting the MCI-to-AD conversion on data obtained from the Alzheimer's Disease Neuroimaging Initiative
(ADNI) database. With the ADNI data, the MRI biomarker achieved a 10-fold cross-validated area under the
receiver operating characteristic curve (AUC) of 0.7661 in discriminating progressive MCI patients (pMCI)
from stable MCI patients (sMCI). Our aggregate biomarker based on MRI data together with baseline cognitive
measurements and age achieved a 10-fold cross-validated AUC score of 0.9020 in discriminating pMCI from
sMCI. The results presented in this study demonstrate the potential of the suggested approach for early AD diag-
nosis and an important role of MRI in the MCI-to-AD conversion prediction. However, it is evident based on our
results that combining MRI data with cognitive test results improved the accuracy of the MCI-to-AD conversion
prediction.
© 2014 Elsevier Inc. All rights reserved.
Introduction
Alzheimer's disease (AD), a common form of dementia, occurs most
frequently in aged population. More than 30 million people worldwide
suffer fromAD and, due to the increasing life expectancy, this number is
expected to triple by 2050 (Barnes and Yaffe, 2011). Because of the
dramatic increase in the prevalence of AD, the identiﬁcation of effective
biomarkers for the early diagnosis and treatment of AD in individuals at
high risk to develop the disease is crucial. Mild cognitive impairment
(MCI) is a transitional stage between age-related cognitive decline and
AD, and the earliest clinically detectable stage of progression towards
dementia or AD (Markesbery, 2010). According to previous studies
(Petersen et al., 2009), a signiﬁcant proportion of MCI patients, approx-
imately 10% to 15% from referral sources such asmemory clinics and AD
centers, will develop intoAD annually. AD is characterized by the forma-
tion of intracellular neuroﬁbrillary tangles and extracellular β-amyloid
plaques aswell as extensive synaptic loss and neuronal death (atrophy)
within the brain (Mosconi et al., 2007). The progression of the neuropa-
thology in AD can be observed many years before clinical symptoms of
the disease become apparent (Braak and Braak, 1996; Delacourte et al.,
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1999; Morris et al., 1996; Serrano-Pozo et al., 2011; Mosconi et al.,
2007). AD pathology has been therefore hypothesized to be detectable
using neuroimaging techniques (Markesbery, 2010). Among different
neuroimaging modalities, MRI has attracted a signiﬁcant interest in
AD related studies because of its completely non-invasive nature, high
availability, high spatial resolution and good contrast between different
soft tissues. Over the past few years, numerous MRI biomarkers have
been proposed in classifying AD patients in different disease stages
(Fan et al., 2008; Duchesne et al., 2008; Chupin et al., 2009; Querbes
et al., 2009; Wolz et al., 2011; Hinrichs et al., 2011; Westman et al.,
2011a,b; Westman et al., 2012; Cho et al., 2012; Coupé et al., 2012;
Gray et al., 2013; Eskildsen et al., 2013; Guerrero et al., 2014; Wang
et al., 2014). Despite of many efforts, identifying efﬁcient AD-speciﬁc
biomarkers for the early diagnosis and prediction of disease progression
is still challenging and requires more research.
In the current study,we present a novelMRI-based technique for the
early detection of AD conversion inMCI patients by using advancedma-
chine learning algorithms and combining MRI data with standard neu-
ropsychological test results. In more detail, we aim to predict whether
an MCI patient will convert to AD over a 3 year period (this is referred
as progressive MCI or pMCI) or not (this is referred as stable MCI or
sMCI) using only data at the baseline. The data used in this work is
obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI)
database (www.loni.usc.edu/ADNI) and it includes MRI scans and neu-
ropsychological test results from normal controls (NC), AD, and MCI
subjects with a matched age range. Recently, several computational
neuroimaging studies have focused on predicting the conversion to
AD in MCI patients by utilizing various types of ADNI data such as MRI
(e.g. Ye et al., 2011; Filipovych and Davatzikos, 2011; Batmanghelich
et al., 2011), positron emission tomography (PET) (Zhang and Shen,
2011, 2012; Cheng et al., 2012; Shaffer et al., 2013), cerebrospinal
ﬂuid (CSF) biomarkers (Zhang and Shen, 2011; Cheng et al., 2012;
Davatzikos et al., 2011; Shaffer et al., 2013), and demographic and
cognitive information (see Tables 1 and 7). Our method is a multi-step
procedure combining several ideas into a coherent framework for AD
conversion prediction:
1. Semi-supervised learning, using data from AD and NC subjects to
help the sMCI/pMCI classiﬁcation
2. Novel random forest based data integration scheme
3. Removal of age related confound.
In the experimental sections we will demonstrate that all these
provide a signiﬁcant contribution towards the accuracy of the combined
prediction model. Our method differs in the following aspects from
earlier studies.
Most of the earlier studies were based on supervised learning
methods, where only labeled data samples are used for learning the
model. Semi-supervised learning (SSL) approaches are able to use unla-
beled data in conjunction with labeled data in a learning procedure for
improving the classiﬁcation performance. The great interest in SSL
techniques over the past few years (Zhu, and Goldberg, 2009) is related
to thewide spread of application domainswhere providing labeled data
is hard and expensive compared to providing unlabeled data. The prob-
lem studied in this work, predicting the AD-conversion in MCI subjects,
is a good example of this scenario sinceMCI subjects have to be followed
for several years after the data acquisition to obtain a sufﬁciently
reliable disease label (pMCI or sMCI). Few recent studies (listed in
Table 1) have investigated the use of different semi-supervised ap-
proaches for diagnosis of AD in different stages of the disease. In
Zhang and Shen (2011), MCI subjects' data were used as unlabeled
data to improve the classiﬁcation performance in discriminating AD
versus NC subjects. They achieved a signiﬁcant improvement, the AUC
score increased from 0.946 to 0.985, which is high for discriminating
AD vs. NC subjects. Ye et al. (2011), Filipovych and Davatzikos (2011),
and Batmanghelich et al. (2011) used AD and NC subjects as labeled
data and MCI subjects as unlabeled data and predicted disease-labels
for theMCI subjects. In all these studies, the improvement in the predic-
tive performance of themodel was signiﬁcant over supervised learning.
The best classiﬁcation performance in discriminating sMCI versus pMCI
using only MRI data was achieved by Ye et al. (2011) with the area
under the receiver operating characteristic curve (AUC) equal to 0.73
for prediction of conversion within 0–18 month period. We hypothe-
size that the classiﬁcation performance of semi-supervised learning
approaches could be improved if MCI subjects who have been followed
up for long enough would be used as labeled data. In this work, we
develop a semi-supervised classiﬁer for AD conversion prediction in
MCI patients based on low density separation (LDS) (Chapelle and
Zien, 2005) and by using MRI data of MCI subjects. Our results demon-
strate applicability of the proposed semi-supervised method in MRI
based AD conversion prediction in MCI patients by achieving a signiﬁ-
cant improvement compared to a state of the art supervised method
(support vector machine (SVM)).
We perform two processing steps in between our voxel based mor-
phometry style preprocessing (Gaser et al., 2013) and the learning of
the LDS classiﬁer. First, we remove age-related effects from MRI data
before training the classiﬁer to prevent the confounding between AD
and age-related effects to brain anatomy. Previously, a similar technique
has been used for the classiﬁcation between AD and NC subjects, but
this study has not considered AD-conversion prediction in MCI subjects
(Dukart et al., 2011). In addition, the impact of age was studied recently
for detecting AD (Coupé et al., 2012) as well as for predicting AD in MCI
patients (Eskildsen et al., 2013). Second, we perform feature selection
on MRI data independently of the classiﬁcation procedure using the
auxiliary data from AD and NC subjects. Feature selection is an essential
part of the combined procedure since the number of features (29,852)
available after the image preprocessing signiﬁcantly exceeds the
number of subjects. We assume that AD vs. NC classiﬁcation is a simpli-
ﬁed version of the pMCI vs. sMCI and the same features that are most
useful for the simple problem are useful for the complex one. This idea
is implemented by applying regularized logistic regression (RLR)
Table 1
Semi-supervised classiﬁcation of AD using ADNI database. AUC: area under the receiver operating characteristic curve, ACC: accuracy, SEN: sensitivity, SPE: speciﬁcity.
Author Data Task Result (supervised) Result (semi-supervised)
Ye et al. (2011) MRI,
53 AD, 63 NC,
237 MCI
sMCI vs. pMCI AUC = 71%
ACC = 55.3%
SEN = 88.2%
SPE = 42%
AUC = 73%
ACC = 56.1%
SEN = 94.1%
SPE = 40.8%
Filipovych and Davatzikos (2011) MRI,
54 AD, 63 NC,
242 MCI
sMCI vs. pMCI AUC = 61%
SEN = 78.8%
SPE = 51%
AUC = 69%
SEN = 79.4%
SPE = 51.7%
Zhang and Shen (2011) MRI, PET, CSF
51 AD, 52 NC,
99 MCI
AD vs. NC AUC = 94.6% AUC = 98.5%
Batmanghelich et al. (2011) MRI,
54 AD, 63 NC,
238 MCI
sMCI vs. pMCI AUC = 61.5% AUC = 68%
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(Friedman et al., 2010) on MRI data of AD and NC subjects for ﬁnding
the image voxels that are best discriminated between AD and NC
subjects. Next, we use these selected voxels for predicting conversion
to AD within MCI patients. Most of existing studies incorporating
feature selection rely only on a dataset of MCI subjects by using it for
feature selection and classiﬁcation task. In particular, previous studies
(Ye et al., 2011, 2012; Janoušová et al., 2012) have considered feature
selection based on RLR for MCI-to-AD conversion prediction, but the
feature selection was performed with the data from MCI subjects not
utilizing data from AD and NC subjects. Auxiliary data from AD and NC
subjects to aid the classiﬁcation of MCI subjects have been considered
by Cheng et al. (2012) in a domain transfer learning method. Brieﬂy,
the method utilizes cross-domain kernel build from target data (MCI
subjects) and auxiliary data (AD and NC) subjects to learn a linear
support vector machine classiﬁer. As Cheng et al. reduced the number
of features to 93 by partitioning each MRI into 93 regions of interest
and did not consider feature selection, the approach to use the auxiliary
data is different from our approach.
We integrate MRI data with age and cognitive measurements, also
acquired at the baseline, for improving the predictive performance of
MCI-to-AD conversion. As opposed to several other studies combining
MRI with other types of data (Davatzikos et al., 2011; Zhang and Shen,
2012; Shaffer et al., 2013; Cheng et al., 2012;Wang et al., 2013),we pur-
posely avoid using CSF or PET based biomarkers, the former because it
requires lumbar puncture, which is invasive and potentially painful for
the patient, and the latter because of its limited availability compared
to MRI, as well as its cost and radiation exposure (Musiek et al., 2012).
Previously, the combination of MRI derived information and cognitive
measurements has been considered by Ye et al. (2012) who trained an
RLR classiﬁer with standard cognitive measurements and volumes of
certain regions of interest as features and Casanova et al. (2013) who
combined outputs of two classiﬁers, one trained based on MRI and the
other trained based on cognitive measurements, based on a sum-rule
for the classiﬁer combination. In order to use more efﬁciently MRI and
basic (age and cognitive) measures, we develop what we call an aggre-
gate biomarker by utilizing two different classiﬁers, i.e. LDS and random
forest (RF), in different stages of the process.We ﬁrst derive a single real
valued biomarker based on MRI data using LDS (our biomarker) and
thereafter use this as a feature for the aggregate classiﬁer (RF). We
will highlight the importance of using a transductive classiﬁer
(e.g., LDS) instead of an inductive one (e.g., a standard SVM) during
the ﬁrst stage of the learning process and provide evidence of the effec-
tiveness of the aggregate biomarker for the AD conversion prediction in
MCI patients based on MRI, age and cognitive measures at the baseline.
Materials and methods
ADNI data
Data used in thiswork is obtained from theAlzheimer's DiseaseNeu-
roimaging Initiative (ADNI) database (http://adni.loni.usc.edu/). The
ADNI was launched in 2003 by the National Institute on Aging (NIA),
the National Institute of Biomedical Imaging and Bioengineering
(NIBIB), the Food and Drug Administration (FDA), private pharmaceuti-
cal companies and non-proﬁt organizations, as a $60 million, 5-year
public–private partnership. The primary goal of ADNI has been to test
whether serial MRI, PET, other biological markers, and clinical and neu-
ropsychological assessment can be combined to measure the progres-
sion of MCI and early AD. Determination of sensitive and speciﬁc
markers of very early AD progression is intended to aid researchers
and clinicians to develop new treatments and monitor their effective-
ness, as well as lessen the time and cost of clinical trials.
The principal investigator of this initiative isMichaelW.Weiner,MD,
VAMedical Center and University of California— San Francisco. ADNI is
the result of efforts of many co-investigators from a broad range of aca-
demic institutions and private corporations, and subjects have been
recruited from over 50 sites across the U.S. and Canada. The initial
goal of ADNI was to recruit 800 subjects but ADNI has been followed
by ADNI-GO and ADNI-2.
To date these three protocols have recruited over 1500 adults, ages
55 to 90, to participate in the research, consisting of cognitively normal
older individuals, people with early or late MCI, and people with early
AD. The follow-up duration of each group is speciﬁed in the protocols
for ADNI-1, ADNI-2 and ADNI-GO. Subjects originally recruited for
ADNI-1 and ADNI-GO had the option to be followed in ADNI-2. For
up-to-date information, see www.adni-info.org.
Data used in this work include all subjects for whom baseline MRI data
(T1-weightedMP-RAGEsequence at 1.5 T, typically 256×256×170 voxels
with the voxel size of approximately 1 mm × 1 mm × 1.2 mm), at least
moderately conﬁdent diagnoses (i.e. conﬁdence N 2), hippocampus vol-
umes (i.e. volumes of left and right hippocampi, calculated by FreeSurfer
Version 4.3), and test scores in certain cognitive scales (i.e. ADAS:
Alzheimer's Disease Assessment Scale, range 0–85; CDR-SB: Clinical
Dementia Rating ‘sumof boxes’, range 0–18;MMSE:Mini-Mental State Ex-
amination, range 0–30) were available.
For the diagnostic classiﬁcation at baseline, 825 subjects were
grouped as (i) AD (Alzheimer's disease), if diagnosis was Alzheimer's
disease at baseline (n = 200); (ii) NC (normal cognitive), if diagnosis
was normal at baseline (n = 231); (iii) sMCI (stable MCI), if diagnosis
was MCI at all available time points (0–96 months), but at least for
36 months (n = 100); (iv) pMCI (progressive MCI), if diagnosis was
MCI at baseline but conversion to ADwas reported after baselinewithin
1, 2 or 3 years, and without reversion to MCI or NC at any available
follow-up (0–96 months) (n= 164); (v) uMCI (unknownMCI), if diag-
nosis was MCI at baseline but the subjects were missing a diagnosis at
36 months from the baseline or the diagnosis was not stable at all avail-
able time points (n = 100). From 164 pMCI subjects, 68 subjects were
converted to ADwithin the ﬁrst 12 months, 69 subjects were converted
to AD between 12 and 24 months of follow-up and the remaining 27
subjects were converted to AD between 24 and 36 month follow-up.
Details of the characteristics of the ADNI sample used in this work are
presented in Table 2. The subject IDs together with the group informa-
tion is provided in the supplement (Tables S2 - S5, see also https://
sites.google.com/site/machinelearning4mcitoad/ for MATLAB ﬁles).
The conversion data was downloaded on April 2014.
Image preprocessing
As described inGaser et al. (2013), preprocessing of the T1-weighted
images was performed using the SPM8 package (http://www.ﬁl.ion.ucl.
ac.uk/spm) and the VBM8 toolbox (http://dbm.neuro.uni-jena.de), run-
ning under MATLAB. All T1-weighted images were corrected for bias-ﬁeld
inhomogeneities, then spatially normalized and segmented into gray
matter (GM), white matter, and cerebrospinal ﬂuid (CSF) within the
same generative model (Ashburner and Friston, 2005). The segmenta-
tion procedure was further extended by accounting for partial volume
effects (Tohka et al., 2004), by applying adaptive maximum a posteriori
estimations (Rajapakse et al., 1997), and by using an hidden Markov
random ﬁeld model (Cuadra et al., 2005) as described previously
(Gaser, 2009). This procedure resulted in maps of tissue fractions of
WM and GM. Only the GM images were used in this work. Following
Table 2
Characteristics of datasets used in this work. There was no statistically signiﬁcant differ-
ence in age (permutation test, p N 0.05) nor gender (proportion test, p N 0.05) between
different MCI groups.
AD NC pMCI sMCI uMCI
No. of subjects 200 231 164 100 130
Males/females 103/97 119/112 97/67 66/34 130/81
Age range 55–91 59–90 55–89 57–89 54–90
400 E. Moradi et al. / NeuroImage 104 (2015) 398–412
the pipeline proposed by Franke et al. (2010), the GM images were
processed with afﬁne registration and smoothed with 8-mm full-
width-at-half-maximum smoothing kernels. After smoothing, images
were resampled to 4 mm isotropic spatial resolution. This procedure
generated, for each subject, 29,852 aligned and smoothed GM density
values that were used as MRI features.
MRI biomarker
As a preprocessing operation, we removed the effects of normal
aging from the MRI data. The rationale for this is related to the fact
that the effects of normal aging on the brain are likely to be similar
(equally directed) with the effects of AD, which can lead to an overlap
between the brain atrophies caused by age and AD. This, in turn,
would bring a possible confounding effect on the estimation of
disease-speciﬁc differences (Franke et al., 2010; Dukart et al., 2011).
We estimated the age-related effects on the GMdensities of NC subjects
by using a linear regression model that is similar to a method applied in
earlier studies (Dukart et al., 2011; Scahill et al., 2003). Once estimated,
the age-related effects were removed from theMRI data of each subject
before training the classiﬁers. For more details, see the algorithmic
description in Appendix B.
The overall structure of the proposed classiﬁcation method is illus-
trated in Fig. 1. The method consists of two fundamental stages: a fea-
ture selection stage, that uses a regularized logistic regression (RLR)
algorithm to select a good subset of MRI voxels for AD conversion
prediction; and a classiﬁcation stage that applies a semi-supervised
low density separation (LDS) method to produce the ﬁnal prediction.
The LDS relies on a transductive support vector machine classiﬁer,
whose hyperparameters are also learned from the data. Note that, for
each test subject, instead of the discrete class, an LDS returns the value
of the continuous discriminant function d∈ℝ thatwe callMRI biomark-
er. If d b 0 then the subject is predicted as sMCI and otherwise pMCI;
more details are presented in Appendix A.
More speciﬁcally, the ﬁrst stage of the classiﬁcation framework
selects the most informative voxels (features) among all MRI voxels
(features) while discarding non-informative ones. The feature selection
uses the regularized logistic regression framework (Friedman et al.,
2010) that produces a path of feature subsetswith different cardinalities
(called regularization path), and has been usedwidely in previousworks
(Huttunen et al., 2012, 2013; Ryali et al., 2010) for the multi-voxel pat-
tern analyses of functional neuroimaging data as well as for AD related
studies using structural MRI data (Ye et al., 2012; Casanova et al.,
2011a,b, 2012; Shen et al., 2011; Janoušová et al., 2012). As the RLR pro-
cedure is a supervised learningmethod, the input has to be fully labeled
data. To this aim, we applied RLR onMRI data of AD and NC subjects for
determining a subset of features (voxels) with the highest accuracy in
discriminating the two classes. The selected voxels (and only them)
were then used for predicting conversion to AD in MCI patients. Note
that this way we avoided using data about MCI subjects for feature
selection and therefore we can use all theMCI data for learning the clas-
siﬁer. The cardinality of the selected subset along the regularization
path was determined using 10-fold cross validation, which estimated
the most discriminative subset among the candidates found by the
RLR. The details of the RLR approach are described in Appendix B.
The second stage trains the ﬁnal semi-supervised LDS classiﬁer. At
this stage, also the unlabeled uMCI samples were fed to the classiﬁer,
after the extraction of the most discriminative features. Since the
LDS approach is based on the transductive SVM classiﬁer, also the
hyperparameters of the transductive SVM have to be selected. The
choice of the SVM parameters was done using a nested cross validation
approach, where each of the cross validation splits of the feature selec-
tion stage was further split into second level of 10 cross validation folds.
In this way we were able to estimate the performance of the complete
framework and simulate the ﬁnal training process with all data after
the hyperparameters have been selected.
The LDS approach for semi-supervised learning (see Appendix A and
Chapelle and Zien, 2005) integrates unlabeled data into the training
procedure. The algorithm assumes that the classes (e.g., pMCI and
sMCI subjects) form high density clusters in the feature space, and
that there are low density areas between the classes. This way the
labeled samples determine the rough shape of the decision rule, while
the unlabeled samples ﬁne-tune the decision rule to improve the
performance. A typical gain due to integrating unlabeled data varies
from a few percent to manifold decrease in prediction error. The LDS
is a two step algorithm, which ﬁrst derives a graph-distance kernel for
enhancing the cluster separability and then it applies transductive
support vectormachine (TSVM) for classiﬁer learning. SSLmethods pre-
viously applied to MCI-to-AD conversion prediction have included
TSVM (Filipovych and Davatzikos, 2011) and Laplacian SVM (Ye et al.,
Fig. 1. Semi-supervised classiﬁcation scheme. Dashed arrows indicate data fed to classiﬁcation process without any label information (in contrast to solid arrows indicating training data
with label information). The test subset is used in the classiﬁcation process without any label information.
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2011). Based on experimental results by Chapelle and Zien (2005), LDS
can be seen as an improved version of TSVM and related to Laplacian
SVM. Moreover, we have provided evidence that the LDS overperforms
the semi-supervised discriminant analysis (Cai et al., 2007) in MCI-to-
AD conversion prediction in our recent conference paper (Moradi
et al., 2014). Finally, we note that as themajority of the semi-supervised
classiﬁers including TSVMs, LDS applies transductive learning, practical-
lymeaning that theMRI data (but not the labels) of the test subjects can
be used for learning the classiﬁer. We point out that this is perfectly
valid and does not lead to double-dipping as the test labels are not
used for learning the classiﬁer. For a clear explanation of the differences
between transductive and inductive machine learning algorithms,
we refer to Gammerman et al. (1998) and relation between semi-
supervised and transductive learning is discussed in detail by Chapelle
et al. (2006).
In order to examine the applicability of the semi-supervisedmethod,
i.e., LDS, we applied it on the MRI data with and without feature
selection and compared its performance with the performance of its
supervised counterpart, the support vector machine (SVM). SVM is a
maximummargin classiﬁer that is widely used in supervised classiﬁca-
tion problems. In SVM, only labeled samples are used for determining
decision boundary between different classes.
Aggregate biomarker
In order to improve AD conversion prediction in MCI patients, we
developed a method for the integration of the baseline MRI data with
age and cognitive measurements acquired at baseline. The measure-
ments we considered were Rey's Auditory Verbal Learning Test
(RAVLT), Alzheimer's Disease Assessment Scale—cognitive subtest
(ADAS-cog), MiniMental State Examination (MMSE), Clinical Dementia
Rating—Sumof Boxes (CDR-SB), and Functional ActivitiesQuestionnaire
(FAQ). These standard cognitive measurements, which are widely used
in assessing cognitive and functional performance of dementia patients,
are explained in the ADNI General Procedures Manual.2 The rationale
was to include the cognitive assessments that are inexpensive to
acquire and available for theMCI subjects in this study.We only consid-
ered the composite scores of the measurements that often include
several subtests. We did not consider CSF or PET measurements for
the reasons outlined in the Introduction section. Since the effects of
normal aging on the MRI data were removed, age was again used as a
predictor, because it is a risk factor for AD.
The way that MRI data is combined with the cognitive measure-
ments is crucial to achieve a good estimation accuracy of the MCI-to-
AD conversion prediction. The simplest way would be to combine the
MRI data (only selected voxels) and cognitive measurements as a long
feature vector which is as the input of the classiﬁer. We will refer to
this as data concatenation. However, this is not the best way, because
of the different natures of MRI data (close to continuous) and cognitive
measurements (mainly discrete) (Zhang et al., 2011). Therefore, we
propose a simple classiﬁer ensemble for constructing the aggregate
biomarker. In effect, we used the MRI biomarker, derived using LDS
classiﬁer, as a feature/predictor for the aggregate biomarker. The MRI
feature was combined with age and cognitive measurements and used
as input features for the random forest (RF) classiﬁer. An RF consists
of a collection of decision trees all trained with different subsets of the
original data. Averaging of the outputs of individual trees renders RFs
tolerant to overlearning, which is the reason for their popularity in clas-
siﬁcation and regression tasks especially in the area of bioinformatics.
Note that an RF is an ensemble learning method that outputs vote
counts for different classes so the aggregate biomarker value approxi-
mates the probability of converting to AD. Random forests are often
used for ranking the importance of input variables by randomly
permuting the values of each variable at a time, and estimating the de-
crease in accuracy on out of bag samples (Breiman, 2001; Liaw and
Wiener, 2002). The overview of the aggregate biomarker and its evalu-
ation is shown in Fig. 2. Previous applications of RFs in the context of AD
classiﬁcation include Llano et al. (2011) who applied RFs to generate a
new weighting of ADAS subscores.
Performance evaluation
For the evaluation of classiﬁer performance and estimation of
the regularization parameters, we used two nested cross-validation
loops (10-fold for each loop) (Huttunen et al., 2012; Ambroise and
Mclachlan, 2002). First, an external 10-fold cross-validation was imple-
mented in which labeled samples were randomly divided into 10
subsets with the same proportion of each class label (stratiﬁed cross-
validation). At each step, a single subset was left for testing and remain-
ing subsets were used for training. Again the train set was divided into
10 subsets thatwere used for the selection of classiﬁer parameters listed
below. The optimal parameters were selected according to the
maximum average accuracy across the 10-fold of the inner loop. The
performance of the classiﬁer was then evaluated based on AUC (area
under the receiver operating characteristic curve), accuracy (ACC, the
number of correctly classiﬁed samples divided by the total number of
samples), sensitivity (SEN, the number of correctly classiﬁed pMCI sub-
jects divided by the total number of pMCI subjects) and speciﬁcity (SPE,
the number of correctly classiﬁed sMCI subjects divided by the total
number of sMCI subjects) using the test subset of the outer loop. The
pooling strategy was used for computing AUCs (Bradley, 1997). The
reported results in the Results section are averages over 100 nested
10-fold CV runs in order tominimize the effect of the random variation.
To compare the mean AUCs of two learning algorithms, we computed a
p-value for the 100 AUC scores with a permutation test.
To perform the survival analysis and estimate the hazard rate for AD
conversion in MCI subjects, Cox proportional hazard model was
employed (see McEvoy et al., 2011; Gaser et al., 2013; Da et al., 2014
for previous applications of the survival analysis in the sMCI/pMCI clas-
siﬁcation). The predictor was the real valued output of the classiﬁer
(i.e., the value of the discriminant function in the case of LDS and
estimated probability of conversion in the case of RF; see the MRI
biomarker and Aggregate biomarker sections) and the conversion
time to AD in MCI subjects was taken as the time-to-event variable.
The duration of follow-up was truncated at 3 years for sMCI subjects
and uMCI subjects were not included in the analysis. The Cox models
implemented by MATLAB's coxphﬁt-function were adjusted for age
and gender. The Cox-regression was performed in the cross-validation
framework similarly as described above for AUC.
Implementation
The implementation of elastic-net RLR for feature selectionwas done
by using the GLMNET library (http://www-stat.stanford.edu/~tibs/
glmnet-matlab/). The support vector machine (SVM) with a Radial
Basis Function (RBF) kernel was used as supervised method for a com-
parison with LDS. The RBF kernel was used with the SVM as this widely
used kernel clearly outperformed the linear kernel in a preliminary test-
ing and linear kernels can be seen as a special case of the RBF kernels
(Keerthi and Lin, 2003). The implementation of SVM was done using
LIBSVM (http://www.csie.ntu.edu.tw/~cjlin/libsvm/index.html) run-
ning under MATLAB. The implementation of LDS was done by using a
publicly available MATLAB implementation (http://olivier.chapelle.cc/
lds/). The SVM has two parameters, C (soft margin parameter, see
Appendix A) and γ (parameter for RBF kernel function). For tuning
these parameters, a grid search was used, i.e., parameter values were
varied among the candidate set {10−4, 10−3, 10−2, 10−1, 100, 101,
102, 103, 104} and each combination was evaluated using cross-
validation as outlined above. LDS has more parameters to tune. Since
2 http://adni.loni.usc.edu/wp-content/uploads/2010/09/ADNI_GeneralProceduresManual.
pdf.
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tuning many parameters with grid search is impractical, we considered
only the most critical parameters, i.e., C (soft margin parameter) and ρ
(softening parameter for graph distance computation) in grid search.
For tuning parameter C, its value was varied among the candidate set
{10−2, 10−1, 100, 101, 102} and for parameter ρ among the candidate
set {1, 2, 4, 6, 8, 10, 12}. For the other parameters, default values were
used except that the 10-nearest neighbor graphs were used for the ker-
nel construction (instead of fully connected graph) and the parameter δ
in (Chapelle and Zien, 2005)was set to be 1. TheMRI features were nor-
malized to have unit variance before the classiﬁcation. The implementa-
tion of RF was the MATLAB port of the R-code of Liaw and Wiener
(2002) available at http://code.google.com/p/randomforest-matlab/.
All parameterswere set to their default values. The CPU time for training
a single classiﬁer (including parameter selection and performance eval-
uation using cross-validation) was in the order of tens of minutes on an
Intel Core 2 Duo processor, 3.00 GHz, 4 GB RAM. The image processing
of the Image preprocessing section required on average 8min per single
image (3.4 GHz Intel Core i7, 8 GB RAM).
Results
MRI biomarker
In this section, we consider the experimental results obtained using
the biomarker based on solely MRI data as described in the MRI
biomarker section. The feature selection reduced the number of voxels
in MRI data from 29,852 to 309 voxels. Fig. 3 shows the locations of
the selected 309 voxels overlaid on the standard template. Supplemen-
tary Table S1 provides the ranking of the brain regions of the loci of the
selected voxels according to the Automatic Anatomical Labeling (AAL)
atlas. It can be observed that the selected voxels were spread all
over the brain (including the hippocampus, the temporal and frontal
lobes, the cerebellar areas, as well as the amygdala, insula, and
parahippocampus). These locations have been previously reported in
studies concerning the brain atrophy in AD (Weiner et al., 2012). The
neuropathology of AD is typically related to changes (e.g. atrophy that
reﬂects the loss and shrinkage of neurons) in the entorhinal cortex,
Fig. 2.Workﬂow for the aggregate biomarker and its cross-validation based evaluation. For computing the output of LDS classiﬁer for test subjects, the test subset is used in the learning
procedure without any label information (shown with dashed arrow).
Fig. 3. The locations of selected voxels by elastic-net RLR with the highest accuracy in discriminating AD and NC subjects within the brain inMNI (Montreal Neurological Institute) space.
One of the voxels appears to be slightly outside the brain due to the effect of smoothing and the larger voxel size of the pre-processed data compared to the voxel size of the template.
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that progress then to the hippocampus, the temporal, frontal and parie-
tal areas, before ultimately diffusing to the whole cerebral cortex
(Casanova et al., 2011b; Salawu et al., 2011). These brain structures,
especially the hippocampus, frontal and temporal areas have been
found to be effective in discriminating between AD patients and NC
(for a review see Casanova et al., 2011b and references therein). Also,
patterns of neuropathology in cerebellar areas have been reported in
previous studies (Sjöbeck and Englund, 2001).
We applied LDS on the MRI data with and without feature selection
and compared its performance with the performance of its supervised
counterpart, the standard SVM.We also evaluated the impact of remov-
ing age-related effects from the MRI data for the purpose of early
diagnosis of AD. Because the age was used as a parameter for removing
age-related effects, the biomarker was based on MRI and age informa-
tion. However, the agewas not used as a feature in the learning process.
Table 3 shows the results of the MRI biomarker. First, second and third
rows show the performance measures obtained using a SVM without
feature selection, with feature selection, and after removing age-
related effects, respectively. The fourth, ﬁfth and sixth rows in Table 3
show the performance measures obtained by the LDS. The classiﬁcation
accuracy of both methods without feature selection was only about
chance level. After the feature selection, the classiﬁcation performance
based on AUC and ACC obtained by both methods improved. The
improvement (in AUC) was statistically signiﬁcant for both LDS
(p b 0.0001) and SVM (p b 0.0001). As a result, the elastic-net RLR
was able to select the relevant voxels corresponding to AD in the high
dimensional MRI data. In addition, feature selection was done indepen-
dently of the classiﬁcation procedure. Using NC and AD datasets for
feature selection was a strategy that allowed a larger sample size for
the training and validating the MCI classiﬁer.
In order to evaluate the performance of the elastic-net RLR for
feature selection within MRI data, we compared the classiﬁcation
performance of MRI biomarker based on different feature selection al-
gorithms. For this purpose we used univariate t-test and graph-net
(Grosenick et al., 2013) feature selection methods. The AUC of MRI
biomarker with the univariate t-test based feature selection (1000 fea-
tures) was 0.71 and with graph-net based feature selection (354 fea-
tures) was 0.74. The elastic-net RLR based feature selection led to a
signiﬁcantly improved performance in MRI biomarker as compared to
the t-test and graph-net based feature selection methods (p b 0.0001).
We experimented with the feature selection directly on MCI subjects'
data for reducing dimensionality of MRI data. More speciﬁcally, the
feature selection (elastic-net RLR) was performed in the outer loop of
two nested cross-validation loops by ﬁrst performing the feature selec-
tion using all features in MRI data (29,852 voxels) and then using these
selected features for parameter selection and learning the model. The
performance of MRI biomarker with the feature selection using MCI
subjects decreased signiﬁcantly compared to the feature selection
using an independent validation set of AD and NC subjects (from
0.7661 to 0.6833, p b 0.0001). When the feature selection was done
combining AD and pMCI subjects into one class, and NC and sMCI
subjects into other, the performance did not signiﬁcantly differ from
the suggested approach (AUCs of 0.7661 vs. 0.7692). As this approach
necessitates an additional CV loop, the suggested feature selection
method remained preferable.
We investigated how much unlabeled data improved the classiﬁca-
tion accuracy. For this, we trained the LDS classiﬁer also without data
fromuMCI subjects. Note that the LDS is a transductive learningmethod
that uses the test MRI data (but not labels) as unlabeled data. As
explained in the MRI biomarker section, because the label information
of the test data was not used in the learning process, this does not
lead to ‘double-dipping’ or ‘training on the testing data’ problems, and
more speciﬁcally, to upward biased classiﬁer performance estimates
(Chapelle and Zien, 2005; Chapelle et al., 2006). Fig. 4 shows the box
plots for AUC, ACC, SEN and SPE of LDS and SVM methods based on
MRI data (with feature selection and age-related effects removed). In
the case of LDS, the results are shown with and without utilizing uMCI
data as unlabeled data in the learning process. As it can be seen from
the results, adding uMCI data samples improved classiﬁcation perfor-
mance slightly, but the improvement was not statistically signiﬁcant
(p = 0.3072). However, it increased the stability of the classiﬁer by
decreasing the variance in AUCs between different cross-validation
runs. The LDS method works based on the cluster assumption and
utilizes unlabeled data for ﬁnding different clusters and placing the
decision boundary in low density regions of the feature space. When
the cluster assumption does not hold, unlabeled data points do not
carry signiﬁcant information and cannot improve the results (Chapelle
and Zien, 2005). Also, the number of unlabeled data might be too
small for signiﬁcant performance improvement. Here, the number of
unlabeled data was only 130 which is few compared to number of la-
beled data (264 subjects). However, LDS either with or without uMCI
data samples, clearly outperformed the corresponding supervised
method (SVM, AUC 0.7430 vs. 0.7661, p b 0.0001). Even though adding
uMCI samples did not signiﬁcantly improve the predictive performance
of the MCI-to-AD conversion, the use of LDS method in a transductive
manner led to a higher predictive performance compared to SVM
method.
Aggregate biomarker
In this section,we present the experimental results for the aggregate
biomarker of the Aggregate biomarker section based on MRI, age, and
cognitive measures, all acquired at the baseline. Table 4 shows the cor-
relation between cognitive measurements used in aggregate biomarker
to the ground-truth label.
In order to demonstrate the advantage of the selected data-
aggregation method and the utility of combining age and cognitive
measurements with MRI data, we also applied LDS and RF on data
formed by concatenating cognitive measurements, age and MRI data
(309 selected voxels with age-related effects removed) as a long vector.
Further, we applied RF on the age and cognitive measurements to pre-
dict AD in MCI patients in the absence of MRI data and combined SVM
with RF (abbreviated as SVM+RF) in the sameway as LDS is combined
to RF in the aggregate biomarker. The box plots for the performance
measures of aggregate biomarker (LDS + RF), SVM + RF as well as RF
and LDS applied on the concatenated data and the RF without MRI are
shown in Fig. 5.
The aggregate biomarker achieved mean AUC of 0.9020, which was
signiﬁcantly better than the AUC of LDS with aggregated data (0.7990,
p b 0.0001) and the AUC of RF with only cognitive measures (0.8819,
p b 0.001). With LDS, there was a signiﬁcant improvement when inte-
grating cognitive measurements and MRI data (mean AUC increased
from 0.7661 to 0.7990, p b 0.0001). However, in the case of RF adding
cognitive measurements with MRI data decreased its performance sig-
niﬁcantly when comparing to RF with only cognitive measurements
Table 3
A comparison of the performances of SVM and LDS methods with and without feature
selection, and with and without age-related effects by using MRI data. The results are
averages over 100 computation times. For the classiﬁcation accuracy (ACC), the chance
level is 62.12%.
Classiﬁer Feature
selection
Age related
effect
AUC ACC SEN SPE
SVM No Not removed 66.37% 64.86% 87.90% 27.09%
SVM Yes Not removed 69.49% 66.01% 78.88% 44.91%
SVM Yes Removed 74.30% 69.15% 86.73% 40.34%
LDS No Not removed 67.60% 66.05% 85.67% 33.90%
LDS Yes Not removed 72.88% 72.60% 84.16% 53.66%
LDS Yes Removed 76.61% 74.74% 88.85% 51.59%
As expected, applying LDS on the MRI data after removing age-related effects increased
the AUC score from 0.7288 to 0.7661, which was signiﬁcant according to the permutation
test (p b 0.0001). Removing age-related effects fromMRI data improved the classiﬁcation
performance signiﬁcantly also in the case of SVM (AUC 0.6949 vs. 0.7430, p b 0.0001).
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(mean AUC decreased from 0.8819 to 0.8313, p b 0.0001). These results
seem to suggest that RF had difﬁculties in aggregating MRI data with
cognitive measures and supports our decision to use two different
learning algorithms when designing the aggregate biomarker. Also,
the performance of SVM+ RF was clearly worse than the performance
LDS + RF (p b 0.001) and even RF with only cognitive measures
(p b 0.001). We hypothesize that this is because SVM overlearned and
failed to provide a useful input to random forest while the images in
the test set regularize LDS in a useful way. Fig. 6 shows the ROC curves
of one computation time (of the median AUC within 100 cross-
validation runs) of MRI biomarker (LDS with only MRI data), RF with
only age and cognitive measures, LDS and RF methods trained on the
concatenated data from MRI, age and cognitive measurements, and of
the aggregate biomarker with MRI, age and cognitive measurements.
The ROC curve of the aggregate biomarker dominates the other ROC
curves nearly everywhere. We also calculated the stratiﬁed AUC for
different pMCI subgroups, i.e., pMCI subjects that are converted to AD
in different time points (1, 2 or 3 years), for both MRI and aggregate
biomarkers. Results are shown in Fig. 7. Fig. 7 shows, as expected, that
the prediction was more accurate the closer the conversion subject
was. Additionally, we evaluated the classiﬁcation performance of the
MRI and aggregate biomarkers against a random classiﬁer, where a bio-
marker value for each subject was drawn randomly from a standard
normal distribution. The mean AUC of the random classiﬁer was
0.5016,whichwas signiﬁcantly lower than the AUCof theMRI biomark-
er (AUC= 0.7661, p b 0.0001) aswell as theAUCof aggregate biomark-
er (AUC = 0.9020, p b 0.0001).
Random forests can (without too much extra computational
burden) produce of an estimate of feature importance via out-of-bag
error estimate (Breiman, 2001; Liaw and Wiener, 2002). Fig. 9 shows
the importance of each feature of the aggregate biomarker calculated
by the RF classiﬁer. The MRI feature was the combined feature generat-
ed by LDS classiﬁer as described in the MRI biomarker section. Accord-
ing to Fig. 9, the MRI biomarker and RAVLT were the most important
features followed by ADAS-cog total, FAQ, ADAS-cog total Mod, age,
CDR-SB, and MMSE. We computed AUCs for each feature, considered
one-by-one, using 10-fold CV. AUCs for MRI, RAVLT, ADAS-cog scores
and FAQ were high while age, CDR-SB and MMSE were less signiﬁcant.
The survival curve for the aggregate biomarker is shown in Fig. 8.
According to Fig. 8 subjects in the ﬁrst quartile have the lowest risk for
conversion to AD and subjects in the last quartile have the highest
risk. Table 5 shows the hazard ratios for the continuous predictor and
for different quartiles compared to the ﬁrst quartile. These are shown
for the aggregate biomarker, the MRI biomarker and the RF trained
with age and cognitive measures. High biomarker values were associat-
ed with the elevated risk for Alzheimer's conversion (p b 0.001 for all
Fig. 4.Box plots for AUC,ACC, SEN and SPEof SVMandLDSmethodsbased onMRI datawith selected features and removedage-related effects,within 100 computation times. In the case of
LDS, the depicted results are obtainedwith (LDS-labeled+ unlabeled) andwithout (LDS-only labeled) utilizing uMCI subjects in the learning. On each box, the central mark is themedian
(red line), the edges of the box are the 25th and 75th percentiles, the whiskers extend to the most extreme data points not considered outliers, and outliers are plotted with a +.
Table 4
The correlation between cognitive measures to the ground-truth labels. The negative
correlation indicates that the higher the value the lower is the risk for AD.
Age MMSE FAQ CDR-SB ADAS-cog
total-11
ADAs-cog
total Mod
RAVLT
Correlation −0.06 −0.28 0.40 0.34 0.43 0.43 −0.46
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three biomarkers). The aggregate biomarker showed over 10 times
higher risk of conversion to AD for the subjects in the last quartile
as compared to the subjects in the ﬁrst quartile while for the MRI
biomarker and the RF with age and cognitive measures (without MRI)
this risk was 3.5 and 5.83 times higher, respectively.
Comparisons to other methods
Cuingnet et al. (2011) tested ten different methods for classiﬁcation
of pMCI and sMCI subjects. Only four of these methods, listed in Table 6
using the naming of Cuingnet et al. (2011), performed better than the
random classiﬁer for the task. However, none of them obtained signiﬁ-
cantly better results than the random classiﬁer, according to McNemar
test. In order to compare the performance of our biomarkers with the
work presented by Cuingnet et al. (2011) we performed the experi-
ments using training and testing set used on their manuscript. The
Supplementary Tables S7 and S8 explain the differences between ours
and Cuingnet's labeling of the subjects. With aggregate biomarker, one
subject was excluded from the training set and two subjects from the
testing set in sMCI groups due to missing cognitive measurements.
The results are reported in Table 6. The McNemar's chi square tests
with signiﬁcance level 0.05 were performed to compare the perfor-
mance of each method with random classiﬁer, as it was done in
Cuingnet et al. (2011). We also list the results of Wolz et al. (2011)
with the dataset used in Cuingnet et al. (2011) in Table 6. According
to McNemar tests, both MRI and aggregate biomarkers performed
signiﬁcantly better than random classiﬁer for this data. Also, with this
dataset, the aggregate biomarker provided better AUC than theMRI bio-
marker. Interestingly, themargin of difference between the AUCs of the
two biomarkers was smaller than with our labeling. This is probably
Fig. 5. Box plots for AUC, ACC, SEN and SPE of RF, LDS and aggregate biomarkerwith LDS+RF andwith SVM+RF, usingMRIwith cognitivemeasurementswithin 100 computation times.
On each box, the central mark shown in red is the median, the edges of the box are the 25th and 75th percentiles, the whiskers extend to the most extreme data points not considered
outliers, and outliers are plotted with a +. The abbreviation CM refers to cognitive measurements. The data for LDS (MRI+ age + CM) and RF (MRI + age + CM) was formed by simple
data concatenation.
Fig. 6. ROC curves of subject's classiﬁcation to sMCI or pMCI using classiﬁcation methods,
LDS, SVM and aggregate biomarker using only MRI and MRI with age and cognitive
measurements. Each ROC curve is froma cross-validation runwith themedianAUCwithin
100 cross-validation runs.
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caused by the difference in the labeling of subjects detailed in Supple-
mentary Tables S7 and S8.
Discussion
For the early identiﬁcation of MCI subjects who are in risk of
converting to AD, we developed a new method by applying advanced
machine learning algorithms for combining MRI data with standard
cognitive test results. First, we presented a new biomarker utilizing
only MRI data that was based on a semi-supervised learning approach
termed low density separation (LDS). The use of LDS in place of more
typical supervised learning approaches based on support vector
machines was shown to provide advantages as demonstrated by signif-
icantly increased cross-validated AUC scores. Second, we presented a
new method for combining MRI-biomarker with age and cognitive
measurements. This method combines the score provided by the MRI-
biomarker and applies it as a feature for the learning algorithm (RF in
this case). This aggregate biomarker provided a cross-validated AUC
score of 0.9020 averaged across 100 different cross-validation runs.
Since the cross-validation was properly nested, i.e., the testing data
was not used for feature nor parameter selection, this AUC can be seen
as promising for the early prediction of AD conversion.
The main novelties of the MRI-biomarker were 1) feature selection
using only the data from AD and NC subjects without using any data
from MCI subjects, thus reserving all the data about MCI subjects for
learning the classiﬁer, and 2) removing age-related effects from MRI
data by using only data from healthy controls. The feature selection in
this way can be seen as a mid-way between whole-brain, voxel-based
MCI-to-AD conversion prediction approaches (as in Gaser et al., 2013)
and approaches that use the volumes of pre-deﬁned regions of interest
(ROIs) (as in Ye et al., 2012) as MRI features. For the feature selection,
we applied elastic-net RLR by selecting all the features that had a non-
zero coefﬁcient value along the regularization path up to a point
which may be considered to provide minimal applicable amount of
regularization. This allowed us to detect all the voxels which may be
thought to provide relevant information for the classiﬁcation task with
concrete evidence that they indeed are useful for the discrimination.
The regularized logistic regression was chosen as a model selection
method because it has beenwidely used inmulti-voxel pattern analyses
of functional neuroimaging data as well as MRI based AD classiﬁcation
approaches and shown to outperform many other feature selection
methods (Huttunen et al., 2012, 2013; Ryali et al., 2010; Ye et al.,
2012; Casanova et al., 2011a,b; Janoušová et al., 2012). According to
the results presented here (see Table 3), elastic-net RLR was able to se-
lect relevant voxels corresponding to AD in the high dimensional MRI
data. We note that the number of selected voxels is not sufﬁcient to
fully capture the AD atrophy. The elastic net succeeded in this task
better than the tested competing methods and provides a voxel set
that, although being sparse, was well distributed all over the brain. If
our aimwould be to capture the full extent of atrophy in AD, amore spe-
cialized feature selection method would probably be more adequate
(Fan et al., 2007; Cuingnet et al., 2013; Grosenick et al., 2013; Michel
et al., 2011).
As normal aging and AD have similar effects on certain brain regions
(Desikan et al., 2008; Dukart et al., 2011), we estimated the effects of
normal aging on the MRI based on the data of healthy controls in a
voxel-wise manner and then removed it fromMRI data of MCI subjects
before training the classiﬁer. Our results indicated that removing age-
related effects from MRI could improve signiﬁcantly the prediction of
AD, especially young pMCI subjects as well as old sMCI subjects were
Fig. 7. The AUC of MRI biomarker and aggregate biomarker for classiﬁcation of different pMCI groups. pMCI1: if diagnosis was MCI at baseline but converted to AD within the ﬁrst
12 months, pMCI2: if diagnosis wasMCI at baseline and conversion to AD occurredwithin the 2nd year of follow-up (24 months), pMCI3: if diagnosis wasMCI at baseline and conversion
to AD was reported at 36 months follow-up.
Fig. 8.Kaplan–Meier survival curve for aggregate biomarker by splitting the predictor into
quartiles. The follow-up period is truncated at 36 months.
Fig. 9. The importance of MRI, age and cognitivemeasurements calculated by RF classiﬁer.
ADAS-cog total 11 and ADAS-cog total Mod are weighted averages of 13 ADAS subscores,
ADAS-cog subscore Q4 (delayed word recall) and Q14 (number cancelation) are not
included in the ADAS-cog total 11. RAVLT is RAVLT-immediate that is sum score for 5
learning trials. The AUC of each individual feature was calculated using RF except for
MRI that LDS was used. MRI: 0.7661, RAVLT: 0.7172, ADAS-cog total-11: 0.7185, FAQ:
0.7290, ADAS-cog total Mod: 0.6554, age: 0.5573, CDR-SB: 0.6789, MMSE: 0.6154.
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classiﬁed more accurately after the age removal. We hypothesize that
this is because the AD related atrophy in young pMCI was mixed to
the normal age related atrophy. Moreover, due to misidentifying age-
related atrophy as AD related atrophy in old sMCI subjects, these
subjects could be misdiagnosed as pMCI.
We constructed the aggregate biomarker by a speciﬁc ensemble
learning method. We ﬁrst derived the MRI biomarker by using LDS
and then added the output of the LDS classiﬁer as a feature together
with the age and cognitive measures for RF, which acts as a classiﬁer
combiner. This aggregate biomarker was shown to outperform data
concatenation with either LDS or RF as a learning algorithm. Moreover,
the data concatenation schemewithRF outperformed theMRI biomark-
er and the data concatenation scheme with LDS. In addition to demon-
strating the utility of combining cognitive measurements with MRI,
these results suggest that different classiﬁers were adequate for the
different stages of the biomarker design method. LDS performed well
with close-to-continuous data (such as MRI) but failed when a part of
the data was discrete. Instead, RF was more immune to the data type
because it is able to handle discrete data and for continuous data type
it applies an efﬁcient discretization algorithm before the learning step.
The difﬁculty of LDS to adapt to discrete features is not surprising
because LDS in our implementation applied the Euclidean distance in
constructing the graph-based kernel (see Appendix A) that is sub-
optimal for discrete features. Recently, Wang et al. (2013), Hinrichs
et al. (2011) and Zhang et al. (2011) consideredmultiple kernel learning
algorithms for combining MRI, PET and CSF biomarkers for AD vs. NC
and NC vs. MCI classiﬁcation and showed that the combination of
multiple data sources improves the classiﬁcation performance. All data
in these works is close-to-continuous and all the data sources have
multiple features. Instead, in our case, only MRI has multiple features
and cognitive measurements provide a single feature as we rely on
the composite cognitive scores with standard weightings. Interestingly,
Zhang et al. (2011) compared the performance of their multiple kernel
learning to a simple classiﬁer ensemble (majority vote between three
SVMs trained with data from three different modalities, MRI, PET, and
CSF), and obtained nearly as good classiﬁcation accuracy with the
classiﬁer ensemble (75.6% for NC vs. MCI) as with the multiple kernel
learning (76.4% for NC vs. MCI).
Compared to several previous studies (listed in Table 7) using ADNI
database, our aggregate biomarker seems promising with an AUC of
0.9020, ACC of 0.8172, SEN of 0.8665 and SPE of 0.7364, on 164 pMCI
and 100 sMCI subjects. To the best of our knowledge, the study by Ye
et al. (2012) reported a highest achieved performance (AUC of
0.8587) to date for predicting AD in MCI patients in a relatively large
data samples (319 labeled MCI subjects).
The comparison of differentmethods for MCI-to-AD conversion pre-
diction is hampered by the fact that the nearly all works use a different
classiﬁcation of the subjects into stable and progressive MCI. For
example, Wolz et al. (2011) used a simple criterion for labeling where
a subject who had not converted to AD before July 2011 was labeled
as stable MCI. This labeling provides a label for every MCI subject, but,
on the other hand, leads to very heterogeneous stable MCI group that
contains subjects with progressive MCI (Runtti et al., 2014) and is not
sensible in our semi-supervised learning setup. Our pMCI group is
almost the same as in Eskildsen et al. (2013) (156 subjects of 164 are
common), but using more recent conversion information, we found
that 41 subjects labeled as stable MCI by Eskildsen et al. (2013) had
converted to AD or the diagnosis had changed from MCI to NC and we
labeled them as uMCI. Finally, the 3-year cut-off period used here is
somewhat arbitrary and was decided based on the length of follow-up
for the original ADNI-1 project while AD-pathologies might be detect-
able in MRI even earlier than 3 years before clinical diagnosis
(Adaszewski et al., 2013) and setting a ﬁxed cut-off period is difﬁcult
due to non-dichotomous nature of the problem, partly caused by the
fact that the pMCI group is composed of subjects who convert to AD
in different time spans from the baseline. Partial remedies for the
problem include the use of more homogeneous groups for the classi-
ﬁer evaluation as we have done in Fig. 7 (following Eskildsen et al.
(2013)) and the use of statistical methods from the survival analysis
to evaluate AD-prediction biomarkers as we have done in Fig. 8 and
Table 5. Survival analysis has been used to evaluate MCI-to-AD con-
version prediction previously in McEvoy et al. (2011), Gaser et al.
(2013), and Da et al. (2014). Speciﬁcally, McEvoy et al. (2011) and Da
et al. (2014) build an MRI-based MCI-to-AD conversion prediction
biomarkers based on data from AD and NC subjects and compare the
biomarker magnitudes in MCI subjects to their time to conversion to
AD using either Kaplan–Meier curves and/or Cox hazard models. As
Da et al. (2014) noted the results of survival analyses cannot be directly
compared to the results of dichotomous classiﬁcation into pMCI and
sMCI groups, but are a complementary approach. As in previous studies
(McEvoy et al., 2011; Gaser et al., 2013; Da et al., 2014), we showed that
the elevated biomarker values are associated with the higher risk of
converting to AD.
An important characteristic of the present study was the use of a
semi-supervised classiﬁcationmethod for the AD conversion prediction
in MCI subjects. The semi-supervised method (LDS) was shown to out-
perform its counterpart supervised method (SVM) in the design of MRI
biomarker. We also found that adding data about uMCI subjects as un-
labeled data in the LDS learning procedure improved the classiﬁcation
performance slightly but not enough to reach the statistical signiﬁcance.
This is probably due to a relatively small number of uMCI subjects.
Previously, Filipovych and Davatzikos (2011) have found that even a
small number of unlabeled data improved the performance of TSVM
in AD versus NC classiﬁcation when the number of labeled data was
Table 5
Hazard rates (HR) ofMCI to AD conversion for aggregate biomarker, MRI biomarker and RFwith only age and cognitivemeasures (allmethods adjusted for age and gender). Note that the
continuous Hazard rate of MRI biomarker is not comparable to other biomarkers because it results from a different classiﬁer (LDS vs. RF) with a different output (SectionsMRI biomarker
and Aggregate biomarker) and one-unit change has a different meaning.
Aggregate biomarker MRI biomarker RF with age & CM
HR 95% CI p HR 95% CI p HR 95% CI p
Continuous 24.63 12.2–49.9 b0.001 2.48 1.9–3.3 b0.001 19.85 10.1–39.1 b0.001
1st vs 2nd quartile 5.14 2.84 2.64
1st vs 3rd quartile 9.16 2.72 5.04
1st vs 4th quartile 10.60 3.52 5.83
Table 6
The performance metrics in the ADNI data used by Cuingnet et al. (2011). Except for MRI
and aggregate biomarker, SEN, SPE values and McNemar test p-scores are extracted from
Cuingnet et al. (2011) and Wolz et al. (2011). McNemar test p-value is not available for
Wolz et al. (2011). Cuingnet et al. and Wolz et al. (2011) did not provide AUCs.
Method SEN SPE AUC McNemar test
MRI biomarker 64% 72% 75% p = 0.0304
Aggregate biomarker 40% 94% 81% p = 0.0013
Cuingnet et al. (2011) Voxel-STAND 57% 78% – p = 0.4
Cuingnet et al. (2011) Voxel-COMPARE 62% 67% – p = 1.0
Cuingnet et al. (2011) Hippo-Volume 62% 69% – p = 0.885
Cuingnet et al. (2011) thickness direct 32% 91% – p = 0.24
Wolz et al. (2011) (all) 69% 54% – –
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very small (10 or 20 samples). However, AD vs. NC classiﬁcation is an
easier problem than sMCI vs. pMCI classiﬁcation (Cuingnet et al.,
2011), especially if the number of labeled training data is small
(Filipovych and Davatzikos, 2011). Generally, unlabeled data improves
the classiﬁcation performance when the assumed model is correct
(Zhang and Oles, 2000) and the amount of improvement depends
strongly on the number of labeled data and the problem complexity
(Cohen et al., 2002). In our recent conference paper (Moradi et al.,
2014) we provided evidence that even a small number of unlabeled
data aids the MRI-based AD conversion prediction, but the size of im-
provement decreases when the number of labeled data increases.
In summary, we developed an approach to predict conversion to AD
withinMCI patients by combiningmachine learning approaches includ-
ing feature selection for selectingmost relevant voxels corresponding to
AD within MRI data, regression for determining normal aging effects
within the brain and supervised and semi-supervised classiﬁcation
methods for discriminating between pMCI vs. sMCI subjects. Our aggre-
gate biomarker achieved a very high predictive performance, with a
cross-validated AUC of 0.9020. Our experimental results demonstrated
also the important role of MRI in MCI-to-AD conversion prediction.
However, the integration of MRI data with age and cognitive measure-
ments improved signiﬁcantly the AD conversion prediction in MCI
patients.
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Appendix AA.1. Low density separation (LDS) (Chapelle and Zien,
2005)
The LDS algorithm is implemented in two steps:
1) Training a graph-distance derived kernel.
2) Training TSVM by gradient descent with the graph-distance derived
kernel.
A.2. Standard support vector machines and transductive support vector
machines
Denote a training data point by xn and associated class label by
yn ∈ {−1, 1}. The task is to learn a linear classiﬁer (possibly in a high-
dimensional kernel space) described by theweight vectorw perpendic-
ular to hyperplane separating the two classes and the bias b so that the
sign of the discriminant function d(x) =wTx+ b determines the class
label for data point x. The standard SVM aims atmaximizing themargin
around decision boundary by solving the following optimization
problem
min
w; ξ; b
1
2
wk k2 þ C
XN
n¼1
ξn
( )
s:t: yn w  xn−bð Þ þ ξn≥1; n ¼ 1;…;N
ð1Þ
where N is the number of labeled data points. This is the soft-margin
SVM allowing some degree of misclassiﬁcation (in the training set)
to prevent overﬁtting by introducing positive slack variables ξn,
n = 1, …, N which measure the degree of misclassiﬁcation of data
xn. The idea with adding the slack variable is to maximize the margin
while ﬁnding a tradeoff between a large margin and a small error
penalty. Here, C is the penalty parameter that controls the tradeoff
between a large margin and a small error penalty.
In the transductive SVM, the idea is to maximize the margin around
decision boundary by using labeled data while simultaneously driving
the hyperplane as far away as possible fromunlabeled points. Therefore,
the optimization problem in TSVM becomes
min
w; ξ; b
1
2
wk k2 þ C
XN
n¼1
ξn þ C
XNþM
n¼Nþ1
ξn
( )
s: t: yn w  xn−bð Þ þ ξn≥1; n ¼ 1;…;N
w  n−bj j þ ξn≥1; n ¼ N þ 1;…;M
ð2Þ
where N is the number of labeled data samples and M is the number
of unlabeled data samples, assuming that samples 1, …, N are labeled
and N+ 1,…,M are unlabeled. This can be rewritten as minimizing
1
2
w2 þ C
XN
n¼1
L yn w  xn−bð Þð Þ þ C
XNþM
nþNþ1
L w  xn−bj j ð3Þ
where the function L(t) = max(0, 1− t) is the classical Hinge Loss. The
implementation of TSVM was introduced ﬁrst by Joachims (1999),
which assigned a Hinge Loss function L(t) on the labeled samples and
Symmetric Hinge Loss function L(|t|) on the unlabeled samples.
However, because the cost function deﬁned in Eq. (3) is not differen-
tiable, it is replaced by
1
2
w2 þ C
XN
n¼1
L2 yn w  xn−bð Þð Þ þ C
XNþM
n¼Nþ1
L w  xn−bj jð Þ: ð4Þ
Here the function L⁎ = exp(−3t2) is the Symmetric Sigmoid
function, a smooth version of the Hinge Loss function. In LDS, Eq. (4)
is minimized by performing the standard conjugate gradient descent
on the primal formulation for optimization.
A.3. Graph based similarities
Graph-based methods for semi-supervised learning use a graph
representation G = (V, E) of the data. The graph consists of a node for
each labeled and unlabeled sample V = {xi: i = 1, ..., N + M} and
edges placed between nodes E = {(i, j)}, which model the similarities
of the samples. The node set V is divided into labeled points Vl of size
N and unlabeled points Vu of sizeM.
Here, the graph is constructed by using pairwise similarities be-
tween samples by squeezing the distances in high density regions. The
cluster assumption states that points are probably in the same class if
they are connected by a path through high density regions. As the idea
here is to construct a graph which captures the true distribution of the
observations, edges must be weighted based on some distancemeasure
such as the Euclidean distance denoted here by d(i,j) := ||xi - xj|| How-
ever, in many problems the Euclidean distance cannot capture the true
distribution in clustering (Lan et al., 2011). Therefore, a nonlinear
weight is assigned to each edge eij = exp(ρd(i, j))− 1 where ρ is the
stretching factor to be selected by cross-validation. After creating the
10-nearest neighbors graph with weights eij, the distances between
two points are calculated as a distance along shortest paths between
the points based on Euclidean distance from all labeled and unlabeled
data points. The distance matrix Dρ according to the density distance
measure is calculated from all labeled points to all data (labeled and
unlabeled points) according to
Dρi; j ¼
1
ρ2
log 1þ min
p∈ Pi; j
Xpj j−1
k¼1
ep kð Þp kþ1ð Þ
  !2
ð5Þ
where ρ is the stretching factor and Pi,j is the set of all paths (p)
connecting xi and xj. As described in Chapelle and Zien (2005), p ∈ Vl
is a path of length l := |p| on G = (V, E), in case (p(k), p(k + 1)) ∈ E
for 1 ≤ k b |p|, which connects the nodes p1 and p|p|. The kernel deﬁned
byDρ is not necessarily positive-deﬁnite, and, therefore, before applying
SVM, we perform the eigenanalysis of Dρ and retain only eigenvectors
corresponding to the highest (and positive) eigenvalues. Inmore detail,
let λ1, λ2,…, λN be the decreasing eigenvalues of HNDρH(N + M), where
Hp is the p × p centering matrix and let the U = (uik) be the matrix of
the corresponding eigenvectors. Then, kernelized representation of x is
x ¼ φ xð Þ : xk ¼ uik
ﬃﬃﬃﬃﬃ
λk
p
fork ¼ 1;…p;
where p is selected as described in Chapelle and Zien (2005).
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Appendix B
Denote the data from the pre-processed MRI of subject i ( i =
1,…, N) by xi = [xi1, …, xiM]T, where M is the number of brain voxels,
let li ∈ {AD, MCI, NC } be the diagnosis of the subject i, and ai the age
of the subject i.
B.1. Age removal
Denote the vector of intensity values of the NC (MCI) subjects at the
voxel j by xjNC (xjMCI) and the vector of ages of theNC (MCI) subjects by a
aNC (aMCI).
1. Estimate the effect of age to data at each voxel separately by a ﬁtting
a linear model xjNC = αjaNC + αj0. Solve this model in the least
squares sense resulting in estimates α^ j; α^ j0.
2. Apply the model from the Step 1 to remove the age effects of each
voxel separately from MCI data: xMCIarj ¼ xMCIj −α^ jaMCI þ α^ j0.
B.2. Feature selection
The goal of this feature selection is to select all the features (voxels)
amongM that are useful in linear separation of the AD class from theNC
class. The feature selection consists of the following steps:
1. Train a sparse logistic regression classiﬁer using elastic-net penalty,
i.e., a combination of l1 and l2 norms of the coefﬁcient vector β, sep-
arating the class AD from the class NC for various λt, t = 1, …, 100
using the full data (all MRI voxels), by maximizing the elastic-net
penalized log-likelihood
X
li¼AD
log LC β0 þ βxið Þ þ
X
li¼NC
log 1−LC β0 þ βxið Þð Þ
− λt α βk k1 þ 1−αð Þ βk k22
  ð7Þ
where yi = 1 if li = AD and yi = 0 if li = NC and LC(z) = 1/(1 +
exp(z)) is the logistic function and we set α = 0.5. Note that the
algorithm used here estimates the classiﬁers along the whole regu-
larization path λt, t= 1,…, 100 at once.
2. To select the best among λt, run 100 10-fold CV runs to yield λCV(j) in
each run that minimize the CV error and select the smallest of
these as λ*.
3. Select all the features that have a non-zero coefﬁcient value βj(λ) (in
the trained logistic regression model) for any λ ≥ λ* the along the
regularization path up to λ*. This ensures that we select all the
features (voxels) that can be considered to be useful for linearly
separating the AD and NC classes.
Appendix C. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.neuroimage.2014.10.002.
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Abstract We present a comparative split-half resampling analysis of various data
driven feature selection and classification methods for the whole brain voxel-based
classification analysis of anatomical magnetic resonance images. We compared sup-
port vector machines (SVMs), with or without filter based feature selection, several
embedded feature selection methods and stability selection. While comparisons of
the accuracy of various classification methods have been reported previously, the
variability of the out-of-training sample classification accuracy and the set of se-
lected features due to independent training and test sets have not been previously
addressed in a brain imaging context. We studied two classification problems: 1)
Alzheimer´s disease (AD) vs. normal control (NC) and 2) mild cognitive impair-
ment (MCI) vs. NC classification. In AD vs. NC classification, the variability in the
test accuracy due to the subject sample did not vary between different methods
and exceeded the variability due to different classifiers. In MCI vs. NC classifica-
tion, particularly with a large training set, embedded feature selection methods
outperformed SVM-based ones with the difference in the test accuracy exceeding
the test accuracy variability due to the subject sample. The filter and embed-
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ded methods produced divergent feature patterns for MCI vs. NC classification
that suggests the utility of the embedded feature selection for this problem when
linked with the good generalization performance. The stability of the feature sets
was strongly correlated with the number of features selected, weakly correlated
with the stability of classification accuracy, and uncorrelated with the average
classification accuracy.
Keywords Magnetic Resonance Imaging · Machine Learning · Feature selection ·
Alzheimer’s Disease · Classification · Multivariate pattern analysis
1 Introduction
Given a training set of brain images and the associated output variables (for ex-
ample, the diagnosis of the subject), machine learning algorithms try to solve the
model that generated the output variables based on the input data (brain im-
ages). The idea is that the inferred model predicts accurately and automatically
the outputs corresponding to inputs not belonging to the training set. This not
only has direct applications to the design of imaging biomarkers for various brain
disorders, but the inferred models can be also analysed as multivariate, discrim-
inative representations of the brain feature of interest. It has been demonstrated
that these multivariate representations can provide complementary information
to the ordinary massively univariate analysis, both in anatomical and functional
imaging (Jimura and Poldrack 2012; Davis et al 2014; Khundrakpam et al 2015;
Mohr et al 2015). However, these two analysis techniques and their interpretation
differ (Haufe et al 2014) and they possess distinct advantages and disadvantages
(Davis et al 2014; Kerr et al 2014).
A fundamental problem in using voxel-based supervised classification algo-
rithms for brain imaging applications is that the dimensionality of data (the num-
ber of voxels in the images of a single subject) far exceeds the number of training
samples available (subjects whose response variable is known). Rigorous solutions
to this problem, termed feature or variable selection, include regularization and
subset selection (Hastie et al 2009). The reasons for using feature selection (FS) are
two-fold: 1) using only a selected subset of features tends to improve the classifica-
tion performance by eliminating the non-informative features, and 2), recognizing
only the significant features contributing to the classification can be analysed as
a multivariate representation of the brain disorder of interest (Kerr et al 2014).
While comparisons of the accuracy of various classification methods have been re-
ported previously (Cuingnet et al 2011; Chu et al 2012; Bron et al 2015; Sabuncu
et al 2015), the stability of the out-of-training sample classification accuracy and
the set of selected features due to independent training and test sets have not
been previously addressed in an anatomical brain imaging context. This paper
addresses two questions: 1) How do the variability among the subject pool alter
the classification accuracy and the selected feature set and 2) do different feature
selection and classification techniques differ in their generalization performance?
Data driven FS selection methods are often divided into filter, wrapper and em-
bedded methods (Huttunen et al 2012; Mwangi et al 2014). Especially, embedded
FS methods have been increasingly applied and developed for brain imaging ap-
plications (Grosenick et al 2008; Ryali et al 2010; Huttunen et al 2013a; Casanova
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et al 2011b; Khundrakpam et al 2015). Embedded FS algorithms solve the learning
and variable selection problems jointly by optimizing a suitably regularized objec-
tive function consisting of a data term and a regularization term whose trade-off
is controlled by regularization parameters. Importantly, a regularization term can
be designed so that the feature selector possesses the grouping effect (Carroll et al
2009; Zou and Hastie 2005), forcing simultaneous selection of features that contain
correlated information, and takes into account the spatial structure in data inher-
ent to brain imaging (Grosenick et al 2013; Van Gerven et al 2010; Michel et al
2011; Baldassarre et al 2012; Cuingnet et al 2013). These brain imaging specific
regularizers utilizing the spatial structure in the data often outperform standard
regularizers, not taking the spatial structure in data into account, in terms of
interpretability of the classifiers (Fiot et al 2014; Mohr et al 2015).
The typical logic of the embedded FS is to train a classification model for
various values of regularization parameters and then select the best of these clas-
sification models, usually using the out-of-the-training-set predictive performance
as the selection criterion. Thus, embedded FS can be seen as a two-stage prob-
lem, where, in the first stage, one trains a series of classifiers and, in the second
stage, selects the best of these classifiers. The research effort in brain imaging
community has been strongly focused on the first of these stages and very little
effort has been placed on studying the second stage. A particular problem in the
second stage is that many feature selection techniques in brain imaging rely on
the cross-validation (CV) based estimation of the generalization error to select
the regularization parameters. This is problematic because CV-based error esti-
mates with small sample sizes have an extremely large variance. This fact was first
demonstrated already by Glick (1978) but it still remains as little known caveat
in small sample classification analysis (Dougherty et al 2010). Stability selection
is a relatively new feature selection approach that utilizes the above mentioned
variability (Meinshausen and Bu¨hlmann 2010). The key idea is that, using random
subsamping of the data, one selects those features that are most frequently selected
on the subsamples of data. Although this idea has been applied in neuroimaging
applications (Ye et al 2012; Rondina et al 2014), its suitability for neuroimaging
has received little direct attention.
A closely related question concerns the replicability of the selected voxel sets.
More specifically, the question is how much do the error rates and selected features
depend on the subject-set studied and to what extent the classifiers represent
generalizable discrimination pattern across the classes. In a very interesting study,
Rasmussen et al (2012) demonstrated that within the context of fMRI choosing the
regularization parameters relying only on the predictive accuracy has a negative
impact on the replicability of the discrimination patterns between the two tasks.
In this paper, we study different linear whole-brain voxel-based classifiers (listed
in Table 1) for the Alzheimer’s disease (AD) and mild cognitive impairment (MCI)
classification based on structural MRI. The studied classification methods include
embedded FS methods based on penalized logistic regression, support vector ma-
chines with or without filter based FS, and stability selection followed by the SVM
classification. We also contrast non-parametric CV based model selection to a re-
cent parametric classification error estimation based model selection (Huttunen
et al 2013b; Huttunen and Tohka 2015). We proceed with an experimental setup
based on split-half resampling similar to the one used in the NPAIRS framework
(Strother et al 2002). The subjects are randomly divided in two non-overlapping
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sets, test and train, and random divisions are repeated 1000 times. We study both
the replicability of the selected variables (voxels) and the error rates of the clas-
sifiers. We vary the number of subjects used for training the classifiers and the
number of variables.
We chose MRI-based AD/MCI classification applications for several reasons.
1) They are well studied problems that can be solved accurately using linear clas-
sifiers (Cuingnet et al 2011; Bron et al 2015; Chu et al 2012). 2) A large enough (at
least 200 subjects per class) high quality dataset is available (ADNI) (Weiner et al
2012) that is a necessity for performing the analysis. We note that this requirement
cannot be fulfilled for stable vs. progressive MCI classification with ADNI1 data
(Moradi et al 2015). 3) The uses of supervised machine learning are more varied
in functional imaging because of the additional time dimension and more complex
experimental designs. We use voxel based morphometry (VBM)-style feature ex-
traction as it has proved effective for this and related applications (Gaser et al
2013; Moradi et al 2015; Cuingnet et al 2011; Bron et al 2015; Retico et al 2015),
and unlike region of interest (ROI) based methods, provides a feature set that
retains the high-dimensional nature of the data and allows to draw conclusions
perhaps extendable to other whole brain pattern classification approaches.
We note that computing the results presented in this study required approxi-
mately 6 years of CPU time.
2 Classification and feature selection
2.1 Linear classifiers
The image of the subject i is denoted by xi = [xi1, . . . , xiP ] where xij is the gray
matter density at the voxel j. Only voxels within the brain mask are considered.
The observation matrix is denoted by X ∈ RN×P , whose rows xi are the images
with corresponding class labels y = (y1, . . . , yN )
T with yi = {−1, 1}. −1 is inter-
preted as not healthy (AD or MCI) and 1 is interpreted as normal control. The
observation matrix is normalized so that (1/N)
∑
i xij = 0 and (1/N)
∑
i(xij)
2 = 1.
We use Nc to denote the number of training examples from the class c.
The predicted class label yˆ for the feature vector x is given by yˆ = sign(β0 +
βTx)
.
= g(x), where the classifier parameters β0 ∈ R and β = (β1, β2, . . . , βP )T ∈
RP are learned from training data.
2.2 Filters for feature selection
Filters form the simplest approach to feature selection. Filters work as a pre-
processing step for classifiers and are completely independent of the classification,
which is often interpreted as their downside (Guyon and Elisseeff 2003). We here
consider only a simple t-test based filter (Inza et al 2004). For each feature j, a
t-score is computed
tj =
|µ−1(j)− µ1(j)|√
0.5(σ2−1(j) + σ21(j))
, (1)
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where µc(j) and σ
2
c (j) are mean and variance of the feature j for the class c,
respectively, and we have assumed that the classes are balanced. Based on the t-
scores tj , the features are ranked and the ones with the highest t-scores are selected
to be used in classification. We used two different kinds of selection thresholds
in this study. We either selected 1000 highest ranking features or selected these
according to a false discovery rate (FDR) corrected threshold (Genovese et al
2002). This filter method is particularly interesting to this work since it resembles
the standard statistical analysis used in VBM.
2.3 Embedded feature selection
In the embedded FS, the idea is to jointly train the classifier and select the rele-
vant features. This can be formulated as a cost function optimization, where the
data term D(X,y,β, β0) models the likelihood of training data given the classifier
parameters and the regularization terms penalize a priori unlikely classification
parameters. The general form of the cost function used in this paper is (Grosenick
et al 2013)
C(β, β0) = D(X,y,β, β0)+λ
α1||β||1 + (α2/2)||β||2 + α3( P∑
i=1
1
2|Ni|
∑
j∈Ni
(βi − βj)2)
 ,
(2)
where λ and αi, i = 1, 2, 3 are the parameters that are selected by a model selection
criteria and Ni is the 6-neighborhood of the voxel i. In above, if α2 = α3 = 0, the
sparsity promoting LASSO penalty follows (Tibshirani 1996). If α3 = 0, then
elastic-net penalty follows (Zou and Hastie 2005), and if all αi are allowed to
take non-zero values, we talk about GraphNet penalty (Grosenick et al 2013). If
α1 = α3 = 0, we have a regularizer that does not promote sparsity that is used in
the SVM (Hastie et al 2004). Note that it is possible to adopt a convention that∑
j αj = 1.
For logistic regression models (Friedman et al 2010)
D(X,y,β, β0) = (1/N)
N∑
i=1
LogPr(yi|xi)
and
Pr(c | x) = 1
1 + exp [c(β0 + xTβ)]
.
for c ∈ {−1, 1} and for SVM models (Hastie et al 2004)
D(X,y,β, β0) =
N∑
i=1
[1− yi(β0 + βTxi)]+
where [x]+ = max(0, x).
Different parameter values (λ, αj) produce different classifiers and the idea of
the embedded FS methods is to train several classifiers with different parameter
values and then select the best classifier according to some model selection crite-
ria. Particularly, the product λα1 controls the strength of the L1 regularization
effectively deciding how many voxels to select.
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2.4 Parameter selection based on error estimation
2.4.1 Cross-validation
K-fold cross-validation is the most widely used technique for the parameter se-
lection in the embedded FS. The training set is divided into K equally sized sets
(folds), K − 1 of which are used for the classifier training and the remaining one
for testing the classifier. This is iterated over the K folds, having a different fold
as the test fold during each iteration. Then, the K obtained test accuracies are
averaged and the parameter combination giving the highest average accuracy is
selected. In this work, we always set K = 10 according to Kohavi (1995).
2.4.2 Bayesian error estimation
The non-parametric error estimation techniques (such as CV or bootstrap) suffer
from excess variability of the error estimates especially in small sample situations
(Dougherty et al 2010). The parametric Bayesian error estimator (BEE) was re-
cently proposed as an alternative to non-parametric error estimation techniques
(Dalton and Dougherty 2011) and we have demonstrated that it can be applied
to model selection also when its parametric assumptions are only approximately
satisfied (Huttunen et al 2013b; Huttunen and Tohka 2015).
The BEE is defined as the minimum mean squared estimator (MMSE) mini-
mizing the expectation between the error estimate and the true error (Dalton and
Dougherty 2011). If we assume Gaussian model for the class-conditional density,
a closed form expression can be derived for the posterior expectation of the clas-
sification error in the binary classification case under mild assumptions about the
covariance structure. The method is attractive, because the errors are estimated
directly from the training data, and no iterative resampling or splitting operations
are required. This also means substantial savings in the computation time. The
closed form equations for BEE are complex and we refer to Dalton and Dougherty
(2011); Huttunen and Tohka (2015) for them. The model selector we use is the
BEE with the full covariance and the proper prior with the hyper-parameters
set exactly as in (Huttunen and Tohka 2015). For the completeness, the hyper-
parameter values along with a short explanation of their meaning are available
in the supplement. The implementation of the BEE model selector is available at
https://sites.google.com/site/bayesianerrorestimate/.
2.5 Stability selection
Stability selection is a recently proposed approach by Meinshausen and Bu¨hlmann
(2010) for addressing the problem of selecting the proper amount of regularization
in embedded FS algorithms. This approach is based on subsampling combined
with the FS algorithm. The key idea of this method is that, instead of finding
the best value of the regularization and using it, one applies a FS method many
times to random subsamples of the data for different value of the regularization
parameters and selects those variables that were most frequently selected on the
resulting subsamples.
Feature selection in MRI 7
Given a set of regularization parameters Λ, fixed parameters αi, the number
of iterations M , and the threshold value pithr, the stability selection performs
following steps:
1) For each regularization parameter λ ∈ Λ,
– Draw a subsample of training data Di of size bN2 c, where N is the number of
training data, without replacement.
– Run the regularized logistic regression on Di using parameter λ (see Eq. (2))
and obtain βi. Keep the selected features Sλ(Di) = {j : βλj 6= 0}.
– Repeat the above step M times and compute the selection probability for all
features j = {1, ..., p},
Πλj =
1
M
M∑
i=1
1{j ∈ Sλ(Di)}, (3)
where the 1{.} is the indicator function.
2) Calculate the stability score for each variable j = {1, ..., p},
Sstable(j) = max
λ∈Λ
(Πλj ) (4)
3) Finally, select the features with higher stability score than pithr.
In this work, we used R = 1000 iterations and the studied regularization param-
eter values were Λ = {k × 0.005; k = 1, 2, ..., 60} for LASSO (α1 = 1, α2 = α3 = 0)
and Λ = {k × 0.01; k = 1, 2, ..., 60} for elastic-net (α1 = α2 = 0.5, α3 = 0). The
GraphNet penalty was not considered with the stability selection as the compu-
tation time would have been prohibitive. The experiments were done with two
different threshold values pithr = {0.1, 0.2}, meaning that a feature was selected if
at least for one value of λ ∈ Λ, it was selected 100 (pithr = 0.1) or 200 (pithr = 0.2)
times among 1000 subsampling experiments. We present the results only for the
better threshold value, which was pithr = 0.2 for 8mm data and pithr = 0.1 for the
4mm data. After the stability selection, we still have to select the classifier for clas-
sifying the data based on selected features. We decided to use SVM in accordance
to Ye et al (2012).
3 Materials
3.1 ADNI data
Data used in this work is obtained from the Alzheimer’s Disease Neuroimaging
Initiative (ADNI) database http://adni.loni.usc.edu/. The ADNI was launched
in 2003 as a public-private partnership, led by Principal Investigator Michael W.
Weiner, MD. The primary goal of ADNI has been to test whether serial magnetic
resonance imaging (MRI), positron emission tomography (PET), other biological
markers, and clinical and neuropsychological assessment can be combined to mea-
sure the progression of mild cognitive impairment (MCI) and early Alzheimer’s
disease (AD). For up-to-date information, see www.adni-info.org.
We used MRIs from 200 AD subjects, 400 MCI subjects, and 231 normal
controls for whom baseline MRI data (T1-weighted MP-RAGE sequence at 1.5
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Tesla, typically 256 x 256 x 170 voxels with the voxel size of 1 mm x 1 mm x 1.2
mm) were available.
3.2 Pre-processing
As described by Gaser et al (2013); Moradi et al (2015) preprocessing of the T1-
weighted images was performed using the SPM8 package (http://www.fil.ion.
ucl.ac.uk/spm) and the VBM8 toolbox (http://dbm.neuro.uni-jena.de), running
under MATLAB. All T1-weighted images were corrected for bias-field inhomo-
geneities, then spatially normalized and segmented into grey matter (GM), white
matter, and cerebrospinal fluid (CSF) within the same generative model (Ash-
burner and Friston 2005). The segmentation procedure was further extended by
accounting for partial volume effects (Tohka et al 2004), by applying adaptive
maximum a posteriori estimations (Rajapakse et al 1997), and by using an hidden
Markov random field model (Cuadra et al 2005) as described previously (Gaser
2009). This procedure resulted in maps of tissue fractions of WM and GM. Only
the GM images were used in this work. Following the pipeline proposed by Franke
et al (2010), the GM images were processed with affine registration and smoothed
with 8-mm full-width-at-half-maximum smoothing kernels.
After smoothing, images were resampled to 4 mm and 8mm isotropic spatial
resolution, producing two sets of the images with different resolutions. This proce-
dure generated, for each subject, 29852 or 3747 aligned and smoothed GM density
values that were used as MRI features. Image downsampling is often used in ma-
chine learning to reduce the number of redundant features in order to improve the
classification performance. For example, (Franke et al 2010) concluded that the
voxel size had negligible effect on age estimation accuracy. For this study, even
more important reason for downsampling is the reduction in computational time
and the memory requirements for classifier training.
Normal aging and AD have partially overlapping effects on the brain (Fjell
et al 2013; Dukart et al 2011), and therefore age effect removal has been suggested
to improve the classification performance in the AD related classification tasks
(Dukart et al 2011; Moradi et al 2015). Briefly, given a set of pre-processed images
of normal controls (representing the GM density values), we estimated the effects
of normal aging to each voxel separately using linear regression. Then, the learned
regression coefficients are used to remove aging effect in any image. The procedure
applied is detailed by Moradi et al (2015), where the rationale behind it is also
more thoroughly described. We performed the AD vs. NC experiments for both
the images with and without age-removal.
4 Methods
4.1 Experimental procedure
We performed a split-half resampling type analysis that was introduced by Strother
et al (2002) for their NPAIRS framework and applied by Rasmussen et al (2012)
to study classification analysis of fMRI data. Specifically, we sampled without
replacement NC = 100 or NC = 50 subjects from each of the two classes so that
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N = 200 or N = 100 and the classification problems were balanced. This procedure
was repeated R = 1000 times. We denote the two subject samples (split halves;
train and test) Ai and Bi for the iteration i = 1, . . . , R and drop the index where it
is not necessary. The sampling was without replacement so that the split-half sets
Ai and Bi were always non-overlapping and are considered as independent train
and test sets. Each learning algorithm, listed in Table 1, was trained on the split
Ai and tested on the split Bi and, vice versa, trained on Bi and tested on Ai. This
was done with each image set (4mm, 8mm, Age removed 4mm, Age removed 8mm
for the AD vs. NC problem and age removed 4mm and age removed 8mm for the
MCI vs. NC problem). Thus, each algorithm was trained and tested 24000 times.
All the training operations (estimation of regression coefficients for age removal,
parameter selections) were done in the training half. The test half was used only
for the evaluation of the algorithms.
We recorded the test accuracy (ACC) of each algorithm (the fraction of the
correctly classified subjects in the test half) averaged across R = 1000 re-sampling
iterations. Moreover, we computed the average absolute difference in ACC between
the two split-halves, i.e.,
∆ACC =
1
R
R∑
i=1
|ACC(Ai, Bi)−ACC(Bi, Ai)| , (5)
where ACC(Ai, Bi) means accuracy when the training set is Ai and the test set
is Bi. We additionally recorded the average area under the curve (AUC) for the
test subjects. As expected for balanced problems, AUC correlated almost perfectly
with ACC and to simplify the exposition of the results, we decided not to present
AUCs in the paper.
Statistical testing on ACCs was done to confirm whether the generalization per-
formance of the classifiers differed. Note that just performing the standard t-test
or some non-parametric alternative (e.g., a permutation test) on test-accuracies
is not correct if we are interested in the true generalization ability to new sub-
jects (not part of the ADNI sample). This is because different replications of the
train/test procedure are not independent (Bouckaert and Frank 2004; Nadeau and
Bengio 2003). As we performed 1000 replications on different split-halves, we used
1000x2 CV approach known as the corrected repeated 2-fold CV t-test (Bouck-
aert and Frank 2004). This corrected t-test, which is an improvement of 5X2 CV
test of Dietterich (1998) and McNemar’s test (see (Bouckaert and Frank 2004)),
relies on the covariance correction of Nadeau and Bengio (2003). The test can
be assumed to be conservative in our setting as the correction factor of Nadeau
and Bengio (2003) was derived using the assumption that the classifiers are stable
with respect to a change in the training set. This is not the case here, and thus
the correction overestimates the correlation between the accuracies of different
replication rounds. However, we feel that this conservative test is better for the
purposes of this work than a liberal uncorrected test, however, for this reason we
report the significance at p = 0.1 level in addition to the standard p = 0.05 level.
We used similar correction in the case where an unpaired t-test had to be used,
that is, when comparing the ACCs of classifiers trained with a different number of
subjects. Finally, where it was appropriate, we combined the test-statistics using a
simple average t method (Lazar et al 2002), which is nearly equivalent to Stouffer’s
statistic due to the high degrees of freedom.
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Abbreviation Algorithm
EN-VA Logistic regression with elastic-net penalty;variable α2, α1 = 1− α2, α3 = 0
EN-05 Logistic regression with elastic-net penalty with α1 = α2 = 0.5 fixed, α3 = 0
LASSO Logistic regression with LASSO penalty α1 = 1, α2 = α3 = 0
LASSOSTAB LASSO with stability selection (see section 2.5).
ENSTAB Elastic net with stability selection (see section 2.5).
GN GraphNet with α1 = 1, α2 = 1;α3 = 1 for 4mm data, α3 = 10 for 8mm data
SVM-Fx SVM with t-test filter selecting x (125 or 1000) best ranked voxels
SVM-FFDR SVM with t-test filter selecting voxels surviving a given FDR threshold
SVM-ALL SVM with all voxels
Table 1: Learning algorithms studied in this work. CV and BEE after the abbre-
viation refer to the criterion used to select λ and possibly α2. The regularization
parameter (λα2 in our notation) for all SVM algorithms was selected by cross-
validation on the training set. The stability selection algorithms were followed by
SVM classification.
Hypothesis tests on ∆ACC were performed using a permutation test. This
assumes the independence of ACC differences between different replications and
therefore these tests might be more liberal than the nominal alpha level indicates.
4.2 Feature agreement measures
We used two measures to quantify the agreement of the selected voxels between
two non-overlapping datasets: Dice index and modified Hausdorff distance. The
Dice index measures the similarity of two sets (or binarized maps) of selected
voxels and is widely used performance measure for evaluating image segmentation
algorithms and has been also used to compare fMRI activation maps (Pajula et al
2012). The Dice index between the voxel sets VA and VB is defined as (Dice 1945)
DICE(VA, VB) =
2|VA ∩ VB |
|VA|+ |VB | (6)
and it varies between 0 (when the two sets do not share any voxels/features)
and 1 (when VA = VB). The Dice index has a close the relationship to Kappa
coefficient (Zijdenbos et al 1994) and we will interpret the Dice values according
to well-known but subjective Kappa categorizations (Pajula et al 2012).
The Dice index does not take into account the spatial closeness of the voxels and
returns the value 0 if the data indicates close-by (but not exactly matching) voxels.
Also, for this reason, the Dice index might favor dense voxel sets over sparse sets.
Therefore, we introduced another similarity measure, modified Hausdorff distance
(mHD), which takes into account spatial locations of the voxels (Dubuisson and
Jain 1994). Let each of the voxels a be denoted by its 3-D coordinates (ax, ay, az).
Then, the mHD is defined as
H(VA, VB) = max(d(VA, VB), d(VB , VA)), (7)
where
d(VA, VB) =
∑
a∈VA
min
b∈VB
||a− b||.
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The rationale of using modified Hausdorff distance instead of the (original) Haus-
dorff distance is that the values of the original Hausdorff distance are large even
in the presence of small differences between the voxel sets and typically remains
constant when difference increases. The modified Hausdorff distance does not suf-
fer from such a problem; we refer to (Dubuisson and Jain 1994) for details. The
permutation test was applied for comparison of the feature agreement measures
between different algorithms.
4.3 Studied classification methods and their implementation
We studied several learning algorithms that are summarized in Table 1. The elas-
tic net and LASSO based methods were implemented with the GLMNET package
(Friedman et al (2010); http://web.stanford.edu/~hastie/glmnet_matlab/) with
the default parameters and default grid to search for the optimal λ. The SVMs
were implemented with LIbSVM (Chang and Lin (2011); http://www.csie.ntu.
edu.tw/~cjlin/libsvm/ ) and the regularization parameter was always selected
based on CV in the training set. The stability selection was based on an in-house
Matlab implementation following the guidelines of (Ye et al 2012) and it was fol-
lowed by SVM classification. For this reason, when referring to Elastic-Net or
LASSO later on, we do not typically mean stability selection. The GraphNet was
implemented based on an in-house C code implementing the cyclical coordinate
descent of (Friedman et al 2010), which uses a quadratic approximation to the
log-likelihood, and then coordinate descent on the resulting penalized weighted
least-squares problem. However, the coordinate descent is modified to account
for the spatial regularizer1. For stability selection and GraphNet, we had to fix
certain parameter values for computational reasons. For stability selection, these
were fixed following suggestions by Ye et al (2012). For GraphNet, these were
fixed using a small-scale pilot study on the AD vs. NC problem with Nc = 100.
We selected the parameter values for the main experiment so that the numbers
of selected features were appropriate , i.e., classification accuracy was not used as
the parameter selection criterion but the same data as for the main experiment
was used. Note that slightly different parameter values were appropriate for 4 mm
and 8 mm data. The studied parameters for the grid search for all the algorithms
are provided in the supplement, where full details about parameter tuning exper-
iments can be found. We performed full-scale experiments for the GraphNet with
α1 = 1, α2 = 0, α3 = {1, 10} called Sparse Laplacian in (Baldassarre et al 2012).
However, all the results (ACC, ∆ACC, mHD, and Dice) were practically equal to
those of GraphNet with parameters as in Table 1, and therefore, they are omitted
from the paper.
With SVMs, the filter parameters, the number of features to select (we selected
1000 features for 4 mm voxel size and repeated the experiments selecting 125 as
well as 1000 features for 8 mm voxel size) and the FDR thresholds, were selected
based on our previous experience on the similar classification problems (Moradi
et al 2015, 2014). We were unable to find a single FDR-threshold which would have
worked well for all settings and choose the values: q = 0.0005 for NC = 100 and
1 This is akin to the implementation in the Donders Machine Learning Toolbox https:
//github.com/distrep/DMLT
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NC = 50, 4mm NC = 100, 4mm NC = 50, 8mm NC = 100, 8mm
ACC ∆ACC ACC ∆ACC ACC ∆ACC ACC ∆ACC
EN-VACV 0.821 0.041 0.844 0.028 0.823 0.041 0.846 0.027
EN-VABEE 0.815 0.039 0.842 0.027 0.817 0.039 0.841 0.026
EN-05CV 0.820 0.040 0.844 0.027 0.824 0.041 0.846 0.027
EN-05BEE 0.811 0.039 0.837 0.027 0.814 0.039 0.837 0.026
LASSOCV 0.813 0.042 0.840 0.029 0.817 0.041 0.842 0.028
LASSOBEE 0.799 0.043 0.828 0.027 0.801 0.042 0.827 0.027
LASSOSTAB 0.809 0.044 0.829 0.034 0.805 0.047 0.822 0.034
ENSTAB 0.814 0.041 0.827 0.030 0.813 0.041 0.827 0.032
GNCV 0.822 0.043 0.847 0.029 0.820 0.044 0.838 0.030
GNBEE 0.814 0.039 0.838 0.026 0.807 0.038 0.830 0.026
SVMF-FDR 0.819 0.044 0.841 0.029 0.817 0.049 0.840 0.030
SVMF-1000 0.829 0.043 0.847 0.028 0.809 0.044 0.839 0.031
SVMF-125 – – – – 0.827 0.044 0.846 0.029
SVM-ALL 0.802 0.038 0.830 0.027 0.798 0.040 0.825 0.027
mean 0.814 0.041 0.838 0.028 0.814 0.042 0.836 0.029
Table 2: The average ACCs and ∆ACC for the AD vs. NC experiments. The
columns ACC refer to the averages over the R = 1000 resamplings. – means that
a measure is not available. Slightly different parameter settings are used for GN,
SVM-FDR and stability selection depending on the data dimensionality (4mm
voxels vs. 8mm voxels.)
NC = 50, 4mm NC = 100, 4mm NC = 50, 8mm NC = 100, 8mm
ACC ∆ACC ACC ∆ACC ACC ∆ACC ACC ∆ACC
EN-05CV 0.785 0.058 0.836 0.033 0.739 0.057 0.797 0.038
EN-05BEE 0.782 0.053 0.833 0.032 0.746 0.050 0.800 0.034
GNCV 0.767 0.070 0.810 0.057 0.732 0.059 0.789 0.037
GNBEE 0.775 0.050 0.828 0.031 0.739 0.045 0.794 0.031
ENSTAB 0.695 0.051 0.753 0.036 0.689 0.049 0.747 0.034
SVMF-FDR 0.700 0.044 0.720 0.043 0.692 0.046 0.710 0.039
SVMF-1000 0.684 0.052 0.719 0.041 0.684 0.054 0.721 0.045
SVMF-125 – – – – 0.674 0.051 0.706 0.040
SVMALL 0.704 0.042 0.758 0.030 0.700 0.045 0.753 0.031
mean 0.736 0.052 0.782 0.038 0.711 0.051 0.757 0.037
Table 3: The average ACCs and ∆ACC for MCI vs. NC experiments, see Table 2
for notation.
q = 0.005 for NC = 50 in the AD vs. NC classification (the same values were used
for both 4mm and 8mm data); For the MCI vs. NC problem, when NC was 100,
we used q = 0.005 for 4mm data and q = 0.05 for 8mm data and when NC = 50,
we used q = 0.5 to prevent empty feature sets that often resulted with normal
q thresholds. The rationale for these selections is explained in more detail in the
supplement.
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5 Results
5.1 Classification accuracy and its variability
5.1.1 AD vs. NC
The average ACC and ∆ACC for the AD vs. NC problems are listed in Table 2. We
discuss only the results with the age removal because it improved the average ACC
with all the classifiers. The improvement remained non-significant with respect to
generalization performance at the p = 0.05 level (corrected t-test) with any of
the classifiers, but the combined effect measured using the average t-statistic was
highly significant (p < 10−5). The improvement in ACC was from 0.004 (GNBEE
with 8mm data and Nc = 100) to 0.021 (LASSOSTAB with 4mm data and Nc =
50) and the average improvement in ACC was 0.014. The classification accuracies
without age removal are given in the supplementary Table S1.
The average ACC varied from 0.798 (SVM-ALL, 8mm, Nc = 50) to 0.847
(GN1CV, 4mm, NC = 100) and showed little dependence on whether 4mm or
8mm data was used (mean ACC was 0.838 for 4mm data and 0.835 for 8mm data
when NC = 100, the difference was not significant in terms of generalization per-
formance, neither with individual classifiers nor when studying average t-statistic).
The accuracy was improved by 0.023 (on average) when doubling the number of
training subjects. Adding more subjects improved the classification accuracy with
all the classifiers, but the improvement remained non significant. However, the
average t was again highly significant (p < 10−5) suggesting that the addition of
subjects was useful as expected.
The average variability of classification accuracies between independent sam-
ples ∆ACC was greater than the difference between the average classification accu-
racy between any two classifiers: the smallest ∆ACC among independent samples
was 0.026 by GraphNet combined with BEE with Nc = 100 while the largest
difference of the classification accuracy among two different classifiers was 0.025
(between EN-VACV and SVMALL with Nc = 50 and 8mm data). The figure 1
illustrates this phenomenon. It shows the scatter plot between the ACC difference
of EN-05CV classifier in the two independent splits of the data and the ACC dif-
ference between EN-05CV and SVMALL trained with the same data. Even in the
case, where the difference between classifiers was maximal (8mm and Nc = 50 red
balls in the figure), the ACC differences between the classifiers were about at the
same level as the ACC differences due to different train and test sets.
The average ∆ACC was reduced by one third (from 0.043 to 0.029 with 4mm
data and 0.042 to 0.028 with 8mm data) when going from Nc = 50 to Nc = 100.
The reduction was significant with all the classifiers according to the permutation
test (p < 10−5). There were no striking differences between ∆ACC values of differ-
ent methods; however, ∆ACC for the feature selection methods that do not try to
estimate classification error (filters and stability selection) was higher on average
than for the methods that select features based on the estimate of the classification
accuracy (CV and BEE based methods). However, the differences were significant
at p = 0.05 level only for certain setups, for example, elastic-net based methods
with Nc = 50 and 4mm data showed significantly smaller ∆ACC than the filter
based methods (SVMF-1000 and SVMF-FDR).
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Fig. 1: The ACC difference of EN-05CV classifier in the two independent splits
of the data (ACCEN−05CV (Ai, Bi) - ACCEN−05CV (Bi, Ai)) plotted against the
ACC difference between EN-05CV and SVMALL trained with the same data
(ACCEN05−CV (Ai, Bi) - ACCSVMALL(Ai, Bi)). The size of the balls correspond
to the number of replications with a certain ACC difference. Left panel: For the
AD vs. NC problem, the train and test sample had equal or larger influence on
ACC than the classifier choice even with the classifiers with the largest difference in
average ACC. Right: For the MCI vs. NC problem (green balls), the situation was
different than for the AD vs. NC problem (blue balls): the choice of the classifier
was important as the green balls are consistently in the positive half of y-axis.
5.1.2 MCI vs. NC
The classification between MCI and NC subjects can be considered as a much
harder problem than the AD vs. NC classification. We did not consider LASSO-
based methods or the elastic net with variable α (EN-VA) to simplify the analysis
of the results 2. The results concerning the classification accuracy are presented
in Table 3.
The average classification accuracy varied from 0.674 (SVMF-125, NC = 50
8mm voxel size) to 0.847 (EN05-CV, NC = 100, 4mm voxel size). Unlike in the
AD vs. NC problem, the choice of the method mattered in this case. GraphNet
and Elastic Net were clearly the most accurate methods: With NC = 100 the
generalization performance improvement was always significant at p = 0.05 level
when comparing Elastic-Net or Graphnet method to any SVM-based method with
4mm data; with 8mm data, the differences were significant at p = 0.05 level against
SVMs with filters (SVMF-1000 and SVMF-FDR) and at p = 0.1 level against
SVMALL and stability selection. This is visible in the scatter plot of the right
panel of Figure 1, where the green balls corresponding to the MCI vs. NC problem
lie predominantly in the positive half of the y-coordinate. With the smaller number
of subjects NC = 50 and 4mm data, the performance of Elastic-Net and GraphNet
still remained superior, however, the improvement was typically significant only
at p = 0.1 level. With 8mm data and NC = 50, the performance differences were
not significant except for SVMF-125 which was less accurate than the embedded
2 Briefly, as the LASSO does not enforce grouping, it is sometimes considered as inappro-
priate for neuroimaging applications (Carroll et al 2009). The performance of EN-VA was very
similar with EN-05 in the AD vs. NC problem. For these reasons, we decided not to perform
the experiments for these methods for MCI vs. NC problem.
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NC = 50, 4mm NC = 100, 4mm NC = 50, 8mm NC = 100, 8mm
AD MCI AD MCI AD MCI AD MCI
EN-VACV 214 – 269 – 121 – 144 –
EN-VABEE 666 – 1002 – 402 – 543 –
EN-05CV 113 109 145 173 72 77 91 131
EN-05BEE 229 225 308 305 142 161 192 225
LASSOCV 32 – 50 – 29 – 44 –
LASSOBEE 57 – 98 – 53 – 91 –
LASSOSTAB 28 – 66 – 17 – 37 –
EN-05STAB 294 250 411 369 103 100 143 159
GNCV 212 225 255 369 358 655 476 1107
GNBEE 814 829 1080 1104 1544 1647 1742 1835
SVMF-FDR 4631 13247 7556 1058 577 1662 942 515
Table 4: Numbers of voxels selected with different classifiers. Columns AD refer
to the AD vs.NC problem and columns MCI refer to the MCI vs. NC problem.
Note that parameters for GN, SVM-FDR, and stability selection were different for
4mm and 8mm data and thus the numbers of selected voxels are not comparable
between 4mm and 8mm data.
methods at p = 0.1 level. The Elastic Net based stability selection, which used the
SVM classifier, performed similarly to the other SVM-based methods and featured
poorer classification performance than the standard Elastic Net. The CV and BEE
based models for the parameter selection performed similarly in the terms of the
average classification performance. Again, and not surprisingly, the addition of
subjects improved the performance of all classifiers. With GraphNet and Elastic
Net, the average ACC was higher with 4mm data than with 8 mm data, however,
the improvement was not statistically significant due to high variability between
independent samples.
The average variability of the classification accuracy ∆ACC was higher (means
0.038 (NC = 100) and 0.052 (NC = 50) for 4mm data and 0.037 (NC = 100)
and 0.051 (NC = 50) for 8mm data) than with the AD vs. NC problem with
the same setups (means 0.041 (NC = 50) and 0.028 (NC = 100) for 4mm data
and 0.029 (NC = 50) and 0.042 (NC = 100) for 8mm data). Typically, ∆ACC
did not vary much between the methods. However, with NC = 50, the methods
that select the parameters based on CV-error estimate (EN-05CV and GNCV)
produced higher ∆ACC than the other methods (p < 0.001 always). With EN-
05CV, ∆ACC decreased to the level of other methods when more subjects were
added. In contrast, even with NC = 100, ∆ACC for GraphNet using the CV-based
model selection was higher than ∆ACC for other methods. Especially, the ACC
difference was large in the iterations i where the differences between MCI classes
of Ai and Bi were large. For analyzing the differences in the MCI groups, we
used the information from the three year follow-up of these patients, specifically
the information whether or not they converted to AD within the 3 year time
window (see (Moradi et al 2015)). We could not find a clear answer to the question
why Graphnet with the CV-based model selection was particularly sensitive to
differences in MCI classes.
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5.2 Selected features
As listed in Table 4, the LASSO methods produced the most sparse voxel set, fol-
lowed by Elastic-net, and then Graphnet. The filter-based SVMs were designed to
give dense voxel sets and it is not particularly informative to analyze the numbers
of features selected by the filter methods as the user has a direct control over the
sparsity of the classifier.
The elastic net with variable α2 tended to select more voxels than its fixed α2
counterpart indicating that model selection strategies favored more dense models.
The approach used for the parameter selection in the embedded FS methods had
a marked influence on the number voxels selected. The stability selection and CV
yielded similar numbers of features whereas the BEE favored more dense models
than the other two model selection strategies. For both 4mm and 8mm data, the
voxel sets were slightly more numerous for the MCI vs. NC problem than for the
AD vs. NC problem with the embedded FS methods.
The selection probabilities of the voxels by different methods are illustrated in
Figure 2 through two axial planes passing through hippocampus. For the AD vs.
NC problem, the embedded variable selection methods focused on hippocampus
and superior temporal cortex and the filter-based methods equally included voxels
from the middle temporal and frontal cortices. In addition, it can be seen that
GNBEE included voxels from cerebellum. All these locations have been implicated
to be involved in AD pathology previously (Weiner et al 2012) and have been found
to be effective in classifying between AD patients and normal controls (Casanova
et al 2011b). For the MCI vs. NC problem, the voxel selection probability patterns
were somewhat different: for all the methods, the selected voxels concentrated in
the frontal regions more than in the AD vs. NC problem. Also, filter and embedded
feature selection methods seemingly disagreed which frontal voxels to include - the
filters favoring medial frontal gyrus and the embedded methods favoring the middle
frontal gyrus.
5.3 Stability of selected feature sets
The feature selection stability measured with Dice coefficient varied from 0.009
(LASSOBEE, AD vs. NC, 4mm, Nc = 50) to 0.710 (with SVM-F1000, AD vs.
NC, 8mm, Nc = 100). The Dice coefficients for the off-the-shelf embedded feature
selection methods (LASSO and Elastic-net) were very low. The stability of feature
sets was increased by taking the spatial context account (Graphnet) and the most
stable feature sets were those based on the fixed number of features to be selected
(SVMF-1000). The stability selection increased the Dice coefficients compared
to the error estimation based parameter selection - however, typically GraphNet
algorithms produced higher Dice coefficients than the ENSTAB. Not surprisingly,
the larger the voxel-size and Nc, the higher the Dice coefficient. All the quoted
differences in the Dice coefficient value were significant (p < 10−5).
While the Dice index values were very low for the off-the shelf embedded meth-
ods and also somewhat discouraging for the GraphNet and stability selection meth-
ods for 4mm data (indicating ’slight agreement’ in the Landis-Koch categorization
which is applicable for Dice indeces in addition to Kappa coefficients (Pajula et al
2012)), the modified Hausdorff distances showed the feature-selection stability of
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AD vs. NC
MCI vs. NC
Fig. 2: The probability of voxels being selected for different classification methods
over 2000 training replications (Nc = 100 and 4mm data was used). Axial slices at
MNI coordinates z = −18mm (showing Hippocampus, upper row) and z = −10mm
(showing Hippocampus and mid-temporal cortices,bottom row) are shown.
several embedded methods in a more positive light. For problems with Nc = 100
and 4mm data, average mHDs for the embedded methods varied from 5.2 voxels
(21 mm, LASSOCV, AD vs. NC) to 2.1 voxels (8.3 mm, GN1BEE) compared to
the range between 0.614 and 3.355 voxels (2.5mm and 14mm) for the filter meth-
ods. mHD values are easy to interpret, a value of 2.25 voxels (GN1BEE, AD vs.
NC, 4 mm Nc = 100) means that, on average, the maximal distance from voxel
selected in one subject sample was 2.25 voxels (10 mm) to a voxel selected in an
independent subject sample. The average mHD values for selected methods are
visualized in Fig. 3 in millimeters. With the MCI vs. NC problem, the most stable
embedded methods featured lower mHD values than SVMF-FDR, which, in the
sense of the selection stability, is equivalent to the standard massively univari-
ate hypothesis testing with FDR based multiple comparisons correction. In terms
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NC = 50, 4mm NC = 100, 4mm NC = 50, 8mm NC = 100, 8mm
mHD Dice mHD Dice mHD Dice mHD Dice
EN-VACV 4.431 0.050 3.931 0.063 2.374 0.092 2.113 0.109
EN-VABEE 3.235 0.060 2.499 0.087 1.430 0.146 1.146 0.189
EN-05CV 4.438 0.048 3.951 0.059 2.272 0.101 2.073 0.120
EN-05BEE 3.586 0.041 3.084 0.047 1.763 0.090 1.554 0.101
LASSOCV 6.040 0.014 5.192 0.023 3.060 0.064 2.670 0.072
LASSOBEE 4.908 0.009 4.008 0.015 2.431 0.043 2.003 0.049
LASSOSTAB01 5.725 0.041 4.093 0.057 3.010 0.121 2.299 0.155
EN-05STAB01 3.000 0.125 2.509 0.164 1.786 0.163 1.557 0.182
GNCV 5.235 0.113 4.318 0.183 2.530 0.201 2.310 0.243
GNBEE 2.643 0.079 2.254 0.093 0.626 0.435 0.557 0.486
SVMF-FDR 1.319 0.440 0.614 0.669 1.011 0.440 0.506 0.668
SVMF-1000 1.648 0.345 1.141 0.490 0.490 0.605 0.343 0.710
SVMF-125 – – – – 1.296 0.332 0.934 0.477
mean 3.851 0.114 3.133 0.163 1.852 0.218 1.543 0.274
Table 5: The average mHD and Dice values for AD vs. NC experiments. The
values refer to the averages over the R = 1000 resamplings. mHDs are expressed
in voxels; the values in millimeters can be obtained by multiplying the mHD in
voxels by the voxel size. The standard deviations of mHD and Dice values across
1000 resamplings are presented in the supplement. Other notation is as in Table
2.
NC = 50, 4mm NC = 100, 4mm NC = 50, 8mm NC = 100, 8mm
mHD Dice mHD Dice mHD Dice mHD Dice
EN-05CV 4.484 0.050 3.423 0.070 2.346 0.072 1.693 0.127
EN-05BEE 3.404 0.046 2.887 0.062 1.641 0.091 1.389 0.135
GNCV 6.433 0.057 4.529 0.076 3.195 0.152 1.293 0.328
GNBEE 2.463 0.077 2.075 0.105 0.578 0.463 0.521 0.516
EN-05STAB02 3.093 0.118 2.511 0.146 1.847 0.119 1.435 0.189
SVMF-FDR 0.879 0.501 3.355 0.181 0.708 0.499 1.327 0.300
SVMF-1000 2.345 0.154 1.906 0.255 0.715 0.420 0.612 0.502
SVMF-125 – – – – 1.816 0.146 1.460 0.259
mean 3.300 0.143 2.955 0.128 1.606 0.245 1.216 0.295
Table 6: The average mHD and Dice values for MCI vs. NC experiments. he
standard deviations of mHD and Dice values across 1000 resamplings are presented
in the supplement.See Table 5 for notation.
of the mHD values, the BEE based parameter selection was more stable than the
CV-based parameter selection with any embedded method (p < 10−5 always). The
variability of the mHD and Dice values of GNCV with 4mm data was far greater
than for other methods. The reason was the same as for the excess variability in the
classification accuracy, namely, that GNCV was sensitive to the slight variations
in the subject characteristics.
As hypothesized earlier correlation between the average number of voxels se-
lected (noF) and the average Dice coefficient across methods was strong: it varied
from 0.67 to 0.98 across the eight conditions (two classification problems, two NC ,
and two voxel sizes) and was, as an example, 0.83 for AD vs. NC with 4mm data
and Nc = 100. Also, the negative correlation between average NoF and average
mHD was strong: it varied from -0.51 to -0.86 across eight conditions (-0.70 for
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AD vs. NC with 4mm data and Nc = 100). Hence, the dense voxel selection pro-
duced more stable feature sets. The average NoF and ∆ACC were not found be
correlated. The correlation between them averaged across conditions (computed
by the z-transform method (Kenny 1987)) was -0.11 (two-sided p = 0.46 according
to the test outlined by Kenny (1987)). Thus, it appears that increasing or decreas-
ing the number of voxels selected resulted in no improvement to the variability of
classification accuracy.
Not surprisingly, we observed no correlations between the average classifica-
tion accuracy and either average Dice coefficient or the average mHD. Instead,
we observed a significant correlation between average mHD and ∆ACC. The cor-
relation averaged by the z-transform method (Kenny 1987) over eight conditions
was 0.39 which is significant (p < 0.005) according to the test outlined by Kenny
(1987). However, the variability in the correlation coefficient was high (from -0.04
to 0.97) between the conditions, with the value 0.97 stemming from the MCI vs.
NC problem with 4 mm data and NC = 50, where the embedded methods suffered
from the high variability. Also, it needs to be noted that similar correlation was
not observed between the average Dice coefficient and ∆ACC.
The Figure 4 shows the probability of the voxel being selected in one split-half
but not in the other. The comparison of this Figure to Figure 2 reveals that the
voxels that were probable to be selected were also the most likely to be selected
differently between two independent replications.
6 Discussion
We have presented a comparative analysis of FS methods for whole brain voxel-
based classification analysis of structural neuroimaging data. The methods were
compared with respect to their classification accuracy and its variation due to
independent subject samples as well as the stability of the selected features between
different subject samples. We focused on two related and well studied problems:
AD vs. NC classification and MCI vs. NC classification with the ADNI data.
The compared FS and classification methods included filter-based FS followed by
SVM based classification, standard embedded FS methods (LASSO and Elastic-
net), stability selection followed by SVM classification, and neuroimaging specific
embedded FS (GraphNet). Further, with embedded FS methods, we analyzed two
different model selection criteria, non-parametric cross-validation and parametric
Bayesian error estimation.
Comparisons of different classification methods on AD related classification
tasks have been presented, for instance, by Bron et al (2015), Cuingnet et al (2011)
and Sabuncu et al (2015). As these comparative studies have used the classification
accuracy, or related quantities, on the whole test sample as the figure of merit, they
do not address the questions related the variability of the classifiers with respect to
subject sample, which was the focus of this work. Rasmussen et al (2012) studied
the selection of regularization parameters for the embedded FS in fMRI using an
NPAIRS framework and concluded that the selection regularization parameters
should not be based solely on the classification performance if the interpretation
of the resulting classifiers is the final goal. The questions we have addressed are
related but different, namely, how do the variability among the subject pool alter
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Fig. 3: The average mHDs in millimeters when NC = 100. Note how mHD values
were similar in the AD vs. NC and MCI vs. NC problems for the embedded and
stability selection methods, but for the filter FS methods, the mHD values were
higher for the more difficult MCI vs. NC problem.
the classification accuracy and features set selected and if some feature selection
methods are better than others in terms of the generalization performance.
Chu et al (2012) studied different FS techniques combined with SVMs (filters
and recursive feature elimination) on ADNI structural MRI data and concluded
that the FS does not have positive influence on the classification accuracy. Our
results concerning the classification accuracy match with those of Chu et al (2012)
in the AD vs. NC classification, where the performance of SVM-ALL (which does
not use any feature selection) was at the same level as with the classifiers incorpo-
rating feature selection. Also, more generally, the variation due to subject sample
was more important than the variation due to selected classification method with
the AD vs. NC problem. This is also in line with Chu et al (2012). On the contrary,
embedded FS methods outperformed the SVM based methods with the MCI vs.
NC problem, particularly when the training set was large enough, and the per-
formance improvement with a large training set was several times larger than the
variability in the classification accuracy due to subject sample. This indicates that
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AD vs. NC
MCI vs. NC
Fig. 4: The probability of voxels for being selected in one split-half while not for the
other one over 1000 replications (Nc = 100 and 4mm data was used). Axial slices at
MNI coordinates z = −18mm (showing Hippocampus, top row) and z = −10mm
(showing Hippocampus and temporal lobes,bottom row) are shown.
data-driven FS can improve the classification accuracy. Note that Chu et al (2012)
did not find FS to be useful for the MCI vs. NC problem. However, this seems to
be due to the fact that they studied only filter based FS methods and recursive
feature elimination and these do not work as well as the embedded FS methods
for this problem according to our results (see also Kerr et al (2014) for similar con-
clusions). We did not find significant differences in the classification performance
between the imaging specific embedded technique (GraphNet) and a more general
embedded technique (Elastic Net). Interestingly, the performance of the stability
selection was similar to SVM-ALL, indicating that it did not provide similar gains
in classification accuracy as more traditional embedded FS methods.
The variability of the classification accuracy due to subject sample (∆ACC)
was almost the same for all methods within the same problem with few exceptions
(particularly GraphNet with CV). Not surprisingly, the variability increased with
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decreasing number of subjects and increasing the problem difficulty (the variabil-
ity was greater in the MCI vs. NC problem than in the AD vs. NC problem).
Instead, the voxel size did not have statistically significant effect on ∆ACC. In
general, ∆ACC measures were a positive surprise, compared to the variability re-
ported in (Glick 1978; Dougherty et al 2010), and although also this work has
demonstrated that classification accuracy has a non-zero variance that must be
taken into account, the variance was on a tolerable level with the sample sizes
studied in this work. The GraphNet with the CV based model selection resulted
in n higher ∆ACC values than the other methods in certain circumstances. This
was the problem of model selection as the GraphNet equipped with the paramet-
ric BEE model selector did not suffer from the same problem. Otherwise, we did
not observe the BEE model selection to differ from the CV based model selection
in terms of the classification accuracy or ∆ACC. However, as the BEE is several
times faster to compute than the CV error estimate (see (Huttunen and Tohka
2015)), the BEE model selection criterion is attractive for neuroimaging purposes.
The selected feature sets were not particularly stable when the stability was
assessed with the Dice index which measures the set similarity without considering
the spatial distances between the voxels. Especially, with embedded methods re-
producibility of the feature sets as measured with Dice index was poor. The filter
based methods produced more stable feature sets. Surprisingly, while the stability
selection improved the Dice measure over the traditional model selection methods
focusing on the prediction accuracy, the improvement was smaller than expected
as the stability selection tries to select models that are maximally stable. How-
ever, the stability selection considers each voxel independently that might not be
optimal in neuroimaging applications and which may explain rather low Dice val-
ues. When accounting for the spatial nature of the data with modified Hausdorff
distance (Dubuisson and Jain 1994), the FS stability appeared in a better light.
For example, for AD vs. NC problem with 4mm data and Nc = 100, the mHD
values varied from 0.614 voxels to 5.192 voxels and for several methods mHD was
below 12mm which can be considered tolerable.
There was a strong linear relation between the sparsity of the classifier and in-
stability of the features, measured either with Dice index or the modified Hausdorff
distance. Generally, the more dense the models were the more reproducible they
were; this phenomenon has also been noticed in the context of fMRI classification
analysis (Rasmussen et al 2012). Especially this is clearly seen when comparing
SVMF-1000 (selecting 1000 features) to SVMF-125 (selecting 125 features). How-
ever, selecting more features did not result in less variation in the classification
accuracy let alone in a better classification accuracy. Likewise, we did not observe
the average classification accuracy and feature stability measures to be correlated.
However, we found correlations between ∆ACC and the modified Hausdorff dis-
tance, which indicates that the feature variability, when quantified with a measure
taking spatial nature of the data into account, explained at least some of the
variability in the classification accuracy.
Different types of feature selection techniques (filters vs. embedded methods
and stability selection) seemingly disagreed on which voxels to select, especially
in the MCI vs. NC problem. This is interesting, because filter based methods are
(in a sense) equivalent to standard massively univariate analysis, where voxel-wise
statistical maps are constructed considering each voxel independently and then
thresholded while accounting for multiple comparisons. While the two approaches
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are different and in many ways complementary, the improved predictive perfor-
mance of the embedded feature selection methods for the MCI vs. NC problem
offers additional evidence that multivariate classification methods could be a use-
ful addition for neuroscientific interpretation, supporting similar conclusions in
(Jimura and Poldrack 2012; Davis et al 2014; Khundrakpam et al 2015; Mohr
et al 2015). In this respect, it is important to bear in mind that machine learning
produces so-called backward models and the classifier weights βi (or selected vox-
els) have a different meaning than the parameter estimates in the forward models
produced by a standard mass-univariate analysis (Haufe et al 2014). Especially,
truly multivariate feature selection can select features that are not by themselves
diagnostic but control for various nuisance factors (Kerr et al 2014; Haufe et al
2014).
An application specific finding was that the age-removal procedure (Moradi
et al 2015) improved the classification performance with every classifier. Although
the performance improvement did not reach significance according to the corrected
repeated t-test, the average t over all the classifiers was significantly different from
zero, verifying the findings in the AD vs. NC classification of Dukart et al (2011)
and in the MCI-to-AD conversion prediction of Moradi et al (2015). The rationale
for age-removal stemmed from strong evidence of overlapping effects of normal
aging and dementia on brain atrophy (Fjell et al 2013; Dukart et al 2011). We
note that there was no stratification according to age or gender when dividing
the data into two sets Ai and Bi. This was because we wanted reproduce the
normal variability between different subject samples: a research group rarely has
the possibility to exactly reproduce demographics of the sample acquired by a
different research group in a different centre. Obviously, in addition to age, there
might be other confounds (such as personal health parameters studied in Franke
et al (2014)), whose removal from MRI could improve the classification accuracy
and a recent study (Klo¨ppel et al 2015) jointly removed the effects of age, gender
and intracranial volume for the diagnosis of dementia.
An obvious limitation of this study is that we have considered only dementia
related applications of machine learning within brain MRI. While we have made a
specific effort to avoid using application related information in the classifier design
(except for age removal), it is still not clear how well the findings of this study
generalize to the studies of other brain diseases. Also, the ADNI study has stringent
inclusion/exclusion criteria (Petersen et al 2010), for example depressed subjects
were excluded, and it might be that the variabilities in the classification accuracy
reported in this study might underestimate the variabilities in the classification
accuracies in more heterogeneous, community based samples.
7 Conclusions
The question that this work addressed was how much classification accuracy and
selected features in machine learning analysis of MRI depend on the subject sam-
ple. This question is important as the machine learning analysis is increasingly
used in brain imaging and it is essential to know how reliable and reproducible
these analyses are. The results in this paper support the use of advanced machine
learning techniques in anatomical neuroimaging, but also raise serious concerns
related to certain methods and underline the need of care when interpreting the
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machine learning results. In brief, the main specific findings of this study were:
1) the embedded feature selection methods (GraphNet and Elastic Net) resulted
in higher generalization performance than the filter based ones or stability selec-
tion in the MCI vs. NC problem; 2) the variability in classification accuracy due
to independent samples did not typically depend on the feature selection method
and was at an acceptable level; 3) the removal of the age confound improved the
classification performance; 4) the feature stability was not correlated with the
average classification performance, but a slight correlation with the stability of
classification performance was observed.
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A B S T R A C T
Rey’s Auditory Verbal Learning Test (RAVLT) is a powerful neuropsychological tool for testing episodicmem-
ory, which is widely used for the cognitive assessment in dementia and pre-dementia conditions. Several
studies have shown that an impairment in RAVLT scores reﬂect well the underlying pathology caused by
Alzheimer’s disease (AD), thusmaking RAVLT an effective earlymarker to detect AD in personswithmemory
complaints. We investigated the association between RAVLT scores (RAVLT Immediate and RAVLT Percent
Forgetting) and the structural brain atrophy caused by AD. The aim was to comprehensively study to what
extent the RAVLT scores are predictable based on structural magnetic resonance imaging (MRI) data using
machine learning approaches as well as to ﬁnd themost important brain regions for the estimation of RAVLT
scores. For this, we built a predictive model to estimate RAVLT scores from gray matter density via elastic
net penalized linear regression model. The proposed approach provided highly signiﬁcant cross-validated
correlation between the estimated and observed RAVLT Immediate (R = 0.50) and RAVLT Percent Forget-
ting (R = 0.43) in a dataset consisting of 806 AD, mild cognitive impairment (MCI) or healthy subjects. In
addition, the selected machine learning method provided more accurate estimates of RAVLT scores than the
relevance vector regression used earlier for the estimation of RAVLT based on MRI data. The top predictors
were medial temporal lobe structures and amygdala for the estimation of RAVLT Immediate and angular
gyrus, hippocampus and amygdala for the estimation of RAVLT Percent Forgetting. Further, the conversion
of MCI subjects to AD in 3-years could be predicted based on either observed or estimated RAVLT scores
with an accuracy comparable to MRI-based biomarkers.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Alzheimer’s disease (AD) is a progressive neurodegenerative
disorder characterized by memory deﬁcit, which is followed by
* Corresponding author.
E-mail address: elaheh.moradi@uta.ﬁ (E. Moradi).
1 A part of this work was performed while Elaheh Moradi was with Department of
Signal Processing, Tampere University of Technology, Finland.
2 Data used in preparation of this article were obtained from the Alzheimer’s
Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the
investigators within the ADNI contributed to the design and implementation of ADNI
and/or provided data but did not participate in analysis or writing of this report. A
complete listing of ADNI investigators can be found at http://adni.loni.usc.edu/wp-
content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf
problems in other cognitive domains that cause a severe decline
in the usual level of functioning. The progressive episodic memory
impairment characteristic to AD is best measured by neuropsycho-
logical testing. This is evident in recent diagnostic recommendations,
which highlight the signiﬁcance of standardized neuropsycholog-
ical testing as well as the supportive role of biological evidence
for AD pathology (Dubois et al., 2010; Jack et al., 2011; American
Psychiatric Association, 2013). Rey’s auditory verbal learning test
(RAVLT) is a well-known measure of episodic memory, and in pre-
vious studies it has had a signiﬁcant role in early diagnosis of AD
(Estévez-González et al., 2003) as well as it has been demonstrated
to be useful in differentiating AD from psychiatric disorders (Ricci et
al., 2012; Schoenberg et al., 2006; Tierney et al., 1996). In particular,
Estévez-González et al. (2003) suggested inclusion of the RAVLT to
http://dx.doi.org/10.1016/j.nicl.2016.12.011
2213-1582/© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
416 E. Moradi et al. / NeuroImage: Clinical 13 (2017) 415–427
the cognitive test battery used in evaluation and early detection of
AD. Moreover, Balthazar et al. (2010) indicated of the importance of
RAVLT in a clinical setting for discriminating normally aging subjects
from mild cognitive impairment (MCI) and AD subjects.
Recently revised diagnostic criteria and recommendations
emphasize the importance of early diagnosis of AD (Dubois et al.,
2010;McKhann et al., 2011; American Psychiatric Association, 2013).
The disease processes leading to AD are known to start while individ-
uals are still cognitively normal and may precede clinical symptoms
by years or decades (Jack et al., 2010; Adaszewski et al., 2013).
Reﬂecting this and the call for the biological evidence for AD diag-
nosis, several AD speciﬁc biomarkers have been identiﬁed, including
multivariate patterns of structural brain atrophy measured by mag-
netic resonance imaging (MRI) (Moradi et al., 2015; Bron et al., 2015;
Salvatore et al., 2015; Coupé et al., 2015; Eskildsen et al., 2013; Wee
et al., 2013). MRI-based biomarkers have the advantages of being
non-invasive and widely available.
However, integrating neuropsychological information and brain
atrophy biomarkers might be extremely valuable for early diagnosis.
In particular, we have previously shown that integrating cognitive
and functional measures to brain atrophy pattern from MRI signif-
icantly improved the prediction performance of conversion to AD
in mild cognitive impairment (MCI) patients as compared to using
either modality alone (Moradi et al., 2015). Among cognitive and
functional measures considered, RAVLT was the most important
measure in the prediction model (as determined by the out-of-bag
variable importance score in the Random Forest classiﬁer (Breiman,
2001; Liaw and Wiener, 2002), which, in part, explains our interest
towards RAVLT.
In order to enhance possibilities to early detection of AD and
tracking disease progression, it is important to explore the associa-
tion between cognitive functions and the pathological mechanisms
of AD. The essential role of medial temporal lobe structures, espe-
cially hippocampus, for episodic memory has been known for long
(Squire andWixted, 2011). The studies of recent years have provided
data on neurobiology of memory and learning and on the neurobio-
logical changes of AD, but many aspects still remain unclear (Masdeu
et al., 2012; Jeong et al., 2015). The great majority of machine learn-
ing based AD studies have been focused on either classiﬁcation
of AD and healthy subjects (Magnin et al., 2009; Beheshti et al.,
2016) or predicting conversion to AD in MCI patients (Moradi et
al., 2015; Eskildsen et al., 2013) using different neuroimaging tech-
niques. However, the relationships between AD related brain atrophy
and decline in cognitive abilities are less studied. In the current
study, we aim to analyze the relation between AD related structural
change within the brain and RAVLT measures. Particularly, we aim
to predict RAVLT scores from MRI based gray matter density images
by applying elastic net linear regression forming a multivariate brain
atrophy pattern predicting the RAVLT score. According to previous
studies (Khundrakpam et al., 2015; Bunea et al., 2011; Carroll et al.,
2009) elastic net linear regression is well suited for learning predic-
tive patterns among high dimensional neuroimaging data withmany
relevant predictors that are correlated with each other. Additionally,
this approach offers an interpretable model by automatically select-
ing a sparse pattern of relevant voxels for predicting RAVLT, thus
providing the possibility of ﬁnding the brain regions most strongly
contributing to the prediction of RAVLT scores.
The association between AD related changes in brain structure
and various cognitivemeasures of dementia (Mattis Dementia Rating
Scale (DRS), Alzheimer’s Disease Assessment Scale-cognitive subtest
(ADAS-Cog), Mini-mental state examination (MMSE) and RAVLT-
Percent Retention) was previously studied by Stonnington et al.
(2010) based on pattern analysis on gray matter voxel-based mor-
phometry maps. Their results indicated that DRS, ADAS-cog and
MMSE measures could be well estimated based on brain structure.
However, the accuracy of predicting the RAVLT percent retention
score based on MRI was much more modest with a dataset that
included a continuum of subjects who were cognitively normal and
persons with MCI or AD. This could reﬂect the small number of sub-
jects or the speciﬁc nature of the machine learning method used,
which might not be the best possible for learning the associations
between MRI and a score related to a speciﬁc aspect of cogni-
tion (episodic memory) rather than to cognitive ability in general.
More recently, the relationship between MRI and RAVLT scores was
investigated by Wang et al. (2011). However, as they averaged grey
matter density, cortical thickness and subcortical volumetry from
MRI into the total of 144 regional measures, they did not probe
the relationship between a high-dimensional atrophy pattern and
RAVLT. Furthermore, these atlas-based averaging strategies of high-
dimensional MRI data may be detrimental to the predictive accuracy
of machine learning analysis (Khundrakpam et al., 2015). Addition-
ally, as Wang et al. (2011) used root mean square error (RMSE)
measure to report the predictive accuracy and provided no p-values
for RMSE, it is diﬃcult to put the prediction accuracy into proper
context.
In this report, we used whole brain gray matter density maps
for predicting different RAVLT measures. We analyzed the relation-
ship between RAVLT measures and AD related structural changes
within the brain by considering a large ADNI dataset of over 800 sub-
jects ranging from severe AD to age-matched healthy subjects. We
also investigated the relationship between AD conversion prediction
and the observed and MRI-estimated RAVLT measures to highlight
the potential clinical implications of the method. We studied two
RAVLT summaries - RAVLT Immediate and RAVLT Percent Forgetting.
These summary scores highlight different aspects of episodic mem-
ory, namely learning (immediate) and delayed memory (percent
forgetting), which both are essential aspects of AD.
2. Materials and methods
2.1. ADNI data
Data used in the preparation of this articlewere obtained from the
Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.
loni.usc.edu). The ADNI was launched in 2003 as a public-private
partnership, led by Principal Investigator Michael W. Weiner, MD.
The primary goal of ADNI has been to test whether serial mag-
netic resonance imaging (MRI), positron emission tomography (PET),
other biological markers, and clinical and neuropsychological assess-
ment can be combined to measure the progression of mild cognitive
impairment (MCI) and early Alzheimer’s disease (AD). For up-to-date
information, see www.adni-info.org.
We used the same dataset as Moradi et al. (2015), but excluded
subjects with missing RAVLT scores; the subject demographics are
presented in Table 1. For RAVLT Immediate (Percent forgetting), the
dataset consisted of 186 (180) AD subjects, 226 (226) NC (normal
control) subjects and 394 (393) MCI subjects. The diagnostic and
inclusion/exclusion criteria is speciﬁed in Petersen et al. (2010) and
roster IDs of the subjects are listed in Supplementary material. Of the
394 (393) MCI subjects, 164 subjects were grouped as progressive
MCI (pMCI) if diagnosiswasMCI at baseline but conversion to ADwas
reported after baseline within 1, 2 or 3 years, and without reversion
to MCI or NC at any available follow-up (0–96 months). 100 sub-
jects were grouped as stable MCI (sMCI) if diagnosis was MCI at all
available time points (0–96 months), but at least for 36 months. The
remaining 130 (129) MCI subjects were grouped as unknown MCI
(uMCI), if diagnosis was MCI at baseline but the subjects were miss-
ing a diagnosis at 36 months from the baseline or the diagnosis was
not stable at all available time points. The labeling of MCI patients
was based on the 3-year cut-off period that was decided based on
the length of follow-up for the original ADNI-1 project (Moradi et
al., 2015). For estimating the RAVLT Percent Forgetting score, we
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Table 1
Subject demographics. RAVLT-Immediate is abbreviated as RAVLT-IR and RAVLT-Percent Forgetting is abbreviated as
RAVLT-PF.
Diagnosis No of subjects Age, mean (std) RAVLT IR RAVLT PF
IR/PF IR/PF mean (std) mean (std)
AD 186/180 75.28 (7.53)/75.39 (7.52) 23.20 (7.74) 90.30 (18.86)
Range: 0–42 Range: 10–100
MCI 394/393 74.91 (7.33)/74.90 (7.34) 30.58 (9.11) 68.15 (30.83)
Range: 11–68 Range: 0–100
NC 226/226 75.97 (5.05)/75.97 (5.05) 43.32 (9.11) 35.04 (33.65)
Range: 16–69 Range: 0–100
excluded 3 AD subjects with the score of zero as outliers (roster IDs
of these three were 724, 1184, and 1253). In addition, there are many
subjects (129 AD, 77 pMCI, 17 sMCI, 38 uMCI and 8 NC subjects) with
percent forgetting score of 100%, who did not recall any words dur-
ing the delayed trial. However, these subjects cannot be considered
as outliers. The RAVLT Percent Forgetting of 100% can be considered
typical for AD and pMCI subjects and, while not typical, this is not
unusual for sMCI subjects. For 8 normal controls, this is an unusual
score, which, however, could be explained by a number of factors
such as nervousness in the testing situation.
For predicting RAVLT scores all MCI subjects with available RAVLT
scores were included regardless of availability of information about
the AD conversion as this is not required in predicting RAVLT scores.
2.2. RAVLT score
Rey’s Auditory Verbal Learning Test (RAVLT) (Rey, 1964) is a
powerful neuropsychological tool that is used for assessing episodic
memory by providing scores for evaluating different aspects ofmem-
ory. The RAVLT is sensitive to verbal memory deﬁcits caused by
a variety of neurological diseases such as AD (Schoenberg et al.,
2006;Balthazar et al., 2010;Estévez-González et al., 2003). Tierney et
al. (1996) and Estévez-González et al. (2003) have shown that the
RAVLT score is an effective early marker to detect AD in persons with
memory complaints.
Brieﬂy, the RAVLT consists of presenting a list of 15 words across
ﬁve consecutive trials. The list is read aloud to the participant, and
then the participant is immediately asked to recall as many as words
as he/she remembers. This procedure is repeated for 5 consecutive
trials (Trials 1 to 5). After that, a new list (List B) of 15 new words is
read to the participant, who then is immediately asked to recall the
words. After the List B trial, the examiner asks participant to recall
thewords from the ﬁrst list (Trial 6). After 30-minutes of interpolated
testing (timed from the completion of List B recall), the participant is
again asked to recall the words from the ﬁrst list (delayed recall).
Different summary scores are derived from raw RAVLT scores.
These include RAVLT Immediate (the sum of scores from 5 ﬁrst tri-
als (Trials 1 to 5)), RAVLT Learning (the score of Trial 5 minus the
score of Trial 1), RAVLT Forgetting (the score of Trial 5 minus score
of the delayed recall) and RAVLT Percent Forgetting (RAVLT Forget-
ting divided by the score of Trial 5). We use naming of the ADNI
merge table3 for these summary measures. We investigated the rela-
tionship between MRI measures and RAVLT cognitive test scores by
estimating the RAVLT Immediate and RAVLT Percent Forgetting from
the gray matter density. These two summary scores were selected
since they highlight different aspects of episodic memory, learning
(RAVLT Immediate) and delayedmemory (RAVLT Percent forgetting),
essential to AD and previous studies (Estévez-González et al., 2003;
Wang et al., 2011; Gomar et al., 2014; Moradi et al., 2015) have
indicated strong relationships between these two RAVLT measures
3 http://adni.bitbucket.org/adnimerge.html.
and Alzheimer’s disease. For example, Estévez-González et al. (2003)
concluded that the most reliable RAVLT measures for AD detection
are RAVLT Immediate, a score of zero at the delayed recall and the
RAVLT percent forgetting. Particularly, we stress that RAVLT percent
forgetting, which is a measure of delayed memory that takes into
account the relationship of immediately and delayed recalled words
is equivalent of RAVLT percent retention considered by Stonnington
et al. (2010).
2.3. MRI and image processing
The downloadedMRIswere acquiredwith T1-weightedMP-RAGE
sequence at 1.5 Tesla, typically with 256 × 256 × 170 voxels with
the voxel size of approximately 1 mm × 1 mm × 1.2 mm. The MRIs
were downloaded as raw images converted to the NIFTI format.
As described by Gaser et al. (2013), Moradi et al. (2015) prepro-
cessing of the T1-weighted images was performed using the SPM8
package4 and the VBM8 toolbox5 , running under MATLAB. All T1-
weighted images were corrected for bias-ﬁeld inhomogeneties, then
spatially normalized and segmented into gray matter (GM), white
matter, and cerebrospinal ﬂuid (CSF) within the same generative
model (Ashburner and Friston, 2005). The dimension after the spa-
tial normalization was 181 × 217 × 181 with 1 mm3 voxels and the
template used for the spatial normalization was the SPM8 version
of the ICBM152 atlas (the linear registration version) provided
by MNI6 . The segmentation procedure was further extended by
accounting for partial volume effects (Tohka et al., 2004), by applying
adaptive maximum a posteriori estimations (Rajapakse et al., 1997),
and by using an hidden Markov random ﬁeld model (Cuadra et al.,
2005) as described previously (Gaser, 2009). This procedure resulted
in maps of tissue fractions of WM and GM. Only the GM images
were used in this work. Following the pipeline proposed by (Franke
et al., 2010), the GM images were processed with aﬃne registration
and smoothed with 8-mm full-width-at-half-maximum smoothing
kernels. After smoothing, images were resampled to 4 mm isotropic
spatial resolution. This procedure generated, for each subject, 29,852
aligned and smoothed GM density values that were used as MRI
features.
2.4. Machine learning framework
We applied elastic net linear regression (ENLR) (Zou and Hastie,
2005) for the estimation of RAVLT score (RAVLT Immediate and
RAVLT Percent forgetting) from MRI measurements. Due to the
high dimensionality of MRI data, the number of predictor variables
(voxels) is greater than the number of subjects. Therefore, the ordi-
nary least squares linear regression cannot be applied. However,
regularization approaches are effective in solving underconstrained
4 http://www.l.ion.ucl.ac.uk/spm.
5 http://dbm.neuro.uni-jena.de.
6 http://nist.mni.mcgill.ca/?p=798.
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problem like this in a statistically principled manner. In particular,
we used the elastic net penalty as regularizer. The ENLR provides
spatially sparse model by performing simultaneously variable selec-
tion andmodel estimation, thus providing a subset of voxels relevant
to predict RAVLT scores. Further, ENLR possesses so called grouping
effect meaning that correlated predictors are selected simultane-
ously. The number of voxels that are included in the regression
model is controlled by a regularization parameter k, which is typ-
ically, and also in this work, selected by cross-validation. A more
detailed description of ENLR is provided in Appendix A.
To compare the performance of ENLR approach, we additionally
applied relevance vector regression (RVR) for estimation of RAVLT
scoresas thiswas themachine learningapproachusedbyStonnington
et al. (2010). The RVR (Tipping, 2001) is a pattern recognitionmethod
that uses Bayesian inference to obtain sparse regression models. We
usedkernelizedRVRwith the linearkernel as Stonningtonetal. (2010)
and also RVR without kernelization. Similarly to ENLR, RVR provides
a sparse solution with only a subset of predictors contributing to the
ﬁnal model. However, having a sparse predictive model in a kernel
spacedoesnotprovideeasily interpretablepredictionmodel inavoxel
space, since enforcing sparsity in the kernel space does not result on
a sparse solution in the original feature space (Khundrakpam et al.,
2015).
We considered different datasets of subjects in our experiments.
The main dataset included all subjects, i.e., AD and MCI patients and
NC subjects. In this way, the dataset included a contiguous range
of RAVLT scores. The range of RAVLT Immediate in this dataset was
from 0 to 69 and the range of RAVLT Percent Forgetting was from 0 to
100. Secondarily, we included only two groups of subjects for learn-
ing the regression model and predicting RAVLT scores. This resulted
in 3 distinct datasets with different subject characteristics (1. AD and
NC subjects, 2. AD and MCI subjects and 3. NC and MCI subjects).
Finally, we included only one group of subjects (only for AD and MCI
groups) and repeated the experiments.
2.5. Implementation and performance evaluation
For the performance evaluation of the model and estimation
of the regularization parameter k, we used two nested and strat-
iﬁed cross-validation loops (10-fold for each loop) (Ambroise and
McLachlan, 2002; Huttunen et al., 2012)7 . The number of folds was
selected to be 10 because this is typically recommended compro-
mise (Hastie et al., 2011; Arlot et al., 2010). First, an external 10-fold
cross-validation was implemented in which the dataset were ran-
domly divided into 10 subsets. At each step, a single subset was
used for testing and remaining subsets were used for training. The
training set was used to train the elastic net regression model. We
re-divided the training set into 10-folds for ﬁnding the optimal k for
the model. The optimal k was selected according to the mean abso-
lute error (MAE) across the inner 10-fold cross-validation loop. Note
that the test sets in the external cross-validation loop were used only
for evaluating the model. The performance of the model was char-
acterized using the (cross-validated) Pearson correlation coeﬃcient
(R), mean absolute error (MAE) and the coeﬃcient of determination8
(Q2) between estimated and true RAVLT scores in the test set. Three
7 The Matlab code used for constructing stratiﬁed cross-validation folds for regres-
sion is available at https://github.com/jussitohka/general_matlab.
8 The Q2 provides a measure of how well out-of-training set RAVLT scores
are predictable by the learned model (http://scikit-learn.org/stable/modules/model_
evaluation.html#regression-metrics). It is deﬁned as Q2 = 1−
∑N
i=1 (si−sˆi)2∑N
i=1 (si−s¯)2
, where sˆi is
the estimated RAVLT for subject i, si is the true RAVLT score for subject i, and s¯ is mean
of the true RAVLT scores. Q2 is bounded above by 1 but is not bounded from below.
Note that Q2 does not equal R2, i.e., the correlation squared, but the Q2 value can never
exceed R2, see the methods supplement of (Moradi et al., 2016).
different metrics are reported to provide complementary informa-
tion. Cross-validated correlation is simple to interpret, but it can hide
the bias in the predictions, which are made apparent by Q2-value.
MAE provides the prediction errors in the equal scale with the orig-
inal scale of the RAVLT scores. The reported metrics in the Results
section are the averages over 100 nested 10-fold CV runs in order
to minimize the effect of the random variation in the division of the
data into different folds. To compare the performance of two learn-
ing algorithms, we computed a p-value for the 100 correlation scores
with a permutation test. For computing p-values associated with the
correlation coeﬃcient between the observed and estimated values,
we used a permutation test (Anderson and Robinson, 2001) and, for
computing the 95% conﬁdence intervals of the correlation coeﬃcient,
we used bootstrap on the run with the median correlation score
across 100 cross-validation runs. For evaluating the power of RAVLT
scores in discriminating between pMCI (progressive MCI) and sMCI
(stable MCI) subjects, we used AUC (area under the receiver operat-
ing characteristic curve) measure (Hanley and McNeil, 1982) and for
comparing AUCs we used StaR tool (Vergara et al., 2008).
The ENLR was implemented with the GLMNET library (Friedman
et al., 2010)9 , and the RVR was implemented with the “SparseBayes”
package (Tipping et al., 2003)10 .
3. Results
3.1. Prediction of RAVLT scores
We estimated RAVLT scores, both RAVLT Immediate and RAVLT
Percent Forgetting, from MRI data. The cross-validated accuracies
of these estimations with different methods (ENLR, KRVR, RVR) and
different subject sets are listed in Table 2.
3.1.1. Accuracy of estimated RAVLT scores with all subjects
As shown in Table 2, the RAVLT scores estimated by ENLR were
the most accurate ones. The correlation score (R) of ENLR was signif-
icantly better compared to KRVR (p < 0.0001) and RVR (p < 0.0001)
approaches when using the whole dataset. In addition, R was highly
signiﬁcant using all three approaches and for both summary scores as
revealed by the permutation test on the runwith themedian correla-
tion score across 100 cross-validation runs (p < 0.0001 in all cases).
The 95% bootstrap conﬁdence intervals (CIs) for the correlation score
for the estimation of RAVLT Immediate were as follows: ENLR: [0.45,
0.55], KRVR: [0.41,0.51], RVR: [0.21,0.33]; and, for the estimation of
RAVLT Percent Forgetting, the 95% bootstrap CIs were as follows:
ENLR: [0.37,0.48], KRVR: [0.35, 0.47], RVR: [0.23, 0.35]. The scatter
plots between the estimated and observed RAVLT scores based on
ENLR and KRVR approaches are illustrated in Fig. 1. The scatter plots
corresponding to the estimated values by using RVR approach are
provided in the supplement.
We investigated the effect of age-correction on the performance
of the prediction model by estimating normal aging effects on MRI
data in NC subjects of the training set and removing it from MRI
data of all subjects as proposed in (Moradi et al., 2015). With the
age correction step for the estimation of RAVLT Immediate using the
ENLR approach, the average correlation score increased from 0.50 to
0.51 (p < 0.001), the average MAE decreased from 7.86 to 7.80 and
the average Q2 increased from 0.25 to 0.26. For estimation of RAVLT
Percent Forgetting with age corrected MRI data, the average correla-
tion score increased from 0.43 to 0.46 (p < 0.001), the average MAE
decreased from 25.53 to 25.18 and the average Q2 increased from
0.185 to 0.21.
9 http://web.stanford.edu/~hastie/glmnet_matlab/.
10 http://www.miketipping.com/sparsebayes.htm.
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Table 2
The generalization performance based on correlation score (R), coeﬃcient of determination (Q2) and mean absolute error (MAE) for different experiments. *** means that the
value was not meaningful, because Q2 values were below −100 and MAE values were above 100. The values are averages across 100 CV runs. The values in parentheses show the
standard deviations across 100 CV runs. RAVLT-Immediate is abbreviated as RAVLT-IR and RAVLT-Percent Forgetting is abbreviated as RAVLT-PF.
Data RAVLT IR RAVLT IR RAVLT IR RAVLT PF RAVLT PF RAVLT PF
ENLR KRVR RVR ENLR KRVR RVR
AD, MCI, NC R 0.50 (0.007) 0.46(0.01) 0.27 (0.02) 0.43 (0.01) 0.41(0.01) 0.28 (0.02)
Q2 0.25 (0.007) 0.17 (0.01) −0.71 (0.06) 0.185 (0.01) 0.14 (0.01) −0.645 (0.07)
MAE 7.86 (0.043) 8.21 (0.08) 11.90 (0.23) 25.53 (0.18) 26.65 (0.18) 34.52(0.82)
AD, NC R 0.61 (0.008) 0.53(0.01) 0.38 (0.03) 0.53 (0.01) 0.50 (0.01) 0.32 (0.03)
Q2 0.37 (0.01) 0.24 (0.02) −0.37 (0.07) 0.28 (0.01) 0.23 (0.02) −0.56 (0.08)
MAE 8.30 (0.07) 9.11 (0.13) 12.23 (0.35) 25.33(0.16) 25.75 (0.37) 35.58 (1.11)
AD, MCI R 0.39 (0.01) 0.32(0.01) 0.21 (0.03) 0.29(0.02) 0.255(0.02) 0.15(0.03)
Q2 0.15 (0.01) −0.03 (0.02) −0.78 (0.08) 0.08 (0.01) −0.05 (0.03) −0.93 (0.08)
MAE 6.57 (0.04) 7.26 (0.09) 9.76 (0.24) 23.39(0.14) 24.52(0.38) 32.60 (0.76)
MCI, NC R 0.43 (0.01) 0.41(0.01) 0.26(0.03) 0.32 (0.02) 0.32 (0.01) 0.19(0.03)
Q2 0.18 (0.01) 0.10 (0.02) −0.70 (0.10) 0.09 (0.02) 0.06 (0.01) −0.88 (0.08)
MAE 67.88 (0.06) 8.21(0.09) 11.34(0.38) 26.58 (0.21) 26.49(0.19) 36.11 (0.83)
AD R 0.32 (0.03) 0.28(0.02) 0.08 (0.05) −0.14 (0.06) 0.06 (0.03) −0.09 (0.06)
Q2 0.10 (0.02) −0.02 (0.03) −1.08 (0.16) −0.03 (0.02) −0.31 (0.05) −1.48 (0.22)
MAE 5.75 (0.07) 6.22 (0.11) 8.84 (0.37) 14.08 (0.15) 16.17 (0.35) 22.8 (1.12)
MCI R 0.15 (0.02) −0.03(0.03) 0.06 (0.06) 0.16 (0.02) −0.01 (0.02) 0.05 (0.04)
Q2 0.02 (0.01) *** *** 0.02 (0.01) *** −1.11 (0.14)
MAE 6.92 (0.035) *** *** 26.07 (0.15) *** 33.65 (1.19)
3.1.2. Top predictors for RAVLT scores
Since we standardized the data before applying ENLR, the abso-
lute value of each regression coeﬃcient provides the importance of
the corresponding predictor in the predictive model. Therefore, we
computed the importance of each brain region based on the max-
imum value of the average magnitudes of regression coeﬃcients.
The magnitude of standardized regression coeﬃcients was averaged
across 100 different 10-fold CV iterations. The top predictors (brain
regions) for estimation of RAVLT scores in the ENLR model are listed
in Table 3 (RAVLT Immediate) and Table 4 (RAVLT Percent Forget-
ting). We considered only the maximum of the average magnitudes
within a region to discount for poor predictors within a region. To
compute the 95% conﬁdence intervals (CIs) for themaximumof aver-
agemagnitudes of regression coeﬃcients, we calculated ﬁrst the 2.5%
and 97.5% percentiles of magnitudes of regression coeﬃcients for
each voxel within 100 runs of 10-fold CV, and then took the max-
imum values of these as the lower and upper bound of the CI. The
lower CI limit larger than zero provides strong evidence that the
region in the question contributes to the prediction model indepen-
dent of the training set used. In addition, we computed the selection
probability for each voxel across 100 different 10-fold CV runs (see
Fig. 2).
3.1.3. Accuracy of estimated RAVLT scores with reduced subject sets
Removing MCI subjects signiﬁcantly improved the performance
of the estimation (see Table 2, the ﬁrst and second rows, the improve-
ment in R was signiﬁcant with all three methods and both scores
(p < 0.0001)). Albeit the predictive performance improved in
terms of correlation score and coeﬃcient of determination, the MAE
increased in all experiments.
Excluding either the NC or AD group from the dataset notably
decreased the prediction performance when comparing to that of
using all subjects (see Table 2, ﬁrst, third and forth rows). The decline
in the performance of model was highly signiﬁcant (p < 0.0001)
in all experiments. As the results show, removing either AD or NC
groups and including subjects from the groups with more similari-
ties such as “AD and MCI” or “NC and MCI” rendered the prediction
problem more challenging.
We experimented with using a single group of subjects for learn-
ing and evaluating of the model. The results are presented in the
last two rows of the Table 2. As it was expected, the estimation of
RAVLT scores with a single group of subjects proved to be a diﬃ-
cult problem due to lack of signiﬁcant differences in the AD related
structural changes within subjects of a single group. However, even
within MCI and AD groups, the correlation between the estimated
and observed RAVLT Immediate score was signiﬁcant when using
ENLR for prediction.With the AD group, the estimation of RAVLT per-
cent forgetting was not successful with any method. However, ENLR
could estimate the RAVLT percent forgetting within the MCI group,
where the correlation was low but signiﬁcant.
The scatter plots of the estimated and observed RAVLT scores
of the CV run with the median R within 100 computation times,
with the proposed approach for different experiments are illustrated
in Fig. 3. The scatter plots corresponding to the KRVR and RVR
approaches are provided in the supplement.
3.2. AD conversion prediction based on RAVLT measures
We studied the use of RAVLT Immediate and RAVLT Percent for-
getting for predicting conversion to AD in MCI patients. For this, we
classiﬁed subjects with MCI as pMCI (progressive MCI) if the subject
converted to AD within 1, 2 or 3 years follow-up without reversion
to MCI or NC at any available follow-up (0–96 months), sMCI (sta-
ble MCI) if the diagnosis was MCI at all available time points (0–96
months), but at least for 36 months and uMCI (unlabeled MCI) if the
diagnosis was missing at 36 months from the baseline or the diag-
nosis was not stable at all available time points. The deﬁnition of
these groups was the same as in our previous work (Moradi et al.,
2015). We used only sMCI and pMCI subjects in order to evaluate the
effectiveness of RAVLT scores (acquired at baseline) for predicting
conversion to AD.
The baseline RAVLT scores differed signiﬁcantly between the two
MCI groups (pMCI and sMCI) in terms of both RAVLT Immediate
(p < 0.0001) and RAVLT Percent Forgetting (p < 0.0001). The aver-
age RAVLT Immediate was 35.08 (standard deviation 9.69) in the
sMCI group and 26.94 (standard deviation 6.19) in the pMCI group.
The average RAVLT Percent Forgetting was 55.35 (standard deviation
30.91) in the sMCI group and 77.48 (standard deviation 27.99) in the
pMCI group.
Furthermore, the longitudinal RAVLTmeasurements showed con-
siderable changes during the 3 years follow-up in pMCI subjects
while they were relatively stable in sMCI subjects as shown in Fig. 4,
which is provided to conﬁrm the close relationship between the
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Fig. 1. Scatter plot for estimation of RAVLT Immediate (left) and RAVLT Percent Forgetting (right) using ENLR (top) and KRVR (bottom) with all available subjects, i.e., AD, MCI
and NC subjects.
RAVLT scores and the suspected AD pathology. Interestingly, in the
pMCI group, RAVLT Immediate displayed a more clear declining
trajectory than the RAVLT percent forgetting.
Fig. 5 shows the ROC curves for discrimination of pMCI and sMCI
subjects of observed baseline RAVLT scores and the estimated RAVLT
scores. The estimated RAVLT scores were learned with all data (AD,
MCI and NC subjects). From these estimated scores, we then selected
the scores of pMCI and sMCI subjects in order to calculate AUC and
plot the ROC curves. The AUC of observed RAVLT Immediate was
0.75 and the AUC of observed RAVLT Percent Forgetting was 0.71,
thus indicating that these scores are powerful in predicting conver-
sion to AD in MCI subjects. The AUC of estimated RAVLT Immediate
was 0.72 (ENLR), 0.72 (KRVR) and 0.63 (RVR). The AUC of estimated
RAVLT Percent Forgetting was 0.71 (ENLR), 0.69 (KRVR) and 0.60
(RVR). The difference between observed and estimated AUCs (based
on either ENLR or KRVR) was 0.03 with the 95 % conﬁdence inter-
val (CI) of [−0.05, 0.11] for RAVLT Immediate. For RVR, the difference
was 0.12 with the CI of [0.03, 0.21]. In the case of RAVLT Percent
Forgetting, the difference between observed and estimated AUCs
was 0.01 with the CI of [−0.07, 0.09] (ENLR), 0.02 with the CIs of
[−0.07,0.10] (KRVR) and 0.12 with the CI of [0.03,0.20] (RVR). As the
results indicate, the AUCs obtained based on estimated RAVLT scores
using ENLR and KRVR methods were similar to AUCs obtained the
observed RAVLT scores, i.e., estimated scores demonstrated similar
power in the detection of AD conversion compared to the observed
scores.
It is interesting to study whether pMCI and sMCI subjects can
be more effectively separated if using both observed and estimated
scores instead of only using observed scores. To test this, we trained a
Gaussian plug-in classiﬁer (Duda et al., 2012) using Matlab’s classify
function. The accuracy of the classiﬁer was measured using 100 runs
of 10 fold CV. The average accuracy when using both estimated and
observed values for RAVLT Immediate (percent forgetting) was 0.75
(0.71). When using only the observed values the accuracy was 0.70
(RAVLT Immediate) and 0.67 (RAVLT percent forgetting)11 . The per-
formance improvement was signiﬁcant in terms of run-wise applied
permutation test (p < 0.0001). By combining the two observed
RAVLT scores, the classiﬁcation accuracywas 0.71. These results indi-
cated that estimated and observed RAVLT scores contained different
information that may be useful for early AD diagnosis.
11 The difference to the AUCs reported above is because the resubstitution method,
not dependent on any classiﬁer, used to compute the values 0.75 and 0.71 above and
the cross-validation based estimate (tied to the speciﬁc classiﬁer) led to the AUCs of
0.70 and 0.67
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Table 3
The top predictors for estimating RAVLT Immediate in all subjects (AD, MCI and NC). For each voxel, the averagemagnitude of the standardized regression coeﬃcients (normalized
with respect to the standard deviation of the response variable) across 100 different 10-fold CV iterations are calculated. The third column shows the number of voxels with the
average magnitude greater than or equal to 0.01 in the corresponding region and the fourth and ﬁfth columns show the maximum value of the average magnitude of regression
coeﬃcients and its CI within the region. The ranking is based on the maximum value of the average magnitude of regression coeﬃcients in each region. The region deﬁnitions
correspond to those of the AAL atlas and we abbreviate gyrus as G.
Region deﬁnition Label Number of voxels Max weight 95 % CI for max weight
Middle temporal G right 86 3 0.05 [0.0185, 0.0784]
Amygdala right 42 4 0.04 [0.0123, 0.0815]
Insula left 29 2 0.04 [0.0076, 0.0645]
Hippocampus left 37 7 0.03 [0.003, 0.0637]
Sup temporal G left 81 2 0.03 [0.0075, 0.0637]
Calcarine right 44 1 0.03 [0.0007, 0.0641]
Thalamus right 78 1 0.03 [0.0074, 0.0540]
Inf parietal G left 61 1 0.02 [0.00004, 0.0479]
Middle cingulum left 33 2 0.02 [0, 0.0440]
Parahippocampal G left 39 1 0.02 [0, 0.0462]
Anterior cingulate left 31 2 0.02 [0, 0.0483]
Supplementary motor area left 19 1 0.02 [0, 0.0435]
Middle temporal G left 85 2 0.02 [0, 0.0469]
Middle frontal G right 8 1 0.02 [0, 0.0419]
Precuneus left 67 2 0.01 [0, 0.0358]
Lingual G right 48 1 0.01 [0, 0.0397]
Inf occipital G left 53 1 0.01 [0, 0.0360]
Inf frontal G, oper. right 12 1 0.01 [0, 0.0382]
Parahippocampal G right 40 1 0.01 [0, 0.0408]
Fusiform G left 55 1 0.01 [0, 0.0435]
4. Discussion
The purpose of the current study was to analyze the relationships
between AD related structural changes within the brain with RAVLT
cognitive measures in order to ﬁnd how accurately RAVLT cognitive
measures reﬂect the structural atrophy caused by AD. To this end, we
build a predictive model to estimate RAVLT scores from gray matter
density via elastic net penalized linear regressionmodel by consider-
ing various datasets of subjectswith different AD severity levels in the
learning and evaluation procedures. The aim of considering different
Table 4
The top predictors for estimating RAVLT Percent Forgetting in all subjects (AD, MCI and NC). For each voxel, the average magnitude of the standardized regression coeﬃcients
(normalized with respect to the standard deviation of the response variable) across 100 different 10-fold CV iterations are calculated. The third column shows the number of
voxels with the average magnitude greater than or equal to 0.01 in the corresponding region and the fourth column shows the maximum value of the average magnitude of
regression coeﬃcients with the region. The ranking is based on the maximum value of the average magnitude of regression coeﬃcients within each region. The region deﬁnitions
correspond to those of the AAL atlas and we abbreviate gyrus as G.
Region deﬁnition Label Number of voxels Max weight 95 % CI for max weight
Angular G right 66 1 0.07 [0,0433, 0.0879]
Hippocampus right 38 1 0.05 [0.0208, 0.0855]
Hippocampus left 37 6 0.05 [0.0148, 0.0863]
Amygdala left 41 2 0.04 [0.0122, 0.0795]
Amygdala right 42 4 0.04 [0.0042, 0.0814]
Insula left 29 1 0.04 [0.002, 0.0683]
Parahippocampal G right 40 3 0.04 [0.0067, 0.0674]
Middle occipital G left 51 2 0.04 [0.0073, 0.0631]
Calcarine left 43 2 0.03 [0.0012, 0.0682]
Temporal pole, middle temporal G right 88 1 0.03 [0, 0.0702]
Sup temporal G right 82 1 0.03 [0, 0.0647]
Lingual G left 47 2 0.03 [0, 0.0644]
Inf occipital G right 54 2 0.03 [0, 0.0597]
Middle cingulum left 33 1 0.03 [0, 0.0528]
Sup frontal G, orb. left 5 1 0.02 [0, 0.0539]
Middle frontal G left 7 2 0.02 [0, 0.0523]
Temporal pole; sup temporal G left 83 2 0.02 [0, 0.0586]
Cerebellum-6 right 100 1 0.02 [0, 0.0465]
Middle frontal G right 8 2 0.02 [0, 0.0477]
Fusiform G left 55 1 0.02 [0, 0.0506]
Inf temporal G right 90 1 0.02 [0, 0.0450]
Inf frontal G, orb. right 16 1 0.02 [0, 0.0647]
Inf parietal G left 61 3 0.02 [0, 0.0450]
Cerebellum-6 left 99 1 0.02 [0, 0.0562]
Precuneus left 67 1 0.02 [0, 0.0434]
Olfactory G left 21 1 0.02 [0, 0.0535]
Parahippocampal G left 39 2 0.02 [0, 0.0443]
Thalamus right 78 2 0.01 [0, 0.0417]
Sup frontal G right 4 2 0.01 [0, 0.0378]
Sup frontal G left 3 1 0.01 [0, 0.0393]
Middle temporal G right 86 1 0.01 [0, 0.0422]
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Fig. 2. The selection probability of voxels in the estimation RAVLT Immediate (A) and RAVLT Percent Forgetting (B) across 100 different 10-fold CV iterations. The images are
displayed according to the neurological convention.
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Fig. 3. Scatter plot for estimation of RAVLT Immediate (left) and RAVLT Percent Forgetting (right) based on ENLR using AD and NC subjects (top), AD and MCI subjects (middle)
and NC and MCI subjects (bottom).
datasets with different levels of memory problemswas to determine
the dependency between the RAVLT performance and the demen-
tia related atrophy. The results of the current study revealed strong
association between information detected by RAVLT scores and AD
related structural atrophy. As the results show (see Table 2), including
subjects from similar groups such as “AD and MCI” or “NC and MCI”
produced lower predictive performance compared to using groups of
subjects with signiﬁcant structural differences within the brain, such
as “AD and NC”.
Several studies have investigated the role of RAVLT cognitivemea-
sures in the evaluation of AD as well as the relationship between AD
related atrophy and RAVLT measures (Estévez-González et al., 2003;
Balthazar et al., 2010; Stonnington et al., 2010; Wang et al., 2011). A
recent study by Stonnington et al. (2010) investigated the association
betweenADrelated structural changes andaRAVLTmeasure (percent
retention) by applying relevance vector regression for the estimation
of RAVLT based onMR structural images. However, they did not ﬁnd a
signiﬁcant correlation between estimated and observed values (R =
0.13, normalized RMSE = 1) in an ADNI dataset of 39 AD, 92MCI and
32 NC subjects. For comparison purposes, we also calculated normal-
izedRMSE (bynormalizing theobserved scores tohave zeromeanand
unit variance) for the estimation of RAVLT immediate (RMSE = 0.87,
R = 0.50) and RAVLT Percent Forgetting (RMSE = 0.90, R = 0.43). In
contrast to Stonnington et al. (2010), our study indicated a signiﬁcant
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Fig. 4. Mean RAVLT scores (A–B) during 3years follow-up assessment in pMCI and sMCI subjects with error bars representing the standard deviation.
relationship between RAVLTmeasures and structural atrophy caused
byAD. The improvedpredictionperformanceof ourmodel stemsboth
from the larger number of subjects used to train the model and from
a better approach for learning the model (ENLR in contrast to KRVR
used by Stonnington et al., 2010). Relative to the machine learning
approach used, Stonnington et al. (2010) speculated that the estima-
tionofRAVLT,whichfocusesonthespeciﬁcaspectsofcognitiveability,
might be challenging based on the whole brain MRI. However, our
results demonstrate that this challenge can be in part overcome by
using sparsity inducing learningmethods, such as ENLR. In addition to
RAVLT Immediate and RAVLT Percent Forgetting, we also estimated
the delayed recall score from gray matter density using proposed
approach in a full dataset (AD,MCI andNC; Results of this experiment
are available in the Supplement). As expected, the predictive accuracy
evaluated by cross-validation (R = 0.44,Q2 = 0.19,MAE = 2.83)
was almost equivalent to that of RAVLT Percent Forgetting, which is
a measure of delayed recall taking into account the relationship of
immediately and delayed recalled words.
The knowledge of top predictors is crucial to understand which
brainregionsaremost inﬂuential inestimationofRAVLTscoresaswell
as how strongly these measures are related to brain atrophy caused
by AD. One proposed use of the elastic net penalized linear regres-
sion for constructing predictive model was to obtain an interpretable
model. As stated in Section 2.4, the ENLR performs variable selection
simultaneouslywithmodel estimation, thus providing a subset of rel-
evant voxels for the learning procedure. Note that while also KRVR
provided relatively high predictive performance for the estimation
of both RAVLT scores (although the predictive performance of KRVR
was consistently lower than the predictive performance of ENLR in
all experiments, see Table 2), the interpretation of the KRVRmodel is
hard due to kernelization. The top ranked predictors for estimating
RAVLT Immediate (learning) are listed in Table 3 and for estimat-
ing RAVLT Percent Forgetting are listed in Table 4. Our ﬁnding of top
predictors of medial temporal lobe structures and amygdala for esti-
mation of RAVLT Immediate and angular gyrus, hippocampus and
amygdala for estimation of RAVLT Percent Forgetting are consistent
with previous knowledge. The essential role of medial temporal lobe
structures, especially hippocampus, for episodic memory has been
known for long (Squire and Wixted, 2011; Jeong et al., 2015). Specif-
ically, these structures are thought to be involved for the formation
and the maintenance of memories after learning before storing to
other cortical areas (Squire and Wixted, 2011). In addition, atrophy
in bilateral temporal white matter close to the structures involved
in memory formation including the hippocampus, entorhinal cortex,
and amygdala has been consistently combined with AD pathology (Li
et al., 2012).
Recent studies have suggested the involvement of widely dis-
tributed cortical network and the importance of its interactive roles
Fig. 5. ROC curves ofMCI subjects classiﬁcation to sMCI or pMCI using observed RAVLT and estimated RAVLT based on differentmethods (ENLR, RVR, KRVR). The learningwas done
using all subjects (AD, MCI and NC) and the evaluation was done on pMCI and sMCI subjects (median within 100 runs). Left: RAVLT Immediate, Right: RAVLT Percent Forgetting.
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in the memory process (Jeong et al., 2015). In addition to temporal
lobe, prefrontal and parietal cortical areas have been associated with
episodic memory (Squire and Wixted, 2011; Brem et al., 2013; Jeong
et al., 2015).
Theinvolvementofangulargyrus,locatedininferiorparietalcortex,
in retrieval has been conﬁrmed by functional neuroimaging studies
(Kwok et al., 2012; Sestieri et al., 2011) and is also reported in a review
study by Jeong et al. (2015). The insular cortex has been related with
tastememoryprocessesbutmayhavea role in interactionwithamyg-
dala in non-taste recognition memory as well (Bermudez-Rattoni,
2014). Insula and angular gyrus are also parts of the default network
(includingalsoanteromedialprefrontal cortex, theprecuneus, and the
medial temporal lobe) which has been discovered to be disrupted in
AD(Jeongetal., 2015).Ourﬁndingsof thebrain regionsbestpredicting
learningandretrieval inRAVLTareinlinewithpreviousresearchbased
onneuroimagingdata of neurobiological changes associatedwithdis-
orders causing dementia and normal memory processes. Speciﬁcally,
our results indicate that in addition to well-known hippocampus and
amygdala, also middle temporal gyrus, angular gyrus and insula are
also associated with verbal episodic memory tasks.
Furthermore, our results suggest that a wide network of brain
regions is involved in memory processes. While making interpreta-
tions about importance of brain regions for prediction is certainly
possible with sparse linear regularization based models such as
ENLR, this does not mean that ranking the importance of different
brain regions in the machine learning analysis of whole brain imag-
ing data would be straight-forward. Even within the same machine
learning algorithm, different complementary measures of variable
importance can be derived. For example, we have provided two sep-
arate and complementary indicators of voxel/region importance in
Fig. 2 and Tables 3 and 4. Also, it is important to bear in mind that
the weights in machine learning models have a different meaning
than the parameter estimates in the forward models produced by a
standard mass-univariate analysis (Haufe et al., 2014).
The accuracy of estimated RAVLT measures improved little by
adding age-correctionprocedure in the learningprocess(although the
improvementwasstatistically signiﬁcantby run-wiseappliedpermu-
tation test). Studies of normal memory processes have indicated that
subject demographics, and especially age, have considerable effect
on the RAVLT cognitive test in the cognitively normal individuals
(Magalhães and Hamdan, 2010; Malloy-Diniz et al., 2007) and at the
same time, aging changes the brain structure Good et al. (2001). How-
ever, in our experiments removing the normal aging effect resulted
only inslight improvement intheestimatedRAVLTscores.Wehypoth-
esize that this was due to a large effect of AD pathology on both MRI
and RAVLT that completely overshadows the effects of normal aging.
In the current work, we explored the utility of estimated and
observed RAVLT measures for predicting conversion to AD in MCI
subjects. The AD conversion prediction in MCI patients has attracted
increasing interest recently, due to an opportunity for an early-stage
AD diagnosis (Eskildsen et al., 2013; Wee et al., 2013; Gaser et al.,
2013). Previous studies have assessed the predictive value of different
neuroimagingtechniques inADconversionprediction. Inourprevious
work (Moradi et al., 2015), we developed a MRI based biomarker by
usingMRI data and age informationwhich resulted in cross-validated
AUC of 77% for discriminating pMCI and sMCI patients, we further
obtained anAUC of 90% by integratingMRI biomarkerwith neuropsy-
chological test results. In another recent study by Eskildsen et al.
(2015), an AUC of 76%was reported for predicting AD inMCI patients
based on structural MRI and age information using machine learning
algorithms. Moreover, the prediction of AD in MCI patients using dif-
ferent biomarkerswas recently studiedbyDukart et al. (2015).Within
different single biomarkers including sMRI, positron emission tomog-
raphy (FDG-PET) andapolipoprotein (APOE), thehighest performance
was achieved by FDG-PET (AUC = 82%). They also showed that inte-
grating several biomarkers signiﬁcantly improved the AD conversion
prediction inMCI patients (AUC = 84%). In overall, the reported accu-
racies based on single neuroimaging modalities in recent studies
varies between 70–80% (Moradi et al., 2014; Eskildsen et al., 2015;
Salvatore et al., 2016), however, studies based on combination of
several data sources such as neuroimaging, genetics information and
cognitive test results, have been reported higher performance for
predicting AD in MCI patients (accuracy between 80–90%) (Moradi
et al., 2015; Dukart et al., 2015; Ritter et al., 2015). Although the
current work did not focus on the AD conversion prediction, the
achievedperformance for predicting conversion toAD inMCI patients
based on both RAVLT Immediate (AUC = 0.75) and RAVLT Percent
Forgetting (AUC = 0.71) were comparable to the predictive perfor-
mance of neuroimaging biomarkers (Teipel et al., 2015; Salvatore et
al., 2016).Moreover, the analysis of longitudinal 3 years follow-up
assessments of RAVLT measures in MCI subjects showed a notable
decline in the RAVLT Immediate score and an increase in RAVLT per-
cent Forgetting in pMCI subjects while remaining relatively stable
for both scores in sMCI subjects. These ﬁndings reconﬁrm the diag-
nostic power of RAVLT for early diagnosis of Alzheimer’s disease as
reported elsewhere Estévez-González et al. (2003). Interestingly, the
estimated RAVLT scores were almost as good as the observed ones in
predicting conversion to AD indicating that structural brain imaging
representations of episodic memory displayed most of the essential
information in RAVLT for detecting AD pathology. However, the con-
version predictions improved when observed and estimated scores
werecombinedsuggesting that thedifferential informationcontained
in these two types of scores might be useful for early AD diagnosis.
In summary, we designed a predictive model for analyzing the
association between RAVLTmeasures (learning and retrieval) and AD
related structural atrophy using MRI scans in a large ADNI dataset.
our experimental results indicated a strong relationship between
RAVLT Immediate and Percent Forgetting scores and the brain atro-
phy caused by AD. Moreover, both RAVLT Immediate and RAVLT
Percent Forgetting were found to be reliable for AD diagnosis and
reﬂect well the underlying AD pathology. However, we found that
RAVLT Immediate is more correlated with AD related brain atrophy
as well as it has a higher predictive accuracy for the AD conversion
prediction in MCI patients.
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Appendix A. Penalized linear regression
Linear regression models the response variable y as a linear
combination of the predictor variables x . The predictor variables
x ∈ RN×D areMRI based graymatter densities, where N is the number
of subjects and D is the number of voxels, i.e., the dimensionality of
MRI data, and the response variable y is the RAVLT score. The linear
model is formalized as
yi = wTxi +w0 + 4i =
D∑
j=1
wjxi,j +w0 + 4i, (A.1)
where the index i refers to a subject, w and w0 are the model
parameters and 4i is the error term. The ordinary least squares (OLS)
estimation determines the model parameters by minimizing the
residual sum of squares (RSS):
RSS(w) =
N∑
i=1
(yi − w0 − w1xi1 − . . . − wDxiD)2, (A.2)
However, when the number of predictors is larger than the num-
ber of subjects (D À N), the OLS does not provide a unique solution.
Moreover, a high number of predictors may cause the curse of
dimensionality, i.e., the lack of generality caused by over-ﬁtting. For
avoiding the curse of dimensionality, many variable/feature selec-
tionmethods have been proposed in neuroimaging data (Tohka et al.,
2016;Mwangi et al., 2014). Among them, the regularizationmethods
have gained considerable attention (Miller, 2002). Similarly to OLS-
based parameter estimation, penalized linear regression estimates
the model parameters by minimizing RSS, but it also shrinks some
of the regression parameters towards zero. In this way, it performs
simultaneously parameter estimation and variable selection. Here,
as the dimensionality of MRI data is high (D = 29852), we used
penalized least squares approach with the elastic net penalty (Zou
and Hastie, 2005). The elastic net penalty is a weighted average of
the LASSO penalty
∑D
j=1 |wj| (Tibshirani, 1996) and the ridge penalty∑D
j=1w
2
j . The LASSO penalty acts as a variable selector by forcing
many parameters to have zero values leading to a sparse solution.
In neuroimaging applications in which many relevant variables are
correlated with each other, LASSO tends to select only one of them
while ignoring other correlated variables albeit they would be rele-
vant (Carroll et al., 2009). This is obviously not desired. In contrast,
ridge regression penalty shrinks the coeﬃcients of the correlated
variables towards each other and assigns similar coeﬃcients values
to them. However, ridge regression does not result in a sparse solu-
tion, with many zero parameters. However, a combination of these
two penalties leads to a sparse model combined with the grouping
effect, providing a good solution in neuroimaging applications (Zou
and Hastie, 2005; Carroll et al., 2009). In ENLR, the model is solved
by minimizing the elastic net cost function:
1
2N
N∑
i=1
(yi − w0 − xTi w)2 + k[(1 − a) ‖w‖22 /2+ a‖w‖1], (A.3)
where the regularization parameter k is found by cross-validation
and a ∈ [0, 1] deﬁnes the compromise between ridge and lasso
penalties. In our experiments, we selected a = 0.5 to give equal
weights for the ridge and lasso penalties. A limitation of the elas-
tic net penalty is that it does not consider spatial relationships of
the voxels and neighboring voxels are not required to receive similar
weights. While there are regularizers that take into account the spa-
tial relationships among the voxels, such as GraphNet Grosenick et
al. (2013), these come with more parameters to select, longer com-
putation times and have found to produce more variable estimate of
the generalization error in the case of dementia related classiﬁcation
tasks Tohka et al. (2016).
Appendix B. Supplementary data
Supplementary data to this article can be found online at http://
dx.doi.org10.1016/j.nicl.2016.12.011.
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A B S T R A C T
Machine learning approaches have been widely used for the identiﬁcation of neuropathology from neuroima-
ging data. However, these approaches require large samples and suﬀer from the challenges associated with
multi-site, multi-protocol data. We propose a novel approach to address these challenges, and demonstrate its
usefulness with the Autism Brain Imaging Data Exchange (ABIDE) database. We predict symptom severity
based on cortical thickness measurements from 156 individuals with autism spectrum disorder (ASD) from four
diﬀerent sites. The proposed approach consists of two main stages: a domain adaptation stage using partial least
squares regression to maximize the consistency of imaging data across sites; and a learning stage combining
support vector regression for regional prediction of severity with elastic-net penalized linear regression for
integrating regional predictions into a whole-brain severity prediction. The proposed method performed
markedly better than simpler alternatives, better with multi-site than single-site data, and resulted in a
considerably higher cross-validated correlation score than has previously been reported in the literature for
multi-site data. This demonstration of the utility of the proposed approach for detecting structural brain
abnormalities in ASD from the multi-site, multi-protocol ABIDE dataset indicates the potential of designing
machine learning methods to meet the challenges of agglomerative data.
1. Introduction
Autism Spectrum Disorder (ASD) is a developmental disorder
characterized by impairments in social interaction and communication,
restricted interests, and repetitive patterns of behavior (Lord and
Jones, 2012; Wing, 1997; Gillberg, 1993). The deﬁnition admits
substantial behavioral heterogeneity (Georgiades et al., 2013); ASD
is, in fact, a family of developmental disorders with unique, but related,
phenotypes, with a variety of genetic associations (Devlin and Scherer,
2012). Moreover, ASDs are developmental disorders, and the beha-
vioral abnormalities evolve over time (Gotham et al., 2012; Szatmari
et al., 2015), adding to the apparent heterogeneity. This large
behavioral heterogeneity appears to be paralleled by a wide array of
neuroanatomical abnormalities, which also evolve over development
(Zielinski et al., 2014; Wolﬀ et al., 2014). Almost every brain region has
been implicated in autism, including subcortical (Jacobson et al., 1988;
Cerliani et al., 2015) and cerebellar regions (Bauman, 1991; Fatemi
et al., 2002), gray-matter and white-matter (Barnea-Goraly et al., 2004;
Rojas et al., 2006), and regions of all lobes of the cerebrum (Zilbovicius
et al., 2000; Courchesne et al., 2011; Lewis et al., 2013, 2014). Indeed,
the neuroanatomical heterogeneity is so great that replication of results
across studies is rare. The inconsistencies in ﬁndings are likely
primarily due to the small sample sizes used in most studies, in
combination with the large behavioral heterogeneity, as well as
measurement related diﬀerences (Auzias et al., 2014, 2016;
Castrillon et al., 2014). Thus, there is an urgent need for larger sample
sizes, if we are to discover clinically useful information (Amaral et al.,
2008; Auzias et al., 2014, 2016; Lefebvre et al., 2015). Large samples
may allow the extraction of core neuroanatomical abnormalities from
the noise introduced by the heterogeneity of the disorder. Such
abnormalities could serve as biomarkers, and could provide insight
into the causes of the disorder, and potential interventions.
However, datasets collected by a single site are not suﬃcient in size
to achieve such goals (albeit making exact claims about the required
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dataset size is a complex matter and depends on the goals of study
(Button et al., 2013)). Further, there are limited publicly available data
from multi-site studies utilizing a single scanner type with the same
acquisition protocol across sites. But, so-called ‘big data’ has come to
neuroscience, including for the study of ASD. There are currently
multiple initiatives to bring together neuroimaging data from multiple
sites, acquired on multiple types of scanners, and with diﬀering
protocols. The Autism Brain Imaging Data Exchange (ABIDE)2 is one
such initiative (Di Martino et al., 2014). ABIDE provides previously
collected datasets composed of both MRI data and phenotypic infor-
mation from 16 diﬀerent international sites for over 1100 individuals,
approximately half of whom are typically developing (TD) and half
have been diagnosed with ASD. This sample size, which is more than an
order of magnitude larger than that used in most single-site studies,
provides the power needed to identify neuroanatomical abnormalities
related to ASD. But, the multi-site, multi-protocol aspect of the data
introduces additional heterogeneity. Indeed, previous studies using the
ABIDE data have shown that acquisition site has signiﬁcant eﬀects on
basic image properties (Nielsen et al., 2013; Castrillon et al., 2014).
This further exacerbates the problem of identiﬁcation of core neuroa-
natomical abnormalities in this extremely heterogeneous data. The
between-site heterogeneity constitutes the main technical challenge in
the current work (Auzias et al., 2014), and the solution that we oﬀer is a
contribution applicable not only to the ABIDE dataset, but to any
neuroimaging data agglomeration.
The solution to the problem lies in ﬁnding a new common space
within diﬀerent datasets for reduction of between-site variation.
Techniques for achieving this are often referred to as domain adapta-
tion (Jiang, 2008; Pan and Yang, 2010). Domain adaptation is a new
branch of machine learning techniques that seeks to improve the
similarity of the data from diﬀerent sources with mismatched distribu-
tions. We utilize these domain adaptation machine learning algorithms
to address the problem that arises in the situation where the data
distribution changes across diﬀerent acquisition sites. We apply this
approach to the ABIDE data to identify neuroanatomical abnormalities
associated with symptom severity in ASD. Between-sites variance in
neuroimaging studies is commonly handled by regressing out the site
identity from the imaging data in a voxel-wise manner before perform-
ing analysis (Gupta et al., 2015) and similar methods have been
adapted for machine learning analysis with limited success (Kostro
et al., 2014). Instead, here we propose a novel approach for reducing
between-sites variability by projecting data from diﬀerent sites into a
new, common space in a way that eﬀectively reduces nuisance variation
between the data from diﬀerent sites. The current approach for dealing
with the site eﬀect is novel in the context of multi-site imaging studies,
and for the estimation of severity scores in ASD patients.
The great majority of ASD studies have focused on identifying
group diﬀerences between typically developing individuals and those
with ASD, or conversely, training classiﬁers to distinguish between
these groups (Ecker et al., 2010; Nielsen et al., 2013; Wang et al.,
2015). But, perhaps the largest source of heterogeneity is associated
with the severity of the disorder. In fact, both individuals with ASD as
well as those deemed to be typically developing display a wide range of
symptoms of autism in a variety of behaviors. This variability may
mask neural abnormalities associated with these symptoms, and limit
the success of attempts to classify an individual based on their
neuroimaging data. Approaches which relate dimensional measures
of symptoms to measures of neuroanatomy appear more useful than
those which aim only to identify abnormalities associated with a
diagnosis of ASD (Sato et al., 2013; Schumann et al., 2009). Thus, in
this work we take this latter approach. We design a model to estimate
symptom severity scores derived from the Autism Diagnostic
Observation Schedule (ADOS) from cortical thickness measurements.
We are motivated by evidence that local cortical thickness measures
provide an index of the maturation of cortex and cortico-cortical
connectivity (Shaw et al., 2008; Raznahan et al., 2011), and that ASD
may be characterized by delayed maturation (Webb et al., 2011;
Johnson et al., 2015).
Our proposed method for estimation of the severity score consists
of two main stages: a domain adaptation stage that uses partial least
squares regression (PLS) with sites as response variable, and the
learning stage which consists of the combination of two diﬀerent
regression methods, i.e. support vector regression (SVR) and elastic-
net penalized linear regression (LR). We evaluate the reliability of the
model across a multisite dataset without standardization of the
acquisition protocol across sites, and the eﬀect of each part of the
algorithm.
2. Materials and methods
2.1. ABIDE data
The data used in this study were from the ABIDE dataset (Di
Martino et al., 2014). ABIDE is a publicly available dataset that
involved 16 international sites, from 532 individuals with ASD and
573 typical controls, yielding 1112 datasets composed of MRI (func-
tional and structural) and phenotypic information for each subject. The
sequence parameters as well as type of scanner varied across sites,
though all data were collected with 3 T scanners. The scan procedures
and parameters are described on the ABIDE website.
2.2. Image preprocessing
The T1-weighted volumes were processed with CIVET, a fully
automated structural image analysis pipeline developed at the
Montreal Neurological Institute. CIVET corrects intensity non-unifor-
mities using N3 (Sled et al., 1998); aligns the input volumes to the
Talairach-like ICBM-152-nl template (Collins et al., 1994); classiﬁes
the image into white matter, gray matter, cerebrospinal ﬂuid, and
background (Zijdenbos et al., 2002; Tohka et al., 2004); extracts the
white-matter and pial surfaces (Kim et al., 2005); and warps these to a
common surface template (Lyttelton et al., 2007). Cortical thickness
(CT) is measured in native space using the linked distance between the
two surfaces at 81,924 vertices. The thickness map was then blurred to
impose a normal distribution on the corticometric data, and to increase
the signal to noise ratio; a 30-millimeter full width at half maximum
surface-based diﬀusion smoothing kernel was used.
Quality control (QC) of the CIVET results was performed by two
independent reviewers. Data with artifacts due to motion, low signal to
noise ratio, hyperintensities from blood vessels, or poor placement of
the gray or white matter (GM and WM) surfaces for any reason were
excluded. 215 subjects with ASD were excluded in the QC.
2.3. Subjects
After image preprocessing and the QC, the number of ASD subjects
reduced from 532 to 317 from 16 diﬀerent sites. Next, we excluded
ASD subjects with missing ADOS total and module information and
then we included only subjects from sites containing at least 20
subjects. The remaining 156 subjects were from 4 diﬀerent sites
(NYU, PITT, TRINITY, USM) which were used for estimating severity
score. Details of the characteristics of the ABIDE samples used in this
work are presented in Table 1. The subject IDs of the included subjects
can be found in the supplement.
2.4. Severity score
This work studies the relation between cortical thickness and
measures derived from the Autism Diagnostic Observation Schedule2 http://fcon_1000.projects.nitrc.org/indi/abide/.
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(ADOS) (Lord et al., 2000). The ADOS is a semi-structured assessment
of communication, social interaction, and stereotypical behaviors for
individuals with autism or other pervasive developmental disorders.
The ADOS applies to individuals ranging from nonverbal to verbally
ﬂuent, and ranging from infants to adults. But diﬀerent ADOS modules
are utilized, depending on the individual's developmental and language
level, and the scores from diﬀerent modules are not directly compar-
able. In order to achieve comparability across modules, the ADOS
scores must be transformed to calibrated severity scores (Gotham et al.,
2009).
The ABIDE data provides the calibrated severity scores for some
but not all subjects; and for those without calibrated severity scores,
the information necessary to compute calibrated severity scores is also
missing. But a proxy calibrated severity score can be derived from the
available ADOS measures. A two-step procedure is used to derive the
calibrated severity scores: (i) a weighted sum of ADOS item scores is
computed, with the weights determined by Gotham et al. (2007); (ii)
the calibrated severity score is retrieved from a lookup table provided
by Gotham et al. (2009), which is indexed with the individual's age, the
ADOS module used, and the weighted sum from step (i). For those
cases in which ABIDE provides both the total of the social and
communication ADOS scores and the weighted sum of the ADOS item
scores, the diﬀerence between the two is small. We thus approximate
the calibrated severity scores by substituting the total of the social and
communication ADOS scores for the weighted sum of the ADOS item
scores in the ﬁrst step of the procedure. Our proxy of the calibrated
severity score is then arrived at by using the lookup table from Gotham
et al. (2009) together with the total of the social and communication
ADOS scores, the ADOS module used, and the individual's age. We
investigate the relation between cortical thickness and these proxy
calibrated severity scores. Note that one reason for transforming the
ADOS scores into calibrated severity scores is to remove eﬀects of the
subject demographics, such as age, thus making the calibrated severity
scores to more truly reﬂect the disease severity.
This proxy of the calibrated severity score is discussed in greater
detail in the supplementary material. There, for comparison, we also
report the experiments of cortical thickness based prediction of the
total of the social and communication ADOS scores, using the
information of which ADOS modules were used. Severity scores of
the included subjects can be found in the supplement.
2.5. Overview of methodology
The generic structure of the proposed method is illustrated in
Fig. 1. The method is divided into two main stages: 1) the domain
adaptation stage and 2) the learning stage. In the domain adaptation,
ﬁrst, the cortical thickness measures along cortex were divided into
separate regional subsets according to the Automated Anatomical
Labeling (AAL) atlas. Each regional subset contains only the vertices
belonging to one AAL cortical region. In order to reduce the between-
sites variability, we performed PLS based domain adaptation for each
subset separately (Section 2.6). This resulted in 78 region-speciﬁc site-
adapted subsets of cortical thickness components (Fig. 1A) with the
same, ﬁxed number of components (25) for each region, thus reducing
regional cortical thickness measures into 25 features per a region and a
subject. The domain adaptation was performed in an unsupervised
manner in all subjects before dividing data into training and test sets.
Note that we did not use the severity score (label information) or any
kind of cognitive information of the subjects in this stage and only the
site information was used as the response variable. This is termed
unsupervised domain adaptation, but since all the cortical thickness
data is used, the whole learning process becomes transductive that is
typical for domain adaptation algorithms (Gong et al., 2012). We stress
that the label information was not used so this does not lead to double-
dipping. For a clear explanation of this fact and the diﬀerences between
transductive and inductive machine learning algorithms, we refer to
Gammerman et al. (1998). It is important to note that the division of
the cortical thickness measures into regional subsets must be done
before the PLS-based domain adaptation stage as otherwise the PLS
components will not be regionally speciﬁc. Also, we need a large
enough number of subjects from each site to be able to recognize the
possible site-diﬀerences.
In the learning stage, ﬁrst, we applied SVR in each (site-adapted,
after domain adaptation) subset separately, with the severity score as
the response variable (Section 2.7). This resulted in 78 outputs, each of
them estimating the severity score based on only one AAL brain region.
In order to combine the results from diﬀerent brain regions, we
concatenated these 78 outputs from SVR to form a new dataset. The
resultant dataset has dimensionality 78, from 78 SVR outputs. Finally,
we applied elastic-net penalized linear regression on the new set to
obtain the ﬁnal estimated severity score (Fig. 1B; Section 2.8).
2.6. Partial Least squares domain adaptation
As our data are from 4 diﬀerent sites, our purpose is to identify a
feature space where the data from diﬀerent sites have similar distribu-
tions. We propose to achieve this by using Partial Least Squares (PLS)
in order to identify a new low dimensional feature space that would
only contain such cortical thickness information that is maximally
invariant between the acquisition sites. PLS is a linear feature
transformation method for modeling relations between sets of ob-
served variables. Similarly to principal component analysis (PCA), PLS
constructs new predictor variables, i.e., latent variables, as linear
combinations of the original predictor variables; regional cortical
thickness values in this case. The diﬀerence between PCA and PLS is
that PLS considers response variables, sites in our case, for construct-
ing latent variables while PCA considers only the predictor variables. In
particular, PLS tries to discover the relation between the predictor
variables X and response variables Y by determining the multidimen-
sional direction in the X space with the maximum multidimensional
variance direction in the Y space.
We denote a regional subset of the cortical thickness values by
X ∈ N D× , where N is the number of subjects and D is the number of
cortical thickness measures in the corresponding subset. D varied from
114 (olfactory cortices) to 2218 (middle frontal gyri). The same process
is applied to each of the 78 cortical regions; we drop the sub-section
index for clarity. The response variable representing the site informa-
Table 1
Subject demographics; The values are site-wise averages and the values in parentheses
provide standard deviations.
Site NYU PITT TRINITY USM
No. of subjects 72 20 23 41
Males/Females 61/11 17/3 23/0 41/0
Full Scale IQ 107.14
(16.64)
112 (13.51) 108.83
(15.23)
102 (17.05)
Range: 76–
148
Range: 86–
131
Range: 72–
135
Range: 65–
132
Verbal IQ 105.64
(16.53)
109.60
(12.56)
107.96
(14.45)
98.51 (19.20)
Range: 73–
139
Range: 89–
132
Range: 85–
135
Range: 55–
130
Performance IQ 107.58
(17.12)
111.05
(13.53)
107.36
(15.33)
105.15
(17.11)
Range: 72–
149
Range: 87–
128
Range: 63–
131
Range: 72–
133
Age 14.82 (7.09) 17.65 (5.84) 17.36 (3.63) 24.61 (8.05)
Range: 7–39 Range: 9–32 Range: 12–26 Range: 14–
50
ADOS total 11.25 (4.06) 11.75 (2.97) 10.57 (2.94) 13.22 (3.34)
Range: 5–22 Range: 7–18 Range: 7–17 Range: 6–21
Severity score 6.32 (2.13) 6.70 (1.56) 5.70 (1.82) 7.38 (1.56)
Range: 2–10 Range: 4–9 Range: 3–9 Range: 3–10
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tion is Y YY = { ,…, }N M1,1 , , where M is the number of sites. Yn m, is 1 if
subject n belongs to site m and otherwise it is 0. PLS assumes the
following relationships between X and Y:
X TP E Y UQ F= + , = + ,T T (1)
where the latent variables corresponding to X and Y are stored in T
and U matrices, respectively; P andQ are loading matrices and E and F
are error terms. In particular, the N K× matrix
T t t t t= [ * ,…, * ] = [ ,…, ]K N T1 1 , where K denotes the number of PLS
components, provides projections of cortical thickness values that we
are going to use to predict severity scores. The decompositions of X and
Y are computed by iterative application of the singular value decom-
position (SVD) (Abdi, 2007; de Leeuw, 2007) in such a way that in each
iteration the covariance between T and U is maximized. That is, in each
iteration, PLS tries to ﬁnd weight vectors w c,i i so that
cov cov covt u Xw Yc Xr Ys[ ( * , )] = [ ( , ) ] = max [ ( , )]r si i i i2 2 | |=| |=1 2 (2)
Fig. 1. Workﬂow of the proposed method for estimating severity score in ASD subjects. A) The PLS based domain adaptation stage and B) the learning stage.
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where cov Nt u t u( * , ) = * /Ti i i i is the covariance between latent variables
corresponding to the cortical thickness and the site information
(Rosipal and Krämer, 2006). For the computation of PLS, we use the
SIMPLS algorithm (De Jong, 1993) that yields cortical thickness
projections t*i directly as linear combinations Xwi and, importantly,
constraints any t*i and t*j to be orthogonal. The idea is that the ﬁrst few
t*i (i V< ) encode the site related information and then the later t*i
(i V≥ ) contain site invariant information; note that V may have the
value of 1. In this reasoning, we utilize the connection between the PLS
and the Fisher's discriminant analysis (Rosipal and Krämer, 2006). We
leave it to the machine learning algorithm to discard the ﬁrst
components that may be useless for the severity score prediction and
keep all the PLS components.
We note that PCA, but not PLS, has previously been used for
unsupervised domain adaptation as a baseline method for the applica-
tions of object recognition and sentiment analysis (Shi and Sha, 2012),
where all data from both source and target domain were projected into
PCA direction computed from the data in the target domain. In Shi and
Sha (2012) the model was trained on a data from the single source
domain and tested on data from the target domain while we consider
the multiple source domain adaptation.
We have additionally developed and tested an inductive version of
the algorithm which comes with certain disadvantages compared to the
transductive version. These and experimental results with the inductive
algorithm are discussed in the Section 4 of the supplement.
2.7. Support vector regression
After PLS analysis on each of the 78 regional subsets of cortical
thickness measures, we have 78 matrices T , ℓ = {1,…,78}ℓ of the site
adapted cortical thickness coeﬃcients corresponding to the 78 cortical
regions. To derive a prediction of the severity score based on a single
cortical region, we apply support vector regression (SVR). Again, the
process is done independently for each region and we drop indexes
pertaining to the regions for clarity.
Support vector machines (SVM) were ﬁrst introduced (Cortes and
Vapnik, 1995; Boser et al., 1992; Vapnik and Vapnik, 1998) as a
pattern recognition method representing decision boundary between
samples from two diﬀerent classes in such a way that the margin (the
distance) between the decision boundary and the closest training
sample to it is maximized. SVM transforms the training data from
the original space into a high dimensional feature space via a kernel-
induced mapping function, and then the separating hyperplane is
computed in this new feature space.
Support vector machines can also be applied to regression problems
when the response variable is a real-valued number, resulting in
support vector regression (SVR). To achieve the maximal margin
property in a regression problem, Vapnik (1995) proposed the ε-SVR
algorithm by devising the ε-insensitive loss function. In SVR, a speciﬁc
value is determined as ε in the loss function, after which the task is to
ﬁt a regression line surrounded by a tube with radius ε to the data. The
data points inside the tube are not considered in determining the
regression line and only the data points lying on the edges or outside
the tube, i.e. support vectors, aﬀect the course of the regression line.
SVR approximates a severity score by a nonlinear function de-
scribed by the weight vector lw and the bias lb so that
llseverity f ϕ bt w t≈ ( ) = ( ) + ,T (3)
where t is a vector of the regional site adapted cortical thickness (CT)
coeﬃcients for a subject, ϕ is a non-linear mapping and the response
variable is the corresponding severity score. SVR handles the non-
linearity via the kernel trick. A high (or inﬁnite) dimensional dot
product l ϕw t( )T can be computed as a sum of dot products implicitly
described in the input space with the original dimensionality
f w kt t t( ) = ∑ ( , )iN i i=1 , where k is the kernel function, ti are the site
adapted CT coeﬃcients for the training subject i and wi are the
parameters to be solved by the SVR algorithm. The kernel-trick makes
otherwise intractable computations feasible and ϕ and lw do not need to
be explicitly deﬁned. In this work, we adopted the radial basis function
kernel (RBF) k γx y x y( , ) = exp(− ∥ − ∥ )2 and set γ to its default value
K1/ , where K=25 is the number of PLS components. The RBF kernel is
the most widely used kernel function in nonlinear SVR. For solving the
SVR parameters lw b,i , we used ν-SVR (Schölkopf et al., 2000). This is a
re-parametrization of the original soft-margin ε-SVR algorithm (Cortes
and Vapnik, 1995) allowing automatic tuning of ϵ by introducing an
additional parameter ν (Smola and Schölkopf, 2004). The ν-SVR aims
to solve the following optimization problem:
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This allows for training errors exceeding ϵ by introducing slack
variables ξ ξ, *n n . The overﬁtting is prevented by the regularization term
l w w kw t t∥ ∥ = ∑ ∑ ( , )i j i j i j12 2 and the tradeoﬀ between the close ﬁt to
the data and regularization is controlled by the parameter C.
We re-iterate that the purpose of this step is to determine a
predictive severity score for each subject based on each cortical region.
This step was repeated for each brain region separately, which resulted
in 78 single scores for each subject, each of them predicting severity
score based on one cortical region.
2.8. Penalized linear regression
From the SVR, we have a predicted severity score
llz ϕ bw t= ( ) +i T i,ℓ ℓ ,ℓ ℓ for a subject i and region ℓ. For each subject i, we
concatenate the regional predictions into a 78-element vector zi. In
order to integrate the predicted severity scores derived from diﬀerent
brain regions, we used least squares linear regression (LR) with elastic
net penalty. The elastic net penalty is a combination of ridge and lasso
penalties (Zou and Hastie, 2005) that has two important advantages in
our case: 1) it allows for variable selection, meaning that the regions
with low predictability are dropped from the model and 2) it possesses
the grouping eﬀect meaning that the regions with similar predictions
receive similar weights in the ﬁnal model. These two properties
improve the interpretability and stability of the elastic-net penalized
models. The LR model is formalized as:
∑severity b a z ba z= + + ϵ = + + ϵ ,i T i i i i
ℓ=1
78
ℓ ,ℓ
(5)
where i refers to a subject, a aa = [ ,…, ]T1 78 and b are the model
parameters and ϵi is the error term. Adding the elastic net penalty,
the model is solved by minimizing the following elastic net cost
function:
∑
N
severity b λ α αz a a a12 ( − − ) + [(1 − )∥ ∥ /2 + ∥ ∥ ],i
N
i i
T
=1
2
22 1
(6)
where N is the number of training samples, λ is the complexity
parameter found by cross-validation, α ∈ [0, 1] deﬁnes the compromise
between ridge a∥ ∥ /222 and lasso penalties a∥ ∥1, and ∥·∥1 denotes the
L1-norm. Here, we selected α = 0.5 to give equal weights for the ridge
and lasso penalties.
2.9. Implementation and validation
It is imperative to avoid using the test subjects' severity scores for
training the model as this would result positively biased estimates of
the prediction accuracy. For dividing data into two training (SVR-
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training and SVR-test) and test sets, we used two nested and stratiﬁed
cross-validation loops (10-folds for each loop) except for site-based
testing where the outer loop was leave-one-site-out loop. In the inner
CV loop, the SVR-train set was used to train the SVRs and the SVR-test
set was used for constructing regional predictions zi,ℓ for every training
subject; we did not use the same dataset both for learning the SVR and
computing regional predictions to avoid over-ﬁtting. The training set
(union of SVR-training and SVR-test) was used to train the Elastic-net
regression model. We re-divided the training set into 10-folds for
ﬁnding the optimal λ for the model. Test data were used only for
evaluating the model. The performance of the model was then
evaluated based on the (cross-validated) Pearson correlation coeﬃcient
(R), mean absolute error (MAE) and the coeﬃcient of determination3
(Q2) between estimated and true severity score in test set. The reported
results are averages over 100 nested 10-fold CV runs in order to
minimize the eﬀect of the random variation. Three diﬀerent metrics are
reported, because these each provide complementary information.
Cross-validated R is simple to interpret, but it can hide the bias in
the predictions, which are made apparent by Q2-value. MAE provides
the prediction errors in the equal scale with the original scale of the
severity scores. Prior to each step, both the predictor variables and
response variable were normalized to have zero mean and unit
variance, except in domain adaptation step in which the data are
centralized/normalized by default. To compare the performance of two
learning algorithms, we computed a p-value for the 100 correlation
scores with a permutation test. For computing p-values associated with
the null hypothesis that the correlation coeﬃcient between the
observed and predicted values is zero, we used a permutation test
(Anderson and Robinson, 2001) and for computing the 95% conﬁdence
interval of the correlation coeﬃcient we used bootstrap on the run with
the median correlation score across 100 cross-validation iterations.
PLS was computed by the PLSREGRESS functions in MATLAB
software with a ﬁxed number of components. The SVR training was
implemented using LIBSVM (Chang and Lin, 2011). The parameters in
SVR, namely C (the soft margin parameter) and γ (parameter for RBF
kernel function), were set to their default values
C ν γ F( = 1, = 0.5, = 1/ , where F is the number of features here
equaling to K=25). Since the cortical thickness measures were divided
into 78 subsets and both PLS and SVR were computed in each subset
separately, tuning the method parameters, inside a nested cross-
validation loop, was impractical. Therefore, we used ﬁxed number of
components in PLS and the default parameters of the SVR across all
subsets. The ﬁxed number of PLS components in the proposed method
was 25, selected by initial experiments among the candidate set
{5, 10, 15, 20, 25, 30}.
The implementation of elastic-net penalized linear regression was
done by using the GLMNET library (Qian et al., 2013) and the
regularization parameter λ was selected using 10-folds CV in the
training data. Note that the penalized LR was done only once in the
outputs of SVR from diﬀerent brain regions and hence tuning the
regularization parameter using CV was easily feasible.
3. Results
The average cross-validated correlation R between the estimated
and observed severity scores among 100 distinct 10-fold CV iterations
was 0.51 (standard deviation 0.04, range from 0.39 to 0.63,
p < 0.0001), the average mean absolute error (MAE) was 1.36 (stan-
dard deviation 0.05, range from 1.25 to 1.51) and the average
coeﬃcient of determination Q2 was 0.26 (standard deviation 0.045,
range from 0.13 to 0.39). These values indicated that the proposed
approach was able to provide information about the severity of the
disease based on structural information of the brain in ASD patients.
Particularly, we note that the union of 95% conﬁdence intervals (CIs) of
R for individual runs was [0.25, 0.72], where CIs were computed based
on the Fisher's r-to-Z transform, and the lower limit of the worst 95%
CI of R was clearly positive. The box-plots of the correlation scores and
MAEs are available in Fig. 2 and the scatter plot of the estimated and
observed severity scores of the CV run with the median R is shown in
the upper left panel of Fig. 3. We note that validation accuracy was
almost the same (the average R was 0.49 or 0.50 depending on whether
module information was used) when predicting raw ADOS scores
instead of the proxy severity scores. The validation results concerning
the prediction of the raw ADOS scores are presented in the
Supplementary Figs. 2–4.
For evaluation of the eﬀectiveness of each stage (PLS, SVR, Elastic-
net LR) of the proposed approach, we performed experiments by
excluding each stage of the method separately and comparing the
accuracy of the predictions obtained this way to the accuracy of the
predictions of the complete method.
To evaluate the PLS based domain adaptation stage, we repeated
the experiments with the same procedure, except that we replaced PLS
by PCA which can be thought as an unsupervised dimensionality
reduction method equivalent to PLS but not utilizing the information
about the acquisition site. In other words, by using PCA, a common
feature space was determined for all data from diﬀerent sites without
considering the site information. The PCA was applied in the trans-
ductive setting as the optimal number of PCA components used (20)
was selected with the same procedure as the number of PLS compo-
nents (see Section 2.9). When the PLS-based domain adaptation was
substituted by PCA, the average correlation score (among 100 diﬀerent
runs) dropped from 0.51 to 0.42 (p < 0.0001 for correlation decrease),
the average MAE increased from 1.36 to 1.45 and the average Q2
dropped from 0.26 to 0.17. Since both PCA and PLS project data into a
new feature space, we omitted this feature transformation step to see
the eﬀect of image acquisition diﬀerences between sites on the
performance of the model. When the feature transformation step was
omitted, the average correlation score (only 5 CV runs were done)
decreased to 0.16, the average MAE increased to 1.65 and the average
Q2 dropped to −0.07. Thus, the feature transformations were useful.
To validate the SVR step, we performed two experiments. First, we
estimated severity score by applying elastic-net penalized regression
directly on the site adapted thickness values, i.e., retaining PLS-based
domain adaptation step but performing it to the 81,924 thickness
values without dividing them to regional subsets and not performing
the nonlinear SVR (PLS+LR (whole brain)). By eliminating the SVR
step, the average correlation score decreased to 0.17 (p < 0.0001 for the
correlation decrease), the average MAE increased to 1.56 and the
average Q2 decreased to 0.03. Second, we averaged the cortical
thickness values within each AAL region, performed the PLS based
domain adaptation on these 78 regional mean cortical thickness
measures and used the Elastic net penalized LR to predict severity
scores based on the resulting PLS components (PLS + LR (regional
mean CT)). The average correlation score decreased to 0.20, the MAE
increased to 1.55 and the Q2 decreased to 0.04. Again, the optimal
number of the PLS components (5) was selected by the same procedure
as for the complete method (see Section 2.9). We also repeated the
experiments (only 5 CV runs were done) by omitting the PLS step and
applying elastic net penalized LR on regional mean of cortical thickness
to predict severity scores. This experiment yielded the average correla-
tion score of 0.05, the average MAE of 1.60 and the average Q2 of −0.02
and it appeared that the severity cannot be estimated based on the
regional mean of cortical thickness values.
3 The Q2 provides a measure of how well out-of-training set severity scores are
predictable by the learned model (http://scikit-learn.org/stable/modules/model_
evaluation.html#regression-metrics). It is deﬁned as
l
Q = 1 − i
N si si
i
N si s
2 ∑ =1( − )2
∑ =1( − )2
, where lsi is
the predicted severity score for subject i, si is the true severity score for subject i, and s is
mean of the actual/true severity scores. Q2 is bounded above by 1 but is not bounded
from below. Note that Q2 does not equal R2, i.e., the correlation squared, but the Q2 value
can never exceed R2. More details about diﬀerent metrics and their relations are available
in the supplement (Section 6).
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Fig. 2 shows box plots for the R andMAE for diﬀerent experiments
across 100 computation runs. It can be observed that the regional SVR
had the largest eﬀect on the performance of the method. The
performance of the method was not good when excluding this step
despite that PLS based domain adaptation was used. Fig. 2 also
illustrates that the PLS based domain adaptation step led to markedly
improved predictions when coupled with the regional SVR. Fig. 3
shows the scatter plot between estimated and observed severity scores
Fig. 2. Box plots for correlation score and mean absolute error within the 100 computation runs of the proposed approach (PLS+SVR+LR), substituting PLS based domain adaptation
by PCA (PCA+SVR+LR) and without the SVR step (PLS+LR). PLS+LR (whole brain) refers to the approach where all 81,924 vertices were used as the input to PLS stage and PLS+LR
(regional mean CT) refers to the approach where the regionally averaged thickness values were used as the input for the PLS; see the text for details. On each box, the central mark is the
median, the edges of the box are the 25th and 75th percentiles, the whiskers extend to the most extreme data points not considered outliers, and outliers are plotted with a +.
Fig. 3. Scatter plots of the estimated severity score vs. observed severity score for the proposed method (PLS+SVR+LR), without PLS based domain adaptation (PCA+SVR+LR), and
without the SVR step (PLS+LR). See the text and Fig. 2 for details. The scatter plots are from a cross-validation run with the median correlation within 100 cross-validation runs. In the
panel corresponding to PLS+SVR+LR, data corresponding to female subjects is shown in red color in order to ensure that they did not act as outliers. (For interpretation of the references
to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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(of the median correlation within 100 computation times). According
to these plots, the severity scores with very high or very low values were
the most diﬃcult to estimate as most of the observed severity scores
were located within the range from 4 to 9. Also, as shown in the upper
left panel of Fig. 3, the few females in the sample did not act as outliers.
Fig. 4 illustrates the eﬀect of age on the estimated severity scores for
the proposed approach. As it can be seen in Fig. 4, there is no eﬀect of
age on the residuals and there is no signiﬁcant diﬀerence within the
residuals of diﬀerent sites. The results of an experiment performed
with a more narrow age range are reported in Section 5 of the
supplement.
Fig. 5 shows the importance of top 24 brain regions identiﬁed by
average magnitude of the regression coeﬃcients in the penalized LR,
i.e., the ﬁnal step of the proposed approach, within 100 computation
times of 10 fold CV. The visualization of these regions is provided in
Fig. 6. Since we standardized the data before applying LR, the absolute
value of each regression coeﬃcient provides the importance of corre-
sponding predictor in the model and therefore we could compute the
importance of each brain region based on the magnitude of the
regression coeﬃcients.
We studied the eﬀect of acquisition site on the performance of the
proposed method. To address this issue, a “site-wise” cross-validation
analysis was performed. To be more speciﬁc, a 4-fold leave-one-site-out
CV was performed in such a way that the data from each site was in its
own fold and the method was trained using data from 3 sites and tested
in the remaining site. The results are listed in the Table 2. Fig. 7 shows
the scatter plot between estimated and observed severity scores (of the
median correlation within 100 computation times) for each site. The
prediction accuracy of the site PITT was comparable with that of the
standard 10 fold CV, but the prediction accuracy in the other sites
decreased markedly from that of the standard 10 fold CV. These results
suggest that utilizing some samples from the same site as the test
sample in the learning procedure might improve notably the prediction
accuracy. One possible explanation for this result is obviously the
decreased number of training subjects available for the method
training, especially in the case of NYU and USM sites, which contained
the largest number of subjects (NYU 72 of 156 subjects and USM 41 of
156 subjects, see Table 1). Also, Q2 scores for TRINITY and USM sites
were strongly negative indicating that the severity scores predicted
from the data of the other sites were biased. One reason for the bias can
be explained when examining the average observed severity scores
from each site (NYU: 6.3; PITT: 6.7; TRINITY: 5.7; USM: 7.4). The
average severity score of TRINITY was lower than the average of the
other sites and the average severity score of USM was higher than the
average of the other sites while the penalized regression creates
shrinkage towards the average severity score (see Zou and Hastie
(2005)) and thus could produce biased severity predictions for the two
sites. We note that the domain adaptation method of this article cannot
correct for possible site diﬀerences in administering the ADOS tests as
it is blind to severity scores.
We experimented with the method by training and testing with
single site data, that is, we trained four diﬀerent prediction models and
tested them with the data from the same site in the nested cross-
validation framework. The average cross-validated correlation R within
ten 10-fold CV runs was the largest for the site USM (average
correlation score R(USM) was 0.22) and for the three other sites the
average correlation score was close to or below zero
R NYU R PITT R TRINITTY( ( ) = −0.05, ( ) = 0.01, ( ) = −0.28).These results
clearly suggested the utility of having a larger number of subjects at the
expense of having to deal with multi-site data. We still point out that
the variance of cross-validated performance measures was inﬂated due
to small sample sizes and the sample sizes for PITT and TRINITY are
too small for adequate error estimation. In particular, the clearly
negative R for the site TRINITY, with the smallest sample size, could be
attributed to the small sample size that, for example, considerably
decreased the stability of the inner CV and led to the selection of poor
models.
Since certain cognitive functions are lateralized (Hugdahl, 2005),
we performed the experiments within right and left hemispheres
separately to study the relative relevance of each hemisphere in
estimating the severity score. The scatter plots resulting from this
experiment are shown in Fig. 8. The experiment pointed to greater
relevance of right hemisphere in estimating the severity score com-
pared to left hemisphere. Using only the cortical thickness measures
belonging to the right hemisphere yielded the average correlation score
of 0.46, the average MAE of 1.41 and the average Q2 of 0.20. The
measures in the left hemisphere produced signiﬁcantly lower average
correlation score of 0.28 p( < 0.0001), the average MAE of 1.53 and the
average Q2 of 0.05. These results support the ﬁndings of Torgerson
et al. (2015) that indicated higher relevance of regions and connections
of the right hemisphere compared to the left hemisphere in predicting
ASD severity based on ADOS score. While using cortical thickness
measurements from only the right hemisphere led to accurate severity
score estimates, combining cortical thickness measurements from both
right and left hemispheres still led to a better performance
(p < 0.0001). This can be also seen in Fig. 5 where among the most
important brain regions for the model there are regions from both
hemispheres, although, the best predictors were located in the right
hemisphere.
In order to demonstrate the suitability of SVR (with an RBF kernel)
for designing regional models in the proposed approach, we replaced it
with diﬀerent linear models (elastic net LR, relevance vector regression
(RVR) and SVR with linear kernel) for predicting severity scores.
Replacing the non-linear SVR with the linear alternatives led to a
marked performance decrease. The correlation score averaged over 10
CV runs dropped to 0.32 when using linear SVR, 0.28 when using
linear RVR and 0.13 when using elastic net LR. The elastic net LR was
selected as the learner for the last step to obtain a model that is easy to
interpret and we did not test other learners for this stage. As explained
in Section 2.8, the elastic net LR provides spatially sparse model by
simultaneously performing variable selection and model estimation
and, furthermore, it possesses so called grouping eﬀect meaning that
correlated predictors are selected simultaneously (Zou and Hastie,
2005).
4. Discussion
The objective of the current study was to devise methods to
overcome the issues associated with multi-site, multi-protocol data in
order to take advantage of the increased sample sizes provided by such
agglomerative data to better predict behavioral outcomes from brain
structure. We explored this problem using data from four sites from the
ABIDE dataset, and used cortical thickness to predict ADOS-based ASD
Fig. 4. Scatter plot of prediction residual vs. age for the proposed method (PLS+SVR
+LR) with a cross-validation run with the median correlation score within 100
computation runs. A ﬁtted line is added for the residuals of each site. There was no
signiﬁcant diﬀerence within the slopes of ﬁtted lines (p > 0.5) and the slopes of all ﬁtted
lines are non-signiﬁcant (p > 0.5). Female subjects are plotted with a diﬀerent color than
the male subjects, however, the regression lines were ﬁtted considering both genders
together.
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Fig. 5. The importance of the top predictors for estimating severity score in ASD subjects. The ranking is based on the average magnitude of standardized regression coeﬃcients across
100 cross-validation runs. The gray bars display the average magnitude and the error bars (in black) of the length equal to twice the standard deviation of the magnitude. Predictors with
the average magnitude higher than 0.03 are included. For the importance of other regional predictors, see Fig. 6.
Fig. 6. The importance of each cortical region in the estimation of severity score using the proposed approach. The importances are the average magnitudes of the standardized
regression coeﬃcients from the Elastic-net penalized regression across 100 cross validation runs.
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symptom severity. We developed a novel two-stage approach consisting
of a domain adaptation stage that uses partial least squares regression
with site as a response variable, and a learning stage which utilizes a
combination of support vector regression and linear regression. We
evaluated the reliability of the method by comparison with variations
without domain adaptation, or without support vector regression. The
proposed two-stage method performed markedly better than the
alternatives, and resulted in a cross-validated correlation score that
was much higher than for any of the sites alone, and considerably
higher than has previously been reported in the literature for multisite
data (Sato et al., 2013).
Recent studies on multisite classiﬁcation of autism using ABIDE
data have shown poor accuracy in classiﬁcation of ASD versus TD
subjects (Nielsen et al., 2013; Haar et al., 2016). The study by Nielsen
et al. (2013) showed that classiﬁcation rate was much lower in a
multisite dataset than for single site data. The eﬀect of scanner
variation in multisite analyses of cortical thickness abnormalities in
ASD patients was also studied by Auzias et al. (2014, 2016). They
showed that scanner variation is a signiﬁcant confounding factor,
which is distributed across the cortical surface and reaches its peaks
in the frontal region. Thus, the eﬀect of acquisition site on the basic
image properties might be a possible reason for the poor classiﬁcation
accuracy in the studies by Nielsen et al. (2013) and Haar et al. (2016),
as well as for the inconsistencies on the reported results from diﬀerent
studies, especially in the context of abnormalities in cortical thickness
measurements (Raznahan et al., 2013; Hadjikhani et al., 2006).
In the current study, we used PLS based domain adaptation in
order to maximize the consistency of the imaging measures over the
multiple scanners/protocols before assessing ASD pathology. Unlike
previous approaches, such as PCA, in which site/scanner are treated as
any other nuisance variable, the PLS based domain adaptation
established a feature space where the data from multiple sites/scanners
have similar distributions. Accommodating multiple sites/scanners in
such a way resulted in signiﬁcantly improved performance (Figs. 2 and
3), indicating the power of our PLS based domain adaptation approach
for dealing with multi-site data. While our domain adaptation method
can correct for diﬀerences in imaging data between sites, it cannot
correct for possible site diﬀerences in administering the ADOS tests
(due to inter-examiner diﬀerences in the administration and scoring of
the tests) as it is blind to severity scores. Also, the domain adaptation
method searches for consistent data projections across sites and tries to
divide the thickness data in the orthogonal site-speciﬁc and site
Table 2
The results of “site-wise” based cross-validation. The reported results are the averages
across 100 10-fold cross-validation runs.
Site Correlation MAE Q2
NYU 0.22 1.57 −0.04
PITT 0.56 1.08 0.22
TRINITY 0.15 1.59 −0.25
USM 0.24 1.44 −0.29
Fig. 7. Scatter plots of the estimated severity score vs. observed severity score for the proposed method for each site separately. The scatter plot for diﬀerent sites are from a cross-
validation run with the median correlation within 100 computation times.
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independent components. Therefore, it has no control what is the cause
for the site-speciﬁcity of the data later left out by the SVR (scanner
diﬀerences, diﬀerent subject characteristics, or interactions of the two,
which are all characteristic to neuroimaging data agglomeration
eﬀorts). The method needs a certain number of subjects for each site
and we have no clear answer what this number should be. We also
hypothesize that the necessary number of subjects per site increases
with the number of diﬀerent sites, as the site adaptation problem
becomes harder as more sites need to be accommodated in a common
feature space. More speciﬁcally, the complexity of the PLS based
domain adaptation step increases when more sites are added due to
the increase of the dimensionality of the response variable. Including
those 4 sites which had at least 20 ASD subjects with severity scores
available led to promising results in this study and the requirement of
having this number of subjects per site does not limit the foreseeable
applications of the method.
The subjects ranged in age from 8 to 40 years, and the age is known
to inﬂuence cortical thickness in ASD (Doyle-Thomas et al., 2013).
Note that while the age inﬂuences cortical thickness, it can be assumed
independent of the severity score due to the calibration, and, therefore,
it acts as a source of nuisance variability for the prediction (similarly to
so called suppressor variables in the ordinary linear regression
(Friedman and Wall, 2005)). Therefore, the age eﬀects on cortical
thickness do not artiﬁcially increase the cross validated performance
measures, but accounting for them could improve the predictions and
we tried to incorporate age information in the learning process, in
order to improve disease severity predictions. However, the experi-
ments with multiple methods were unsuccessful with the best results
reached by including the subject age in the domain adaptation step so
that the response variable in PLS was constructed based on subjects
site and age information. However, by doing this the performance of
the model dropped considerably (cross-validated R was 0.44), techni-
cally probably due to increase of the complexity of the domain
adaptation. Linearly regressing out the age information, that is a
widely used in dementia related machine learning applications
(Klöppel et al., 2015) and has often improved the predictions (Tohka
et al., 2016), did not work here (R was 0.42 when the age was regressed
out vertex wise before the domain adaptation step and R was 0.30
when the age was regressed out component-wise after the domain
adaptation). We speculate that these results are due to 1) less
pronounced age related cortical thickness changes in autistic subjects
than those of normal controls (Doyle-Thomas et al., 2013); 2) strong
variation in the age related change according to the disease severity,
which undermines the suitability of severity score independent age
corrections; and 3) since the age is one of the probable sources of the
data heterogeneity, possibly projecting the data in the new space
manages to separate some of age eﬀects into their own components
aiding machine learning algorithm to handle the nuisance variability
caused by age. Finally, results with the data set with a more restricted
age range are reported in the supplement (Section 5) suggesting that,
for our method, it is more important to have a larger number of
training subjects than to try to balance the subject demographics across
the sites.
Haar et al. (2016) suggested that their poor decoding accuracy for
classiﬁcation of multisite ABIDE data was not only because of between-
site variation, but also weak anatomical abnormalities in the ASD
pathology which oﬀer very limited diagnostic value. Substantial
variability within each diagnostic group complicates classiﬁcation,
hence our decision to predict symptom severity from neuroimaging
measures. The prediction of raw ADOS scores based on MRI and
cortical thickness was previously investigated by Sato et al. (2013).
They predicted ADOS from MRI based inter-regional thickness corre-
lations with SVR as the machine learning method. The method yielded
a cross-validated Spearman correlation of 0.36 with a dataset consist-
ing of MRIs of 82 autistic patients acquired at three diﬀerent sites with
a standardized protocol. To compare our results to theirs, we calculated
the cross-validated Spearman correlation between the estimated and
observed severity scores, which was 0.51. The higher correlation value
that we obtained must be understood in the context of the following
diﬀerences between our study and that performed by Sato et al. (2013).
First, our data are from 4 diﬀerent sites without any standardization
protocol, so the between-site variation was an additional challenge in
the current work. Second, Sato et al. (2013) used inter-regional
thickness correlation for estimation ADOS score, instead, we deter-
mined a predictive score for each distinct brain region and then
combined them via a linear regression model to estimate severity
score. Third, we used severity score instead of using raw ADOS score.
Lastly, our method was evaluated with almost double the sample size
(156 subjects).
In addition to the PLS-based domain adaptation, the other novel
technical characteristic of the proposed method was our treatment of
the whole-brain problem of prediction as a set of regional problems of
prediction. We divided the cortical thickness measures into regional
subsets, determined a predictive score for each region separately, and
Fig. 8. Scatter plots of the estimated severity score vs. observed severity score for the proposed method for each brain hemisphere separately. The scatter plots are from a cross-
validation run with the median correlation within 100 computation times.
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then combined the regional scores into a whole brain measure of
disease severity. This enabled us to divide the problem into several sub-
problems with lower complexity while better retaining the original
spatial resolution of the thickness measures. We hypothesized that
both of these properties are important for successful predictions:
Khundrakpam et al. (2015) have previously demonstrated that a ﬁne
parcellation of the cortical thickness measures was advantageous for
age estimation within healthy children. However, increasing spatial
resolution results in higher dimensionality, which increases the com-
plexity of the model. Speciﬁcally, in the domain adaptation stage,
ﬁnding a low dimensional site-independent representation for the high
dimensional data (81,924 cortical thickness measures) is considerably
more challenging than is the problem for any regional subset.
Moreover, the regional predictions are themselves of value, provid-
ing insight into which brain regions are related to a particular behavior,
and how strongly the measures in those regions predict that behavior.
Here we have shown that cortical thickness predicts autism symptom
severity in a number of regions, and have ranked the strongest
predictors. Each of these predictor regions has been associated with
autism in previous research, but the much larger sample size provided
by the ABIDE data lends conﬁdence to these ﬁndings. As expected
based on existing literature and given that problems with communica-
tion are part of the deﬁnition of ASD, a number of the strongest
predictors are related to language: the left pars triangularis, rolandic
operculum, superior temporal gyrus, and angular gyrus. The left pars
triangularis is part of Broca's area, which is critical for language
production, and has been implicated in autism in numerous studies
(Just et al., 2004; Zielinski et al., 2014; Lewis et al., 2014). The left
rolandic operculum is involved in the production of prosody, a lack of
which is one of the hallmarks of autistic speech, as well the perception
of prosody, and shows abnormal levels of activiation in ASD (Paul
et al., 2005; Gebauer et al., 2014). The superior temporal gyrus also
does acoustic processing important for language, as well as housing
Wernicke's area, a core area for receptive language ability, and is
consistently reported to show abnormalities in ASD (Lewis et al., 2014;
Zilbovicius et al., 2000; Bigler et al., 2007). The angular gyrus has also
been shown to be important for language (Binder et al., 1997), and to
exhibit abnormalities in ASD (Just et al., 2004). Issues with social
interaction is also a core feature of ASD. The superior temporal gyrus is
also involved in non-language social cognition (Adolphs, 2001), as well
as the adjacent superior temporal sulcus (Allison et al., 2000); both
have been implicated in this domain in ASD (Di Martino et al., 2009;
Zilbovicius et al., 2006; Redcay, 2008). The bilateral intraparietal sulci
are also involved in social cognition. They are considered part of the
mirror neuron system (Rizzolatti and Fabbri-Destro, 2010), and play a
role in interpreting the intentions of the actions of others (Hamilton
and Grafton, 2006). Another core aspect of social cognition is social
orienting/joint attention, which has been argued to be defective in ASD
(Mundy et al., 1990; Dawson et al., 2004). These aspects of social
cognition have been linked to the anterior cingulate cortex and to
dorsal medial frontal cortex, both of which show abnormalities in ASD
(Mundy et al., 2009; Mundy, 2003). The third part of the ASD
deﬁnition involves repetitive patterns of behavior, exempliﬁed by
stereotypic body movements such as hand-ﬂapping. Such repetitive
behaviors have been suggested to relate to basal ganglia dysfunction in
the inhibition of supplementary motor and motor areas (Mink, 1996).
In addition to these core behavioral abnormalities, motor and
sensory processing abnormalities are pervasive in children and adults
with autism (Smith, 2004; Marco et al., 2011; Leekam et al., 2007).
Individuals with autism exhibit a range of motor abnormalities (Smith,
2004), and both hypo- and hyper-sensitivity to visual, auditory, and
tactile inputs (Leekam et al., 2007). In this respect, it is interesting to
note that some of the strongest predictors seen here are in regions
associated with low level processing of motor, visual, auditory, and
tactile inputs. Abnormalities in motor behaviors in ASD are associated
with abnormalities in motor and supplementary motor cortex
(Mostofsky et al., 2007). Visual processing involves the striate cortex
within the calcarine ﬁssure, and the surrounding cortex, including the
cuneus, the caudal portion of the precuneus, and the lingual gyrus.
Findings of abnormalities in visual cortex in ASD are common
(Barbeau et al., 2015; Samson et al., 2012; Philip et al., 2012; Green
et al., 2013). Auditory processing involves Heschl's gyrus and the
surrounding cortex within the superior temporal gyrus. Individuals
with ASD have been reported to show abnormalities in these areas
(O'Connor, 2012; Samson et al., 2011; Green et al., 2013). Tactile
processing involves the postcentral gyrus, which also exhibits abnorm-
alities in individuals with ASD (Rumsey et al., 1985; Horwitz et al.,
1988; Kaiser et al., 2015).
A possible limitation of the study is that the severity scores that we
aim to predict are integer valued with a limited range (as can be
observed in Fig. 3) and therefore the continuity assumption made in
the regression models might not be correct. A possible solution would
be the use of the methods for ordinal regression, where the response
variables are treated as ordered categories and not as continuous
variables (Bender and Grouven, 1997; Chu and Keerthi, 2007).
However, since the severity scores also carry metric information
(Gotham et al., 2009), not used in the ordinal regression,it is unclear
if ordinal regression models would be suitable for the task.
It bears repeating that the methods described here for research with
multi-site, multi-protocol data are applicable to any such data. The
results here served to demonstrate the validity of the methods, and
their use in identifying and ranking regional brain measures as
predictors of behavior. But the brain measures need not be cortical
thickness, and the predicted behavioral measures need not be the
severity of symptoms of ASD.
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